10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

OR

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number 001-39443

NETSTREIT Corp.

(Exact name of registrant as specified in its charter)

Maryland			84-3356606
(State or other jurisdiction of			(I.R.S. Employer
incorporation or organization)			Identification No.)
2021 McKinney Avenue Suite 1150
Dallas, Texas			75201
(Address of principal executive offices)			(Zip Code)
	(972) 200-7100
	(Registrant’s telephone number, including area code)
	Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class		Trading Symbol(s)	Name of Each Exchange on Which Registered
Common stock, par value $0.01 per share		NTST	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of the issuer’s common stock, par value $0.01, outstanding as of April 26, 2024 was 73,366,371.

NETSTREIT CORP. AND SUBSIDIARIES

TABLE OF CONTENTS

		Page
	PART I — FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023	3
	Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three Months Ended March 31, 2024 and 2023	4
	Condensed Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2024 and 2023	5
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023	6
	Notes to the Condensed Consolidated Financial Statements	7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	38
Item 4.	Controls and Procedures	38
	PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	40
Item 1A.	Risk Factors	40
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	40
Item 3.	Defaults Upon Senior Securities	40
Item 4.	Mine Safety Disclosures	40
Item 5.	Other Information	40
Item 6.	Exhibits	41
	Signatures	42

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

	March 31, 2024		December 31, 2023
Assets
Real estate, at cost:
Land	$	472,330	$	460,896
Buildings and improvements	1,209,333		1,149,809
Total real estate, at cost	1,681,663		1,610,705
Less accumulated depreciation	(110,632)		(101,210)
Property under development	21,800		29,198
Real estate held for investment, net	1,592,831		1,538,693
Assets held for sale	58,856		52,451
Mortgage loans receivable, net	124,617		114,472
Cash, cash equivalents and restricted cash	22,334		29,929
Lease intangible assets, net	165,507		161,354
Other assets, net	61,402		49,337
Total assets	$	2,025,547	$	1,946,236
Liabilities and equity
Liabilities:
Term loans, net	$	621,500	$	521,912
Revolving credit facility	75,000		80,000
Mortgage note payable, net	7,876		7,883
Lease intangible liabilities, net	24,639		25,353
Liabilities related to assets held for sale	1,110		1,158
Accounts payable, accrued expenses and other liabilities	26,265		36,498
Total liabilities	756,390		672,804
Commitments and contingencies (Note 12)
Equity:
Stockholders’ equity
Common stock, $0.01 par value, 400,000,000 shares authorized; 73,328,411 and 73,207,080 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	733		732
Additional paid-in capital	1,368,312		1,367,505
Distributions in excess of retained earnings	(126,270)		(112,276)
Accumulated other comprehensive income	18,020		8,943
Total stockholders’ equity	1,260,795		1,264,904
Noncontrolling interests	8,362		8,528
Total equity	1,269,157		1,273,432
Total liabilities and equity	$	2,025,547	$	1,946,236

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except share and per share data)

(Unaudited)

	Three Months Ended March 31,
	2024		2023
Revenues
Rental revenue (including reimbursable)	$	35,189	$	28,474
Interest income on loans receivable	2,484		978
Total revenues	37,673		29,452
Operating expenses
Property	4,102		3,936
General and administrative	5,707		4,909
Depreciation and amortization	17,541		14,949
Provisions for impairment	3,662		—
Transaction costs	129		109
Total operating expenses	31,141		23,903
Other (expense) income
Interest expense, net	(6,180)		(3,944)
Gain (loss) on sales of real estate, net	997		(319)
Other (expense) income, net	(280)		152
Total other (expense) income, net	(5,463)		(4,111)
Net income before income taxes	1,069		1,438
Income tax (expense) benefit	(17)		43
Net income	1,052		1,481
Net income attributable to noncontrolling interests	7		9
Net income attributable to common stockholders	$	1,045	$	1,472
Amounts available to common stockholders per common share:
Basic	$	0.01	$	0.03
Diluted	$	0.01	$	0.03
Weighted average common shares:
Basic	73,248,804		58,155,738
Diluted	74,565,790		58,883,386
Other comprehensive income:
Net income	$	1,052	$	1,481
Change in value on derivatives, net	9,128		(5,979)
Total comprehensive income (loss)	10,180		(4,498)
Comprehensive income (loss) attributable to noncontrolling interests	58		(40)
Comprehensive income (loss) attributable to common stockholders	$	10,122	$	(4,458)

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands, except share data)

(Unaudited)

	Common stock
	Shares	Par Value		Additional Paid-in Capital		Distributions in Excess of Retained Earnings		Accumulated Other Comprehensive Income		Total Stockholders’ Equity		Noncontrolling Interests		Total Equity
Balance at December 31, 2023	73,207,080	$	732	$	1,367,505	$	(112,276)	$	8,943	$	1,264,904	$	8,528	$	1,273,432
OP Units converted to common stock	7,119	—		126		—		—		126		(126)		—
Dividends and distributions declared on common stock and OP units	—	—		—		(15,031)		—		(15,031)		(98)		(15,129)
Dividends declared on restricted stock, net	—	—		—		(143)		—		(143)		—		(143)
Vesting of restricted stock units	176,197	2		(2)		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(61,985)	(1)		(1,068)		—		—		(1,069)		—		(1,069)
Stock-based compensation, net	—	—		1,751		135				1,886		—		1,886
Other comprehensive income	—	—		—		—		9,077		9,077		51		9,128
Net income	—	—		—		1,045		—		1,045		7		1,052
Balance at March 31, 2024	73,328,411	$	733	$	1,368,312	$	(126,270)	$	18,020	$	1,260,795	$	8,362	$	1,269,157

	Common stock
	Shares	Par Value		Additional Paid-in Capital		Distributions in Excess of Retained Earnings		Accumulated Other Comprehensive Income		Total Stockholders’ Equity		Noncontrolling Interests		Total Equity
Balance at December 31, 2022	58,031,879	$	580	$	1,091,514	$	(66,937)	$	23,673	$	1,048,830	$	9,593	$	1,058,423
Issuance of common stock in public offerings, net of issuance costs	2,759,481	28		52,875		—		—		52,903		—		52,903
OP Units converted to common stock	5,694	—		105		—		—		105		(105)		—
Dividends and distributions declared on common stock and OP units	—	—		—		(11,650)		—		(11,650)		(101)		(11,751)
Dividends declared on restricted stock, net	—	—		—		(122)		—		(122)		—		(122)
Vesting of restricted stock units	83,428	1		(1)		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(18,016)	—		(360)		—		—		(360)		—		(360)
Stock-based compensation, net	—	—		1,027		—				1,027		—		1,027
Other comprehensive loss	—	—		—		—		(5,930)		(5,930)		(49)		(5,979)
Net income	—	—		—		1,472		—		1,472		9		1,481
Balance at March 31, 2023	60,862,466	$	609	$	1,145,160	$	(77,237)	$	17,743	$	1,086,275	$	9,347	$	1,095,622

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2024		2023
Cash flows from operating activities
Net income	$	1,052	$	1,481
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	17,541		14,949
Amortization of deferred financing costs	558		308
Amortization of above/below-market assumed debt	29		29
Noncash revenue adjustments	(583)		(509)
Amortization of deferred gains on interest rate swaps	(979)		—
Stock-based compensation expense	1,751		1,027
(Gain) loss on sales of real estate, net	(997)		319
Provisions for impairment	3,662		—
Loss (gain) on involuntary conversion of buildings and improvements	414		(12)
Changes in assets and liabilities, net of assets acquired and liabilities assumed:
Other assets, net	(4,015)		(1,845)
Accounts payable, accrued expenses and other liabilities	(6,782)		(441)
Lease incentive payments	—		(500)
Net cash provided by operating activities	11,651		14,806
Cash flows from investing activities
Acquisitions of real estate	(95,153)		(67,717)
Real estate development and improvements	(12,281)		(2,480)
Investment in mortgage loans receivable	(10,191)		(45,917)
Principal collections on mortgage loans receivable	7		—
Earnest money deposits	(42)		(1,773)
Purchase of computer equipment and other corporate assets	(8)		—
Proceeds from sale of real estate	20,466		15,463
Proceeds from the settlement of property-related insurance claims	—		12
Net cash used in investing activities	(97,202)		(102,412)
Cash flows from financing activities
Issuance of common stock in public offerings, net	—		52,903
Payment of common stock dividends	(15,031)		(11,650)
Payment of OP unit distributions	(98)		(101)
Payment of restricted stock dividends	(384)		(92)
Principal payments on mortgages payable	(39)		(26)
Proceeds under revolving credit facilities	82,000		99,000
Repayments under revolving credit facilities	(87,000)		(116,000)
Proceeds from term loans	100,000		—
Repurchase of common stock for tax withholding obligations	(1,069)		(360)
Deferred offering costs	(423)		(15)
Net cash provided by financing activities	77,956		23,659
Net change in cash, cash equivalents and restricted cash	(7,595)		(63,947)
Cash, cash equivalents and restricted cash at beginning of the period	29,929		70,543
Cash, cash equivalents and restricted cash at end of the period	$	22,334	$	6,596
Supplemental disclosures of cash flow information:
Cash paid for interest	$	6,536	$	3,641
Supplemental disclosures of non-cash investing and financing activities:
Dividends declared and unpaid on restricted stock, net	$	7	$	122
Deferred offering costs included in accounts payable, accrued expenses and other liabilities	$	107	$	—
Cash flow hedge change in fair value	$	10,107	$	(5,979)
Accrued capital expenditures and real estate development and improvement costs	$	1,110	$	2,516

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

NETSTREIT CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Organization and Description of Business

NETSTREIT Corp. (the “Company”) was incorporated on October 11, 2019 as a Maryland corporation and commenced operations on December 23, 2019. The Company conducts its operations through NETSTREIT, L.P., a Delaware limited partnership (the “Operating Partnership”). NETSTREIT GP, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, is the sole general partner of the Operating Partnership.

The Company elected to be treated and to qualify as a real estate investment trust (“REIT”) for U.S. federal income tax purposes beginning with its short taxable year ended December 31, 2019. Additionally, the Operating Partnership formed NETSTREIT Management TRS, LLC (“NETSTREIT TRS”), which together with the Company jointly elected to be treated as a taxable REIT subsidiary under Section 856(a) of the Internal Revenue Code of 1986, as amended, (the “Code”) for U.S. federal income tax purposes.

The Company is structured as an umbrella partnership real estate investment trust (commonly referred to as an “UPREIT”) and is an internally managed real estate company that acquires, owns, invests in and manages a diversified portfolio of single-tenant, retail commercial real estate leased on a long-term basis to high credit quality tenants across the United States. As of March 31, 2024, the Company owned or had investments in 628 properties, located in 45 states, excluding 16 property developments where rent has yet to commence.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The accompanying condensed consolidated financial statements include the accounts of the Company and subsidiaries in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation and the Company’s net income is reduced by the portion of net income attributable to noncontrolling interests.

Interim Unaudited Financial Information

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. These unaudited interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements, and should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto on the Annual Report on Form 10-K as of and for the year ended December 31, 2023, which provide a more complete understanding of the Company’s accounting policies, financial position, operating results, business properties, and other matters. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2024 and 2023 are not necessarily indicative of the results for the full year.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s most significant assumptions and estimates relate to the useful lives of real estate assets, lease accounting, real estate impairment assessments, and allocation of fair value of purchase consideration. These estimates are based on historical experience and other assumptions which management believes are reasonable under the circumstances. The Company evaluates its estimates on an ongoing basis and makes revisions to these estimates and related disclosures as experience develops or new information becomes known. Actual results could differ from those estimates.

7

Impairment of Long-Lived Assets

Fair value measurement of an asset group occurs when events or changes in circumstances related to an asset indicate that the carrying amount of the asset is no longer recoverable. An example of an event or changed circumstance is a reduction in the expected holding period of a property. If indicators are present, the Company will prepare a projection of the undiscounted future cash flows of the property, excluding interest charges, and determine if the carrying amount of the asset group is recoverable. When a carrying amount is not recoverable, an impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair market value. The Company estimates fair value using data such as operating income, estimated capitalization rates or multiples, leasing prospects, local market information, and discount rates, and with regard to assets held for sale, based on the estimated or negotiated selling price, less estimated costs of disposal. Based on these unobservable inputs, the Company determined that its valuations of impaired real estate and intangible assets fall within Level 2 and Level 3 of the fair value hierarchy under ASC Topic 820.

The following table summarizes the provision for impairment during the periods indicated below (in thousands):

	Three Months Ended March 31,
	2024		2023
Total provision for impairment	$	3,662	$	—
Number of properties: (1)
Classified as held for sale	4		—
Disposed within the period	2		—

(1) Includes the number of properties that were either (i) impaired during the period on the held for sale classification date and remained as held for sale as of period-end or (ii) impaired and disposed of during the respective period. Excludes properties that did not have impairment recorded during the period. Of the total provision for impairment during the three months ended March 31, 2024, the Company recorded $0.3 million of additional impairment expense on two properties that were classified as held for sale in prior periods, and $2.2 million of impairment expense on four properties held for investment.

Cash, Cash Equivalents and Restricted Cash

The Company considers all cash balances, money market accounts and highly liquid investments with original maturities of three months or less to be cash and cash equivalents. Restricted cash includes cash restricted for property tenant improvements and cash proceeds from the sale of assets held by qualified intermediaries in anticipation of the acquisition of replacement properties in tax-free exchanges under Section 1031 of the Code. Restricted cash is included in cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets. The Company had $0.7 million restricted cash as of March 31, 2024, and $11.5 million of restricted cash as of December 31, 2023.

The Company’s bank balances as of March 31, 2024 and December 31, 2023 included certain amounts over the Federal Deposit Insurance Corporation limits.

Fair Value Measurement

Fair value measurements are utilized in the accounting of the Company’s assets acquired and liabilities assumed in an asset acquisition and also affect the Company’s accounting for certain of its financial assets and liabilities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The hierarchy described below prioritizes inputs to the valuation techniques used in measuring the fair value of assets and liabilities. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs to be used when available. The hierarchy is broken down into three levels based on the reliability of inputs as follows: Level 1 inputs, such as quoted prices in an active market; Level 2 inputs, which are observable inputs for similar assets; or Level 3 inputs, which are unobservable inputs.

The Company uses the following inputs in its fair value measurements:

– Level 2 and Level 3 inputs for its debt and derivative financial instrument fair value disclosures. See “Note 6 - Debt” and “Note 7 - Derivative Financial Instruments,” respectively; and

– Level 2 and Level 3 inputs when assessing the fair value of assets and liabilities in connection with real estate acquisitions and impairment. See “Note 4 - Real Estate Investments.”

8

Additionally, companies are required to disclose the estimated fair values of all financial instruments, even if they are not carried at their fair value. The fair values of financial instruments are estimates based on market conditions and perceived risks as of March 31, 2024 and December 31, 2023. These estimates require management’s judgment and may not be indicative of the future fair values of the assets and liabilities.

The fair value of the Company’s cash, cash equivalents and restricted cash (including money market accounts), other assets and accounts payable, accrued expenses and other liabilities approximate their carrying value because of the short-term nature of these instruments. Additionally, the Company believes the following financial instruments have carrying values that approximate their fair values as of March 31, 2024:

•Borrowings under the Company’s Revolver (as defined in “Note 6 - Debt”) approximate fair value based on their nature, terms and variable interest rates.

•Carrying values of the Company’s mortgage loans receivable approximate fair values based on a number of factors, including either their short-term nature, the availability of market quotes for comparable instruments, and a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

•Carrying value of the Company’s mortgage note payable approximates fair value based on a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

Provisions for impairment recognized during the three months ended March 31, 2024 partially related to assets held for sale where impairment was determined based on the estimated or negotiated selling price, less costs of disposal, compared to the carrying value of the property. Of the total provision for impairment during the three months ended March 31, 2024, the Company also recorded $2.2 million of impairment expense on four properties held for investment. These properties were accounted for at fair value on a nonrecurring basis using a cash flow model (Level 3 inputs) with adjusted carrying values ranging from $0.6 million to $1.6 million. The Company estimated the fair value using capitalization rates ranging from 9.0% to 12.1% which it believes is reasonable based on current market rates. As of December 31, 2023, there were two real estate assets held for investment accounted for at fair value. Of these properties, one was accounted for at fair value on a nonrecurring basis using a cash flow model (Level 3 inputs) with an adjusted carrying value of $1.5 million.

The following table discloses estimated fair value information for the Company’s 2027 Term Loan, 2028 Term Loan, and 2029 Term Loan (each as defined in “Note 6 - Debt”) which is derived based primarily on unobservable market inputs such as interest rates and discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates and credit spreads (in thousands):

	March 31, 2024				December 31, 2023
	Carrying Value (1)		Estimated Fair Value		Carrying Value (1)		Estimated Fair Value
2027 Term Loan	$	174,155	$	172,770	$	174,037	$	175,641
2028 Term Loan	199,066		198,101		199,006		201,396
2029 Term Loan	248,279		247,002		148,869		150,666

(1) The carrying value of the debt instruments are net of unamortized debt issuance and discount costs.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company is exposed to credit risk with respect to cash held at various financial institutions, access to its credit facilities, amounts due under mortgage loans receivable, and amounts due or payable under derivative contracts. The credit risk exposure with regard to the Company’s cash, credit facilities, and derivative instruments is spread among a diversified group of investment grade financial institutions.

During the three months ended March 31, 2024, one tenant, Dollar General, accounted for 10.43% of total revenues. During the three months ended March 31, 2023, there were no tenants or borrowers with rental revenue or interest income on loans receivable that exceeded 10% of total rental revenue.

9

Segment Reporting

ASC Topic 280, Segment Reporting, establishes standards for the manner in which companies report information about operating segments. Substantially all of the Company’s investments, at acquisition, are comprised of real estate owned that is leased to tenants on a long-term basis or real estate that secures the Company's investment in mortgage loans receivable. The Company allocates resources and assesses operating performance based on individual investment and property needs. Therefore, the Company aggregates these investments for reporting purposes and operates in one reportable segment.

Recent Accounting Pronouncements Issued But Not Yet Adopted

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to improve reportable segment disclosures by requiring disclosure of incremental segment information on an annual and interim basis such as, annual and interim disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, interim disclosure of a reportable segment’s profit or loss and assets, and the requirement that a public entity that has a single reportable segment provide all the disclosures required by ASU 2023-07 and all existing segment disclosures in Topic 280. The amendments in ASU 2023-07 do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The disclosures are applied retrospectively to all periods presented and early adoption is permitted. The Company has one reportable segment and continues to evaluate additional disclosures that may be required for entities with a single reportable segment.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires annual disclosure of specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold within the rate reconciliation. In addition, the amendments require annual disclosure of income taxes paid disaggregated by federal, state and foreign jurisdictions as well as individual jurisdictions in which income taxes paid is equal to or greater than 5 percent of total income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, however early adoption and retrospective application is permitted. The Company continues to evaluate the potential impact of the guidance and potential additional disclosures required.

Note 3 – Leases

Tenant Leases

The Company acquires, owns and manages commercial single-tenant lease properties, with the majority being long-term triple-net leases where the tenant is generally responsible for all improvements and contractually obligated to pay all operating costs (such as real estate taxes, utilities and repairs and maintenance costs). As of March 31, 2024, exclusive of mortgage loans receivable, the Company’s weighted average remaining lease term was 9.2 years.

The Company’s property leases have been classified as operating leases and some have scheduled rent increases throughout the lease term. The Company’s leases typically provide the tenant one or more multi-year renewal options to extend their leases, subject to generally the same terms and conditions, including rent increases, consistent with the initial lease term.

All lease-related income is reported as a single line item, rental revenue (including reimbursable), in the condensed consolidated statements of operations and comprehensive income (loss) and is presented net of any reserves, write-offs, or recoveries for uncollectible amounts.

Fixed lease income includes stated amounts per the lease contract, which include base rent, fixed common area maintenance charges, and straight-line lease adjustments.

Variable lease income primarily includes recoveries from tenants, which represent amounts that tenants are contractually obligated to reimburse the Company for, specific to their portion of actual recoverable costs incurred. Variable lease income also includes percentage rent, which represents amounts billable to tenants based on their actual sales volume in excess of levels specified in the lease contract.

10

The following table provides a disaggregation of lease income recognized under ASC 842 (in thousands):

	Three Months Ended March 31,
	2024		2023
Rental revenue
Fixed lease income (1)	$	31,865	$	24,723
Variable lease income (2)	3,228		3,538
Other rental revenue:
Above/below market lease amortization, net	287		412
Lease incentives	(191)		(199)
Rental revenue (including reimbursable)	$	35,189	$	28,474

(1) Fixed lease income includes contractual rents under lease agreements with tenants recognized on a straight-line basis over the lease term.

(2) Variable lease income primarily includes tenant reimbursements for real estate taxes, insurance, common area maintenance, and lease termination fees, and the write-off of uncollectible amounts. There were no material reserves, write-offs, or recoveries of uncollectible amounts during the three months ended March 31, 2024 and March 31, 2023.

Scheduled future minimum base rental payments (excluding base rental payments from properties classified as held for sale and straight-line rent adjustments for all properties) due to be received under the remaining non-cancelable term of the operating leases in place as of March 31, 2024 are as follows (in thousands):

	Future Minimum Base Rental Receipts
Remainder of 2024	$	94,421
2025	125,888
2026	123,362
2027	119,701
2028	112,884
Thereafter	615,487
Total	$	1,191,743

Future minimum rentals exclude amounts that may be received from tenants for reimbursements of operating costs and property taxes. In addition, the future minimum rents do not include any contingent rents based on a percentage of the lessees' gross sales or lease escalations based on future changes in the Consumer Price Index or other stipulated reference rate.

Note 4 – Real Estate Investments

As of March 31, 2024, the Company owned or had investments in 628 properties, excluding 16 property developments where rent has yet to commence. The gross real estate investment portfolio, including properties under development, totaled approximately $1.9 billion and consisted of the gross acquisition cost of land, buildings, improvements, lease intangible assets and liabilities, and property development costs. The investment portfolio is geographically dispersed throughout 45 states with gross real estate investments in Illinois and Texas representing 9.4% and 8.8%, respectively, of the total gross real estate investment of the Company’s investment portfolio.

Acquisitions

During the three months ended March 31, 2024, the Company acquired 28 properties for a total purchase price of $95.2 million, inclusive of $1.2 million of capitalized acquisition costs.

During the three months ended March 31, 2023, the Company acquired 20 properties for a total purchase price of $67.7 million, inclusive of $0.7 million of capitalized acquisition costs.

The acquisitions were all accounted for as asset acquisitions. An allocation of the purchase price and acquisition costs paid for the completed acquisitions is as follows (in thousands):

11

	Three Months Ended March 31,
	2024		2023
Land	$	16,608	$	14,304
Buildings	59,379		43,133
Site improvements	6,428		3,479
Tenant improvements	1,445		391
In-place lease intangible assets	11,293		6,410
Purchase price (including acquisition costs)	$	95,153	$	67,717

Development

As of March 31, 2024, the Company had 13 property developments under construction. During the three months ended March 31, 2024, the Company invested $11.0 million in property developments, including the land acquisition of two new developments with a combined initial purchase price of $0.8 million. During the three months ended March 31, 2024, the Company completed development on seven projects and reclassified approximately $18.4 million from property under development to land, buildings and improvements, and other assets (leasing commissions) in the accompanying condensed consolidated balance sheets. Rent commenced for four of the seven completed developments in the first quarter of 2024, while rent is expected to commence for the other three completed developments in the second quarter of 2024. The remaining 13 developments are expected to be substantially completed with rent commencing at various points throughout 2024. The purchase price, including acquisition costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of March 31, 2024.

During the three months ended March 31, 2023, the Company invested $4.5 million in property developments. During the three months ended March 31, 2023, the Company completed development on two projects and reclassified approximately $14.8 million from property under development to land, buildings and improvements in the accompanying condensed consolidated balance sheets. Rent commenced for the completed developments in the first quarter of 2023. The purchase price, including acquisitions costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of March 31, 2023.

Additionally, during the three months ended March 31, 2024 and 2023, the Company capitalized approximately $0.4 million and $0.1 million, respectively, of interest expense associated with properties under development.

Dispositions

During the three months ended March 31, 2024, the Company sold 12 properties for a total sales price, net of disposal costs, of $20.5 million, recognizing a net gain of $1.0 million.

During the three months ended March 31, 2023, the Company sold eight properties for a total sales price, net of disposal costs, of $15.5 million, recognizing a net loss of $0.3 million.

12

Investment in Mortgage Loans Receivable

The Company’s mortgage loans receivable portfolio as of March 31, 2024 and December 31, 2023 is summarized below (in thousands):

Loan Type	Monthly Payment (1)	Number of Secured Properties	Effective Interest Rate (2)	Stated Interest Rate	Maturity Date	March 31, 2024		December 31, 2023
Mortgage (3) (4) (5)	I/O	1	6.74%	7.00%	4/8/2024	$	43,612	$	43,612
Mortgage (4)	I/O	46	9.55%	9.55%	3/10/2026	41,940		41,940
Mortgage (4) (6)	I/O	3	8.10%	6.89%	4/10/2026	4,132		4,132
Mortgage (3) (4) (6)	I/O	9	7.59%	7.59%	6/10/2025	14,023		14,024
Mortgage	None (7)	1	8.50%	8.50%	12/29/2024	660		660
Mortgage (3)	P+I	1	7.50%	7.50%	1/8/2025	3,239		3,246
Mortgage (3) (4) (8)	I/O	11	10.22%	10.25%	3/19/2025	14,209		5,007
Mortgage (3) (4)	I/O	2	10.25%	10.25%	12/22/2024	2,915		1,909
Total						124,730		114,530
Unamortized loan origination costs and fees, net						(10)		58
Unamortized discount						(103)		(116)
Total mortgage loans receivable, net						$	124,617	$	114,472

(1) I/O: Interest Only; P+I: Principal and Interest.

(2) Includes amortization of discount and loan origination costs, as applicable.

(3) The Company has the right, subject to certain terms and conditions, to acquire all or a portion of the underlying collateralized properties.

(4) Loans require monthly payments of interest only with principal payments occurring as borrower disposes of underlying properties, limited to the Company’s allocated investment by property. Any remaining principal balance will be repaid at or before the maturity date.

(5) The $43.6 million mortgage note receivable was scheduled to mature on April 8, 2024, however, the Company executed an amendment in April 2024 that extended the maturity date to January 8, 2025.

(6) The stated interest rate is variable up to 15.0% and is calculated based on contractual rent for existing collateralized properties subject to the loan agreement.

(7) Payments of both interest and principal are due at maturity.

(8) The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from December 5, 2024 to March 19, 2025.

Assets Held for Sale

As of March 31, 2024 and December 31, 2023, there were 23 properties classified as held for sale.

Provisions for Impairment

The Company recorded provisions for impairment of $3.7 million on 12 properties for the three months ended March 31, 2024. The Company recorded no provisions for impairment for the three months ended March 31, 2023.

13

Note 5 – Intangible Assets and Liabilities

Intangible assets and liabilities consisted of the following (in thousands):

	March 31, 2024						December 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Assets:
In-place leases	$	190,133	$	(48,667)	$	141,466	$	181,564	$	(45,210)	$	136,354
Above-market leases	21,635		(4,749)		16,886		21,661		(4,361)		17,300
Lease incentives	8,577		(1,422)		7,155		8,996		(1,296)		7,700
Total intangible assets	$	220,345	$	(54,838)	$	165,507	$	212,221	$	(50,867)	$	161,354
Liabilities:
Below-market leases	$	33,170	$	(8,531)	$	24,639	$	33,196	$	(7,843)	$	25,353

The remaining weighted average amortization period for the Company’s intangible assets and liabilities as of March 31, 2024 and as of December 31, 2023 by category were as follows:

	Years Remaining
	March 31, 2024	December 31, 2023
In-place leases	8.9	8.8
Above-market leases	12.0	12.2
Below-market leases	10.7	10.9
Lease incentives	10.8	11.1

The Company records amortization of in-place lease assets to amortization expense, and records net amortization of above-market and below-market lease intangibles as well as amortization of lease incentives to rental revenue. The following amounts in the accompanying condensed consolidated statements of operations and comprehensive income (loss) related to the amortization of intangible assets and liabilities for all property and ground leases (in thousands):

	Three Months Ended March 31,
	2024		2023
Amortization:
Amortization of in-place leases	$	4,875	$	4,670
Amortization of assembled workforce	—		—
	$	4,875	$	4,670
Net adjustment to rental revenue:
Above-market lease assets	(416)		(371)
Below-market lease liabilities	702		783
Lease incentives	(191)		(199)
	$	95	$	213

14

The following table provides the projected amortization of in-place lease assets to amortization expense and the net amortization of above-market, below-market, and lease incentive lease intangible assets and liabilities to rental revenue as of March 31, 2024, for the next five years and thereafter (in thousands):

	Remainder of 2024		2025		2026		2027		2028		Thereafter		Total
In-place leases	$	15,531	$	20,386	$	19,153	$	17,160	$	14,356	$	54,880	$	141,466
Above-market lease assets	(1,241)		(1,655)		(1,632)		(1,568)		(1,523)		(9,267)		(16,886)
Below-market lease liabilities	2,098		2,776		2,686		2,615		2,483		11,981		24,639
Lease incentives	(564)		(752)		(752)		(696)		(666)		(3,725)		(7,155)
Net adjustment to rental revenue	$	293	$	369	$	302	$	351	$	294	$	(1,011)	$	598

Note 6 – Debt

Debt consists of the following (in thousands):

				Amounts Outstanding as of
	Contractual Maturity Date	Fully Extended Maturity Date (1)	Interest Rate (2)	March 31, 2024		December 31, 2023
Debt:
2027 Term Loan (3)	January 15, 2026	January 15, 2027	3.12%	$	175,000	$	175,000
2028 Term Loan (4)	February 11, 2028	—	3.88%	200,000		200,000
2029 Term Loan (5)	July 3, 2026	January 3, 2029	4.99%	250,000		150,000
Revolver (6)	August 11, 2026	August 11, 2027	6.42%	75,000		80,000
Mortgage Note	November 1, 2027	—	4.53%	8,322		8,361
Total debt				708,322		613,361
Unamortized discount and debt issuance costs				(3,946)		(3,566)
Unamortized deferred financing costs, net (7)				(1,757)		(1,942)
Total debt, net				$	702,619	$	607,853

(1) Date represents the fully extended maturity date available to the Company, subject to certain conditions, under each related debt instrument.

(2) Rate represents the effective interest rate as of March 31, 2024 and includes the effect of interest rate swap agreements, as described further in “Note 6 - Debt” and “Note 7 - Derivative Financial Instruments.”

(3) Loan is a floating-rate loan which resets daily at daily SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into five interest rate swap agreements that effectively convert the floating rate to a fixed rate. The hedged fixed rate reset effective November 27, 2023 to 1.87% and will reset again effective December 23, 2024 to 2.40%.

(4) Loan is a floating-rate loan which resets monthly at one-month term SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into three interest rate swap agreements that effectively convert the floating rate to a fixed rate.

(5) Loan is a floating-rate loan which resets daily at daily SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into four interest rate swap agreements that effectively convert the floating rate to a fixed rate.

(6) The annual interest rate of the Revolver assumes daily SOFR as of March 31, 2024 of 5.32% plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.00% as of March 31, 2024.

(7) The Company records deferred financing costs associated with the Revolver in other assets, net on its condensed consolidated balance sheets. The Company reclassed the net amount of loan commitment fees associated with the 2029 Term Loan from other assets, net to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan.

2029 Term Loan

On July 3, 2023, the Company entered into an agreement (the “2029 Term Loan Agreement”) related to a $250.0 million sustainability-linked senior unsecured term loan (the “2029 Term Loan”) which may, subject to the terms of the 2029 Term Loan Agreement, be increased to an amount of up to $400.0 million at the Company’s request. The 2029 Term Loan contains a 12-month delayed draw feature and $150.0 million was drawn on July 3, 2023. The 2029 Term Loan is prepayable at the Company’s option in whole or in part without premium or penalty. The 2029 Term Loan matures on July 3, 2026, subject to extension options at the Company’s election on two occasions, by one year and, on one occasion, by six months (subject to certain conditions). Subject to the terms of the 2029 Term Loan Agreement, the Company drew an additional $100.0 million under the 2029 Term Loan on March 1, 2024.

The interest rate applicable to the 2029 Term Loan is determined by the Company’s Investment Grade Rating (as defined in the 2029 Term Loan Agreement). Prior to the date the Company obtains an Investment Grade Rating, interest shall accrue at either

15

(i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the 2029 Term Loan Agreement), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company’s consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company’s Investment Grade Rating.

The Company has hedged the entire $250.0 million of the 2029 Term Loan at an all-in fixed interest rate of 4.99%, through January 2029, which consists of a fixed SOFR rate of 3.74%, plus a credit spread adjustment of 0.10% and, at current leverage levels, a borrowing spread of 1.15%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings.

The 2029 Term Loan also contains sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the Company’s annualized based rent attributable to tenants with commitments or quantifiable targets for reduced GHG emission in accordance with the standards of the Science Based Targets initiative (“SBTi”).

In connection with the 2029 Term Loan, the Company incurred $1.4 million of deferred financing costs. Additionally, the Company incurred $0.9 million of loan commitment fees associated with the 2029 Term Loan, which were capitalized to other assets, net on the condensed consolidated balance sheets and subsequently reclassed to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan. Deferred financing costs are amortized over the term of the loan and are included in interest expense, net on the Company’s condensed consolidated statements of operations and comprehensive income (loss).

Credit Facility

On August 11, 2022, the Company entered into a sustainability-linked senior unsecured credit facility consisting of (i) a $200.0 million senior unsecured term loan (the “2028 Term Loan”) and (ii) a $400.0 million senior unsecured revolving credit facility (the “Revolver”, and together with the 2028 Term Loan, the “Credit Facility”). The Credit Facility may be increased by $400.0 million in the aggregate for total availability of up to $800.0 million.

The 2028 Term Loan matures on February 11, 2028. The Revolver matures on August 11, 2026, subject to a one year extension option at the Company’s election (subject to certain conditions) to August 11, 2027. Borrowings under the Credit Facility are repayable at the Company’s option in whole or in part without premium or penalty. Borrowings under the Revolver may be repaid and reborrowed from time to time prior to the maturity date.

Prior to the date the Company obtains an Investment Grade Rating (as defined in the credit agreement governing the Credit Facility (the “Credit Agreement”)), interest rates are based on the Company’s consolidated total leverage ratio, and are determined by (A) in the case of the 2028 Term Loan either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 1.15% to 1.60%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.15% to 0.60%, based on the Company’s consolidated total leverage ratio and (B) in the case of the Revolver either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 1.00% to 1.45%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.00% to 0.45%, based on the Company’s consolidated total leverage ratio.

After the date the Company obtains an Investment Grade Rating, interest rates are based on the Company’s Investment Grade Rating, and are determined by (A) in the case of the 2028 Term Loan either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 0.80% to 1.60%, based on the Company’s Investment Grade Rating, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.00% to 0.60%, based on the Company’s Investment Grade Rating and (B) in the case of the Revolver either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 0.725% to 1.40%, based on the Company’s Investment Grade Rating, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.00% to 0.40%, based on the Company’s Investment Grade Rating.

Additionally, the Company will incur a facility fee based on the total commitment amount of $400.0 million under the Revolver. Prior to the date the Company obtains an Investment Grade Rating, the applicable facility fee will range from 0.15% to 0.30% based on the Company’s consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, the applicable facility fee will range from 0.125% to 0.30% based on the Company’s Investment Grade Rating.

The Credit Facility also contains a sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the

16

Company’s annualized base rent attributable to tenants with commitments or quantifiable targets for reduced greenhouse gas emission in accordance with the standards of the SBTi.

The Company has fully hedged the 2028 Term Loan with an all-in interest rate of 3.88%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedge is further described in “Note 7 – Derivative Financial Instruments.”

In connection with the Credit Facility, the Company incurred approximately $3.8 million of deferred financing costs which were allocated between the Revolver and 2028 Term Loan in the amounts of $2.4 million and $1.3 million, respectively. Additionally, $0.5 million of unamortized deferred financing costs associated with the Company’s previous revolving credit facility were reclassed to the Revolver. Deferred financing costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

2027 Term Loan

In December 2019, the Company entered into an agreement governing a $175.0 million senior unsecured term loan that was scheduled to mature in December 2024 (the “2024 Term Loan”). On June 15, 2023, the Company amended and restated the agreement governing the 2024 Term Loan to provide for a $175.0 million senior unsecured term loan with a maturity date of January 15, 2026 that is subject to a one year extension option at the Company’s election (subject to certain conditions) (the “2027 Term Loan”). The 2027 Term Loan is repayable at the Company’s option in whole or in part without premium or penalty.

The interest rate applicable to the 2027 Term Loan is determined by the Company’s Investment Grade Rating (as defined in the 2027 Term Loan). Prior to the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the 2027 Term Loan), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company’s consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company’s Investment Grade Rating.

Interest is payable monthly or at the end of the applicable interest period in arrears. The Company has fully hedged the 2027 Term Loan. The interest rate hedges are described in “Note 7 – Derivative Financial Instruments.”

Mortgage Note Payable

As of March 31, 2024, the Company had total gross mortgage indebtedness of $8.3 million, which was collateralized by related real estate and a tenant’s lease with an aggregate net book value of $12.5 million. The Company incurred debt issuance costs of less than $0.1 million and recorded a debt discount of $0.6 million, both of which are recorded as a reduction of the principal balance in mortgage note payable, net in the Company’s condensed consolidated balance sheets. The mortgage note matures on November 1, 2027, but may be repaid in full beginning August 2027.

Debt Maturities

Payments on the 2027 Term Loan, 2028 Term Loan, and 2029 Term Loan are interest only through maturity. As of March 31, 2024, scheduled debt maturities, including balloon payments, are as follows (in thousands):

	Scheduled Principal		Balloon Payment (1)		Total
Remainder of 2024	$	123	$	—	$	123
2025	170		—		170
2026	178		500,000		500,178
2027	170		7,681		7,851
2028	—		200,000		200,000
Total	$	641	$	707,681	$	708,322

(1) Does not assume the exercise of any extension options available to the Company.

17

Interest Expense

The following table is a summary of the components of interest expense related to the Company’s borrowings (in thousands):

	Three Months Ended March 31,
	2024		2023
Revolving credit facilities (1)	$	1,158	$	1,150
Term loans (2)	5,672		2,499
Mortgage note payable	95		93
Non-cash:
Amortization of deferred financing costs	238		185
Amortization of debt discount and debt issuance costs, net	349		151
Amortization of deferred gains on interest rate swaps	(979)		—
Capitalized interest	(353)		(134)
Total interest expense, net	$	6,180	$	3,944

(1) Includes facility fees and non-utilization fees of approximately $0.2 million for both the three months ended March 31, 2024 and 2023.

(2) Includes the effects of interest rate hedges in place as of such date.

Deferred financing, discount, and debt issuance costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

During the three months ended March 31, 2024 and 2023, term loans had a weighted average interest rate, exclusive of amortization of deferred financing costs and the effects of interest rate hedges, of 6.69% and 5.77%, respectively.

During the three months ended March 31, 2024 and 2023, the Company incurred interest expense on revolving credit facilities with a weighted average interest rate, exclusive of amortization of deferred financing costs and facility fees, of 6.54% and 5.86%, respectively.

The estimated fair values of the Company’s term loans have been derived based on market observable inputs such as interest rates and discounted cash flow analysis using estimates of the amount and timing of future cash flows. These measurements are classified as Level 2 within the fair value hierarchy. Refer to “Note 2 - Summary of Significant Accounting Policies” for additional detail on fair value measurements.

The Company was in compliance with all of its debt covenants as of March 31, 2024 and expects to be in compliance for the twelve-month period ending December 31, 2024.

Note 7 – Derivative Financial Instruments

The Company uses interest rate derivative contracts to manage its exposure to changes in interest rates on its variable rate debt. These derivatives are considered cash flow hedges and are recorded on a gross basis at fair value. Assessments of hedge effectiveness are performed quarterly using either a qualitative or quantitative approach. The Company recognizes the entire change in the fair value in Accumulated Other Comprehensive Income (“AOCI”) and the change is reflected as cash flow hedge changes in fair value in the supplemental disclosures of non-cash investing and financing activities in the condensed consolidated statements of cash flows.

Effective July 3, 2023, such derivatives were initiated to hedge the variable cash flows associated with the 2029 Term Loan. The interest rate for the variable rate 2029 Term Loan is based on the hedged fixed rate of 3.74% compared to the variable 2029 Term Loan daily SOFR rate as of March 31, 2024 of 5.32%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15%. The maturity dates of the interest rate swaps coincide with the fully extended maturity date of the 2029 Term Loan.

Effective September 1, 2022, such derivatives were initiated to hedge the variable cash flows associated with the 2028 Term Loan. The interest rate for the variable rate 2028 Term Loan is based on the hedged fixed rate of 2.63% compared to the variable 2028 Term Loan one-month SOFR rate as of March 31, 2024 of 5.33%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15%. The maturity dates of the interest rate swaps coincide with the maturity date of the 2028 Term Loan.

18

Effective January 27, 2023, the Company converted its four existing LIBOR swap agreements associated with the 2024 Term Loan into four new SOFR swaps that convert the SOFR variable rate to a fixed rate of 0.12% and on June 15, 2023, the Company amended and restated its 2024 Term Loan, providing for the 2027 Term Loan. In anticipation of the amendment and restatement of the 2024 Term Loan, additional derivatives, effective November 27, 2023 and December 23, 2024 at hedged fixed rates of 1.87% and 2.40%, respectively, were initiated to hedge the variable cash flows associated with the 2027 Term Loan through the fully extended maturity date. The interest rate on the variable 2027 Term Loan includes a daily SOFR rate as of March 31, 2024 of 5.31%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15%.

Amounts will subsequently be reclassified to earnings when the hedged item affects earnings. The Company does not enter into derivative contracts for speculative or trading purposes and does not have derivative netting arrangements.

The Company is exposed to credit risk in the event of non-performance by its derivative counterparties. The Company evaluates counterparty credit risk through monitoring the creditworthiness of counterparties, which includes review of debt ratings and financial performance. To mitigate credit risk, the Company enters into agreements with counterparties it considers credit-worthy, such as large financial institutions with favorable credit ratings.

The Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk (in thousands, except number of instruments):

	Number of Instruments		Notional
Interest Rate Derivatives	March 31, 2024	December 31, 2023	March 31, 2024		December 31, 2023
Interest rate swaps	12	12	$	650,000	$	650,000

The following table presents the fair value of the Company's derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023 (in thousands):

	Derivative Assets
		Fair Value as of March 31,
Derivatives Designated as Hedging Instruments:	Balance Sheet Location	2024		2023
Interest rate swaps	Other assets, net	$	21,476	$	14,442

	Derivative Liabilities
		Fair Value as of March 31,
Derivatives Designated as Hedging Instruments:	Balance Sheet Location	2024		2023
Interest rate swaps	Accounts payable, accrued expenses and other liabilities	$	—	$	3,073

The following table presents the effect of the Company's interest rate swaps on the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2024 and 2023 (in thousands):

	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
Derivatives in Cash Flow Hedging Relationships	2024		2023			2024		2023
Interest Rate Products	$	13,761	$	(3,141)	Interest expense, net	$	4,633	$	2,837

The Company did not exclude any amounts from the assessment of hedge effectiveness for the three months ended March 31, 2024 and 2023. During the next twelve months, the Company estimates that an additional $14.5 million will be reclassified as a decrease to interest expense.

The valuation of these instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves.

19

To comply with the provisions of ASC 820, the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. However, as of March 31, 2024, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivatives. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.

The table below presents the Company’s derivative assets measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023, aggregated by the level in the fair value hierarchy within which those measurements fall (in thousands):

	Fair Value Hierarchy Level
Description	Level 1		Level 2		Level 3		Total Fair Value
March 31, 2024
Derivative assets	$	—	$	21,476	$	—	$	21,476
December 31, 2023
Derivative assets	$	—	$	14,442	$	—	$	14,442
Derivative liabilities	$	—	$	3,073	$	—	$	3,073

Note 8 – Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets

Other assets, net consist of the following (in thousands):

	March 31, 2024		December 31, 2023
Accounts receivable, net	$	10,813	$	10,074
Deferred rent receivable	8,594		7,744
Prepaid assets	3,904		1,387
Earnest money deposits	492		450
Fair value of interest rate swaps	21,476		14,442
Deferred offering costs	1,554		1,031
Deferred financing costs, net	1,757		2,724
Right-of-use asset	3,772		3,866
Leasehold improvements and other corporate assets, net	1,651		1,723
Interest receivable	1,929		1,397
Other assets, net	5,460		4,499
	$	61,402	$	49,337

Accounts payable, accrued expenses and other liabilities consists of the following (in thousands):

	March 31, 2024		December 31, 2023
Accrued expenses	$	8,176	$	8,826
Accrued bonus	520		2,575
Prepaid rent	3,394		3,896
Operating lease liability	4,994		5,104
Accrued interest	2,958		2,921
Deferred rent	3,627		3,257
Accounts payable	622		4,691
Fair value of interest rate swaps	—		3,073
Other liabilities	1,974		2,155
	$	26,265	$	36,498

20

Note 9 – Shareholders’ Equity, Partners’ Capital and Preferred Equity

ATM Program

On September 1, 2021, the Company entered into a $250.0 million at-the-market equity program (the “2021 ATM Program”). In March 2023, the Company issued 146,745 shares of common stock under the 2021 ATM Program at a weighted average price of $20.22 per share for net proceeds of approximately $2.9 million, net of sales commissions and offering costs of less than $0.1 million. The Company contributed the net proceeds to the Operating Partnership in exchange for 146,745 Class A OP Units.

On October 25, 2023, the Company entered into a $300.0 million at-the-market equity program (the “2023 ATM Program”) through which, from time to time, it may sell shares of its common stock in registered transactions. Effective October 24, 2023, in connection with the establishment of the new at-the-market offering program, the 2021 ATM Program was terminated.

On March 28, 2024, the Company entered into a forward confirmation with respect to 107,500 shares of its common stock under the 2023 ATM Program, at a public offering price of $18.29 per share. 107,500 shares remain unsettled under the forward confirmation as of March 31, 2024. The Company may physically settle this forward confirmation (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than April 12, 2025.

The following table presents information about the 2023 ATM Program and the 2021 ATM Program (in thousands):

				Maximum Sales Authorization		Gross Sales through March 31, 2024
Program Name	Date Established	Date Terminated
2021 ATM Program (1)	September 2021	October 2023		$	250,000	$	150,391
2023 ATM Program (2)	October 2023	—	0	$	300,000	$	77,323

(1) Includes 1,516,289 shares of common stock partially physically settled at a price of $16.49 per share under the forward confirmation with respect to the 2021 ATM Program. 5,983,711 shares remain unsettled under the forward confirmation as of March 31, 2024 at the available net settlement price of $16.46.

(2) 107,500 shares remain unsettled under the forward confirmation as of March 31, 2024 at the available net settlement price of $18.12.

January 2024 Follow-On Offering

In January 2024, the Company completed a registered public offering of 11,040,000 shares of its common stock at a public offering price of $18.00 per share. In connection with the offering, the Company entered into forward sale agreements for 11,040,000 shares of its common stock. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than January 9, 2025. The Company may also elect to cash settle or net share settle all or a portion of its obligations under a forward sale agreement if it concludes it is in its best interest to do so. If the Company elects to cash settle a forward sale agreement, it may not receive any proceeds and it may owe cash to the relevant forward counterparty in certain circumstances. As of March 31, 2024, 11,040,000 shares remain unsettled under the January 2024 forward sale agreements.

Surrendered Shares on Vested Stock Unit Awards

During the three months ended March 31, 2024 and 2023, portions of restricted stock unit awards (“RSUs”) granted to certain of the Company’s officers, directors, and employees vested. The vesting of these awards, granted pursuant to the NETSTREIT Corp. 2019 Omnibus Incentive Plan (the “Omnibus Incentive Plan”), resulted in federal and state income tax liabilities for the recipients. During the three months ended March 31, 2024 and 2023, as permitted by the terms of the Omnibus Incentive Plan and the award grants, certain executive officers and employees elected to surrender an approximate total of 62 thousand and 18 thousand RSUs, respectively, valued at approximately $1.1 million and $0.4 million, respectively, solely to pay the associated statutory tax withholding. The surrendered RSUs are included in the row entitled “repurchase of common stock for tax withholding obligations” in the condensed consolidated statements of cash flows.

21

Dividends

During the three months ended March 31, 2024, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Three Months Ended March 31, 2024
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 13, 2024	$	0.205	March 15, 2024	$	15,031	March 28, 2024

During the three months ended March 31, 2023, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Three Months Ended March 31, 2023
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 21, 2023	$	0.200	March 15, 2023	$	11,650	March 30, 2023

The holders of OP Units are entitled to an equal distribution per each OP Unit held as of each record date. Accordingly, during each of the three months ended March 31, 2024 and 2023, the Operating Partnership paid distributions of $0.1 million to holders of OP Units.

Noncontrolling Interests

Noncontrolling interests represent noncontrolling holders of OP Units in the Operating Partnership. OP Units are convertible into common stock as the OP Units may be redeemed for cash or, at the Company’s election, exchanged for shares of the Company’s common stock on a one-for-one basis. As of March 31, 2024 and December 31, 2023, noncontrolling interests represented 0.6% and 0.7%, respectively, of OP Units. During the three months ended March 31, 2024 and 2023, OP Unit holders redeemed 7,119 and 5,694 and OP units, respectively, into shares of common stock on a one-for-one basis.

Note 10 – Stock-Based Compensation

Under the Omnibus Incentive Plan, 2,094,976 shares of common stock are reserved for issuance. The Omnibus Incentive Plan provides for the grant of stock options, stock appreciation rights, restricted shares, RSUs, long-term incentive plan units, dividend equivalent rights, and other share-based, share-related or cash-based awards, including performance-based awards, to employees, directors and consultants, with each grant evidenced by an award agreement providing the terms of the award. The Omnibus Incentive Plan is administered by the Compensation Committee of the Board of Directors.

As of March 31, 2024, the only stock-based compensation granted by the Company were RSUs. The total amount of stock-based compensation costs recognized in general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive income (loss) was $1.8 million and $1.0 for the three months ended March 31, 2024 and 2023, respectively. All awards of unvested restricted stock units are expected to fully vest over the next one to five years.

Performance-Based RSUs (effectiveness of Initial Public Offering)

Pursuant to the Omnibus Incentive Plan, the Company made performance-based RSUs to certain employees and non-employee directors. The performance condition required the Company to effectively file a resale registration statement. Up until the point of filing the registration statement, performance was not deemed probable and accordingly, no RSUs had the capability of vesting and no stock-based compensation expense was recorded. As a result of the Company's initial public offering in August 2020, the performance condition was satisfied and the Company recorded a stock-based compensation expense catch-up adjustment of $1.4 million. The vesting terms of these grants are specific to the individual grant and are expected to fully vest during the current year.

22

The following table summarizes performance-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	30,379	$	19.75
Granted during the period	—	—
Forfeited during the period	—	—
Vested during the period	—	—
Unvested RSU grants outstanding as of March 31, 2024	30,379	$	19.75

For the three months ended March 31, 2024, the Company recognized less than $0.1 million in stock-based compensation expense associated with performance-based RSUs. As of March 31, 2024 and December 31, 2023, the remaining unamortized stock-based compensation expense totaled $0.1 million and $0.1 million, respectively, and as of March 31, 2024, these awards are expected to be recognized over a remaining weighted average period of 0.7 years. These units are subject to graded vesting and stock-based compensation expense is recognized ratably over the requisite service period for each vesting tranche in the award.

The grant date fair value of unvested RSUs is calculated as the per share price in the private offering that closed on December 23, 2019.

Service-Based RSUs

Pursuant to the Omnibus Incentive Plan, the Company has made service-based RSU grants to certain employees and non-employee directors. The vesting terms of these grants are specific to the individual grant and vest in equal annual installments over the next one to five years.

The following table summarizes service-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	298,108	$	19.79
Granted during the period	200,140	17.33
Forfeited during the period	—	—
Vested during the period	(130,220)	19.85
Unvested RSU grants outstanding as of March 31, 2024	368,028	$	18.50

For the three months ended March 31, 2024, the Company recognized $1.0 million in stock-based compensation expense associated with service-based RSUs. As of March 31, 2024 and December 31, 2023, the remaining unamortized stock-based compensation expense totaled $5.4 million and $3.4 million, respectively, and as of March 31, 2024, these awards are expected to be recognized over a remaining weighted average period of 2.2 years. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award.

The grant date fair value of service-based unvested RSUs is calculated as the per share price determined in the initial public offering for awards granted in 2020, and as the per share price of the Company’s stock on the date of grant for those granted in years subsequent to 2020.

23

Performance-Based RSUs (total shareholder return)

Pursuant to the Omnibus Incentive Plan, the Company has made market-based RSU grants to certain employees. These grants are subject to the participant’s continued service over a three year period with 40% of the award based on the Company’s total shareholder return (“TSR”) as compared to the TSR of identified peer companies and 60% of the award based on total absolute TSR over the cumulative three year period. The performance period of these grants runs through February 28, 2025, February 28, 2026, and December 31, 2026. Grant date fair value of the market-based share awards was calculated using the Monte Carlo simulation model, which incorporated stock price volatility of the Company and each of the Company’s peers and other variables over the performance period. Significant inputs for the current period calculation were expected volatility of the Company of 24.9% and expected volatility of the Company's peers, ranging from 19.9% to 49.4%, with an average volatility of 27.1% and a risk-free interest rate of 4.41%. The fair value per share on the grant date specific to the target TSR relative to the Company’s peers was $18.03 and the target absolute TSR was $14.56 for a weighted average grant date fair value of $15.77 per share. Stock-based compensation expense associated with unvested market-based share awards is recognized on a straight-line basis over the minimum required service period, which is three years.

The following table summarizes market-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	258,558	$	20.38
Granted during the period	169,002	16.05
Forfeited during the period	(69,959)	16.92
Vested during the period	(45,977)	20.29
Unvested RSU grants outstanding as of March 31, 2024	311,624	$	18.82

For the three months ended March 31, 2024, the Company recognized $0.6 million in stock-based compensation expense associated with market-based RSUs. As of March 31, 2024, the remaining unamortized stock-based compensation expense totaled $4.0 million and as of March 31, 2024, these awards are expected to be recognized over a remaining weighted average period of 2.4 years.

Alignment of Interest Program

During March 2021, the Company adopted the Alignment of Interest Program (the “Program”), which allows employees to elect to receive a portion of their annual bonus in RSUs in the first quarter of the following year, that vests from one to four years based on the terms of the grant agreement. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award, which begins in the period the bonus relates. The Program is deemed to be a liability-classified award (accounted for as an equity-classified award as the service date precedes the grant date and the award would otherwise be classified as equity on grant date), which will be fair-valued and accrued over the applicable service period. The total estimated fair value of the elections made for 2024 under the Program was approximately $1.7 million. The award will be remeasured to fair value each reporting period until the unvested RSUs are granted. For the three months ended March 31, 2024, the Company recognized approximately $0.1 million in stock-based compensation expense associated with these awards. Previous awards under the Program that have been granted are included within service-based RSUs above.

Note 11 – Earnings Per Share

Net income per common share has been computed pursuant to the guidance in the FASB ASC Topic 260, Earnings per Share. Basic earnings per share is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is similarly calculated except that the denominator is increased by using the treasury stock method to determine the potential dilutive effect of the Company’s outstanding unvested RSUs and unsettled shares under open forward equity contracts and using the if-converted method to determine the potential dilutive effect of the OP Units. The Company has noncontrolling interests in the form of OP Units which are convertible into common stock and represent potentially dilutive securities, as the OP Units may be redeemed for cash or, at the Company’s election, exchanged for shares of the Company’s common stock on a one-for-one basis.

24

The following table is a reconciliation of the numerator and denominator used in the computation of basic and diluted net income per common share for the three months ended March 31, 2024 and 2023.

	Three Months Ended March 31,
(In thousands, except share and per share data)	2024		2023
Numerator:
Net income	$	1,052	$	1,481
Net (income) attributable to noncontrolling interest	(7)		(9)
Net income attributable to common shares, basic	1,045		1,472
Net income attributable to noncontrolling interest	7		9
Net income attributable to common shares, diluted	$	1,052	$	1,481
Denominator:
Weighted average common shares outstanding, basic	73,248,804		58,155,738
Effect of dilutive shares for diluted net income per common share:
OP Units	478,524		511,402
Unvested RSUs	168,556		175,859
Unsettled shares under open forward equity contracts	669,906		40,387
Weighted average common shares outstanding, diluted	74,565,790		58,883,386
Net income available to common stockholders per common share, basic	$	0.01	$	0.03
Net income available to common stockholders per common share, diluted	$	0.01	$	0.03

As of March 31, 2024 and December 31, 2023, there were 472,179 and 479,298 of OP Units outstanding, respectively.

Note 12 – Commitments and Contingencies

Litigation and Regulatory Matters

In the ordinary course of business, from time to time, the Company may be subject to litigation, claims and regulatory matters, none of which are currently outstanding, which the Company believes could have, individually or in the aggregate, a material adverse effect on its business, financial condition or results of operations, liquidity or cash flows.

Environmental Matters

The Company is subject to environmental regulations related to the ownership of real estate. The cost of complying with the environmental regulations was not material to the Company’s results of operations for any of the periods presented. The Company is not aware of any environmental condition on any of its properties that is likely to have a material adverse effect on the condensed consolidated financial statements when the fair value of such liability can be reasonably estimated and is required to be recognized.

Commitments

In the normal course of business, the Company enters into various types of commitments to purchase real estate properties, fund development projects, or extend funds under mortgage notes receivable. These commitments are generally subject to the Company’s customary due diligence process and, accordingly, a number of specific conditions must be met before the Company is obligated to purchase or extend funding. As of March 31, 2024, the Company had tenant improvement allowance commitments totaling approximately $4.1 million, which is expected to be funded over the next two years. Additionally, as of March 31, 2024, the Company had commitments to fund 13 properties under development totaling $25.0 million, all of which is expected to be funded throughout the remainder of 2024. The Company also had commitments to extend funds under mortgage notes receivable of $12.4 million as of March 31, 2024, which is expected to occur throughout 2024.

In August 2021, the Company entered into a lease agreement on a new corporate office space, which is classified as an operating lease. The Company began operating out of the new office in February 2022. The lease has a remaining noncancellable term of 8.3 years that expires on July 31, 2032 and is renewable at the Company’s option for two additional periods of five years. Annual rent expense, excluding operating expenses, is approximately $0.5 million during the initial term.

25

As of March 31, 2024, the Company did not have any other material commitments for re-leasing costs, recurring capital expenditures, non-recurring building improvements, or similar types of costs.

Note 13 – Subsequent Events

The Company has evaluated all events that occurred subsequent to March 31, 2024 through the date on which these condensed consolidated financial statements were issued to determine whether any of these events required disclosure in the financial statements.

Common Stock Dividend

On April 23, 2024, the Company's Board of Directors declared a cash dividend of $0.205 per share for the second quarter of 2024. The dividend will be paid on June 14, 2024 to stockholders of record on June 3, 2024.

Revolver Activity

In April 2024, the Company paid $12.0 million, net of borrowings, on the 2026 Revolver.

2023 ATM Program

In April 2024, the Company entered into forward sale agreements with respect to an aggregate 1,635,600 shares of its common stock under the 2023 ATM Program at a weighted average price of $17.63 per share. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchaser. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than April 12, 2025. The Company may also elect to cash settle or net share settle all or a portion of its obligations under a forward sale agreement if it concludes it is in its best interest to do so. If the Company elects to cash settle a forward sale agreement, it may not receive any proceeds and it may owe cash to the relevant forward counterparty in certain circumstances. No physical settlement has occurred through the date on which these consolidated financial statements were issued.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements concerning our business and growth strategies, investment, financing and leasing activities and trends in our business, including trends in the market for single-tenant, retail commercial real estate. Words such as “expects,” “anticipates,” “intends,” “plans,” “likely,” “will,” “believes,” “seeks,” “estimates,” and variations of such words and similar expressions are intended to identify such forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from the results of operations or plans expressed or implied by such forward-looking statements. Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore such statements included in this Quarterly Report on Form 10-Q may not prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that the results or conditions described in such statements or our objectives and plans will be achieved. For a further discussion of these and other factors that could impact future results, performance or transactions, see the information under the heading “Risk Factors” Part I, Item 1A. in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”) on February 14, 2024, and other reports filed with the Securities and Exchange Commission from time to time.

Forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this Quarterly Report on Form 10-Q. New risks and uncertainties may arise over time and it is not possible for us to predict those events or how they may affect us. We expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, to reflect any change in our expectations with regard thereto, or any other change in events, conditions or circumstances on which any such statement is based, except to the extent otherwise required by law.

26

Business Overview

We are an internally managed real estate company that acquires, owns, invests in and manages a diversified portfolio of single-tenant, retail commercial real estate subject to long-term net leases with high credit quality tenants across the United States. As of March 31, 2024, we owned or had investments in 628 single-tenant retail net leased properties that were diversified by tenant, industry and geography, including 88 different tenants, across 26 retail sectors in 45 states. This excludes 16 property developments where rent has yet to commence. We focus on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants, all of which we refer to as defensive retail industries. As of March 31, 2024, our investments generated ABR1 of $140.3 million. Approximately 71% of our ABR is from investment grade2 credit rated tenants and an additional 13% of our ABR is derived from tenants with an investment grade profile3. Exclusive of mortgage loans receivable, our portfolio was 100% occupied with a weighted average remaining lease term (“WALT”) of 9.2 years, which we believe provides us with a strong stable source of recurring cash flow from our portfolio.

January Follow-On Offering

In January 2024, we completed a registered public offering of 11,040,000 shares of our common stock at a public offering price of $18.00 per share. In connection with the offering, we entered into forward sale agreements for 11,040,000 shares of our common stock. We did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. We expect to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than January 9, 2025. We may also elect to cash settle or net share settle all or a portion of our obligations under a forward sale agreement if we conclude it is in our best interest to do so. If we elect to cash settle a forward sale agreement, we may not receive any proceeds and we may owe cash to the relevant counterparty in certain circumstances. No physical settlement has occurred under the January 2024 forward sale agreements through March 31, 2024.

2023 ATM Program

On October 25, 2023, we entered into a $300.0 million at-the-market equity program (the “2023 ATM Program”) through which, from time to time, we may sell shares of our common stock in registered transactions. On March 28, 2024, we entered into a forward sale agreement for 107,500 shares of our common stock under the 2023 ATM Program at a public offering price of $18.29 per share. As of March 31, 2024, we had $222.7 million in remaining gross proceeds available for future issuances of shares of our common stock under the 2023 ATM Program, inclusive of unsettled shares under forward confirmation.

2029 Term Loan

On July 3, 2023, we entered into an agreement (the “2029 Term Loan Agreement”) related to a $250.0 million sustainability-linked senior unsecured term loan (the “2029 Term Loan”) which may, subject to the terms of the 2029 Term Loan Agreement, be increased to an amount of up to $400.0 million at our request. We drew an additional $100.0 million under the 2029 Term Loan on March 1, 2024.

We have hedged the entire $250.0 million of the 2029 Term Loan at an all-in fixed interest rate of 4.99%, through January 2029, which consists of the fixed rate SOFR swap of 3.74%, plus a credit spread adjustment of 0.10% and, at current leverage levels, a borrowing spread of 1.15%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. See further discussion of our debt, interest rate, and interest rate hedges included in “Note 6 - Debt” in “Item 1 - Financial Statements (unaudited).”

(1) Annualized base rent (“ABR”) is annualized base rent as of March 31, 2024, for all leases that commenced, and annualized cash interest on mortgage loans receivable in place as of that date.

(2) We define “investment grade” tenants as tenants, or tenants that are subsidiaries of a parent entity, with a credit rating of BBB- (S&P/Fitch), Baa3 (Moody's) or NAIC2 (National Association of Insurance Commissioners) or higher.

(3) We define “investment grade profile” tenants as tenants with metrics of more than $1.0 billion in annual sales and a debt to adjusted EBITDA ratio of less than 2.0x but do not carry a published rating from S&P, Moody’s or NAIC.

27

Results of Operations

Overall

We continued to grow our assets during the first quarter of 2024 through the acquisition of properties, property developments, and investment in mortgage loans receivable. This growth was financed through a $100.0 million draw on our 2029 Term Loan, the usage of existing cash balances as a result of borrowings on our Revolver, the usage of existing restricted cash balances as a result of tax-free exchanges under Section 1031 of the Internal Revenue Code of 1986, and cash flows from operations during the three months ended March 31, 2024.

Acquisitions

During the three months ended March 31, 2024, we acquired 28 properties for a total purchase price of $95.2 million, inclusive of $1.2 million of capitalized acquisition costs. The acquisitions were all accounted for as asset acquisitions. These properties are located in 16 states with a WALT of approximately 10.6 years. The underwritten weighted-average capitalization rate on our year to date acquisitions was approximately 7.3%.

Development

As of March 31, 2024, we had 13 property developments under construction. During the three months ended March 31, 2024, we invested $11.0 million in property developments, including the land acquisition of two new developments with a combined initial purchase price of $0.8 million. During the three months ended March 31, 2024, we completed development on seven projects and reclassified approximately $18.4 million from property under development to land, buildings and improvements, and other assets (leasing commissions) in the accompanying condensed consolidated balance sheets. Rent commenced for four of the seven completed developments in the first quarter of 2024, while rent is expected to commence for the other three completed developments in the second quarter of 2024. The remaining 13 developments are expected to be substantially completed with rent commencing at various points throughout 2024. The purchase price, including acquisition costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of March 31, 2024.

Dispositions

During the three months ended March 31, 2024, we sold 12 properties for a total sales price, net of disposal costs, of $20.5 million, recognizing a net loss of $1.0 million.

Investment in Mortgage Loans Receivable

During the three months ended March 31, 2024, we invested an additional $10.2 million in fully collateralized mortgage loans receivable with stated interest rates of 10.25%. The mortgage loans receivable are collateralized by real estate, primarily leased by investment grade credit rated tenants. The funds provided under the loans, in addition to loan origination costs, net of loan origination fees of less than $0.1 million, are included in mortgage loans receivable, net in the accompanying consolidated balance sheets as of March 31, 2024. See “Note 4 - Real Estate Investments” in “Item 1 - Financial Statements (unaudited)” for further discussion on our mortgage loans receivable portfolio.

Economic and Financial Environment

The average inflation rate for the three months ended March 31, 2024 was 3.5% as compared to 5.0% for the prior year period. While the Federal Reserve had been raising interest rates in an effort to lower inflation throughout 2022 and the first half of 2023, there continues to be uncertainty entering into 2024 as to whether rates will be maintained or potentially cut, and the timing of potential cuts, leading to uncertainties in the financing market and a volatile economy.

In the commercial real estate market, property prices generally continue to fluctuate which may impact our investment capitalization rates and operating costs. Likewise, during certain periods, including the current market, the credit markets have experienced significant price volatility, dislocations, and liquidity disruptions, which may impact our access to and cost of capital. We continually monitor the commercial real estate and credit markets carefully and, if required, will make decisions to adjust our business strategy accordingly.

28

Three Months Ended March 31, 2024 Compared with Three Months Ended March 31, 2023

The following table sets forth our operating results for the periods indicated (in thousands):

	Three Months Ended March 31,
	2024		2023
Revenues
Rental revenue (including reimbursable)	$	35,189	$	28,474
Interest income on loans receivable	2,484		978
Total revenues	37,673		29,452
Operating expenses
Property	4,102		3,936
General and administrative	5,707		4,909
Depreciation and amortization	17,541		14,949
Provisions for impairment	3,662		—
Transaction costs	129		109
Total operating expenses	31,141		23,903
Other (expense) income
Interest expense, net	(6,180)		(3,944)
Gain (loss) on sales of real estate, net	997		(319)
Other (expense) income, net	(280)		152
Total other (expense) income, net	(5,463)		(4,111)
Net income before income taxes	1,069		1,438
Income tax (expense) benefit	(17)		43
Net income	$	1,052	$	1,481

Revenue. Revenue for the three months ended March 31, 2024 increased by $8.2 million to $37.7 million from $29.5 million for the three months ended March 31, 2023 which is attributed to an increase in the number of our operating leases and properties securing our mortgage loans. The increase includes additional cash rental receipts of $6.9 million, combined with net increases of property expense reimbursements of $0.1 million, an increase of $1.5 million related to interest income on mortgage loans receivable, and an increase in straight-line rental revenue of $0.2 million. The increase in revenue is offset by a $0.2 million decrease in above/below market lease adjustments and a $0.3 million decrease related to prior year recoveries.

Total Operating Expenses. Total expenses increased by $7.2 million to $31.1 million for the three months ended March 31, 2024 as compared to $23.9 million for the three months ended March 31, 2023. The increase is primarily attributed to an increase in the number of operating properties, with the most significant increases being depreciation and amortization expense, provisions for impairment, property-specific reimbursable expenses, and payroll and severance costs. Total operating expenses include the following:

•Property Expenses. Property expenses increased $0.2 million to $4.1 million for the three months ended March 31, 2024 from $3.9 million for the three months ended March 31, 2023. The increase is primarily attributed to the increase in the number of operating properties, including combined net increases of reimbursable property expenses, including $0.3 million of reimbursable property taxes, offset by a decrease of $0.3 million of reimbursable common area maintenance costs. Additionally, non-reimbursable expenses increased by $0.1 million, primarily consisting of roof repairs.

•General and Administrative Expenses. General and administrative expenses increased $0.8 million to $5.7 million for the three months ended March 31, 2024 from $4.9 million for the three months ended March 31, 2023. The increase is primarily due to an increase in employee severance of $0.8 million, including cash severance of $0.5 million and the expense associated with the accelerated vesting of stock-based compensation of $0.3 million, an increase of $0.4 million of stock-based compensation, offset by a decrease of $0.2 million of payroll expenses, and other combined net decreases of $0.2 million. While our general and administrative expenses will continue to rise in some measure as our portfolio grows, we expect that such expenses as a percentage of our portfolio will decrease over time due to efficiencies and economies of scale.

29

•Depreciation and Amortization. Depreciation and amortization expense increased $2.6 million to $17.5 million for the three months ended March 31, 2024 from $14.9 million for the three months ended March 31, 2023. The increase in depreciation and amortization is proportionate to the increase in the size of the portfolio over the comparable period with associated increases in building depreciation expense of $1.7 million, building improvements depreciation expense of $0.5 million, in-place lease amortization expense of $0.2 million, and leasing commissions amortization expense of $0.2 million.

•Provisions for impairment. For the three months ended March 31, 2024, we recorded provisions for impairment of $3.7 million on 12 properties, the majority of which were either previously classified as held-for-sale, newly classified as held-for-sale or disposed of during three months ended March 31, 2024. Four of the properties are held for investment as of the three months ended March 31, 2024. For the three months ended March 31, 2023, we recorded no provisions for impairment. For the three months ended March 31, 2024, we sold two properties that were impaired. These disposals relate to management’s continuous assessment of the Company’s portfolio in an effort to improve returns and manage risk exposure.

Interest Expense. Interest expense increased by $2.3 million to $6.2 million for the three months ended March 31, 2024 from $3.9 million for the three months ended March 31, 2023. The increase is primarily attributed to an increase of $2.3 million of interest incurred under the 2029 Term Loan executed on July 3, 2023, an increase of $0.8 million of interest incurred under the 2027 Term Loan (amendment and restatement of the 2024 Term Loan on June 15, 2023), offset by a net decrease of less than $0.1 million under the Revolver as a result of a decrease in average borrowings outstanding which was offset by higher interest rates. An additional increase of $0.3 million was attributable to increased loan fee amortization. This is offset by $1.0 million in amortization of deferred gains on interest rate swaps and $0.2 million of increased capitalized interest on our property developments.

Gain (loss) on sales of real estate, net. Net gain on sales of real estate increased by $1.3 million to $1.0 million for the three months ended March 31, 2024 from a $0.3 million net loss for the three months ended March 31, 2023. The table below summarizes the properties sold for the periods indicated (in thousands):

	Three Months Ended March 31,
	2024		2023
Number of properties sold	12		8
Sales price, net of disposal costs	$	20,466	$	15,463
Gain (loss) on sales of real estate, net	$	997	$	(319)

Other (expense) income, net. Other (expense) income, net decreased by $0.4 million for the three months ended March 31, 2024 primarily due to a $0.4 million loss recorded on one property as a result of foundation issues in 2024.

Net income. Net income decreased $0.4 million to $1.1 million for the three months ended March 31, 2024 from $1.5 million for the three months ended March 31, 2023. Net income decreased primarily due to increases in provisions for impairment, interest expense, and depreciation and amortization expense, offset by increases in gains on sales of real estate and additional rental revenues primarily due to the growth in the size of our real estate investment portfolio, including interest income associated with our mortgage loans receivable.

Liquidity and Capital Resources

Our primary capital requirements are to fund property acquisitions and developments, fund investments in mortgage loans receivable and required interest payments, and fund working capital needs, operating expenses, and capital expenditures. Our capital resources primarily consist of cash from operations, sales of equity securities and available borrowing facilities. As of March 31, 2024, we had $175.0 million outstanding principal amount under the senior unsecured term loan (the “2027 Term Loan”), $200.0 million outstanding principal amount under the senior unsecured term loan (the “2028 Term Loan”), $250.0 million outstanding principal amount under the 2029 Term Loan, and $75.0 million of borrowings outstanding under our $400.0 million senior unsecured revolving credit facility (the “Revolver”). Additionally, as of March 31, 2024, we had $98.5 million and $1.9 million of unsettled forward equity under the 2021 ATM Program and 2023 ATM Program, respectively. As of March 31, 2024, $222.7 million of remaining gross proceeds were available for future issuances of shares of our common stock under the 2023 ATM Program, inclusive of unsettled shares under forward confirmation. Lastly, we had $190.5 million of unsettled forward equity under the January 2024 forward sale agreements as of March 31, 2024.

30

We believe the availability of proceeds from the settlement of unsettled outstanding forward confirmations, future issuances of shares of our common stock under the 2023 ATM Program or subsequent at-the-market sale programs, as well as our cash flows from operations and available borrowing capacity under the Revolver, will be adequate to support our ongoing operations and to fund our debt service requirements, capital expenditures and working capital requirements for at least the next 12 months. We anticipate funding our long-term capital needs through cash provided from operations, borrowings under our Revolver, and issuances of common stock.

Contractual Obligations and Commitments

As of March 31, 2024, our contractual debt obligations primarily include the maturity of our 2027 Term Loan with the scheduled principal payment due on January 15, 2026, the maturity of our 2028 Term Loan with the scheduled principal payment due on February 11, 2028, the maturity of our 2029 Term Loan with the scheduled principal payment due on July 3, 2026, and repayment of borrowings on our Revolver with a maturity of August 11, 2026. During the three months ended March 31, 2024, we borrowed $82.0 million at a weighted average interest rate of 6.54% and also repaid $87.0 million on our revolving credit facilities.

The following table provides information with respect to our commitments as of March 31, 2024 (in thousands):

	Payment Due by Period
	Total		From April 1, 2024 to December 31, 2024		2025 - 2026		2027 - 2028		Thereafter
Contractual Obligations
2027 Term Loan – Principal	$	175,000	$	—	$	175,000	$	—	$	—
2027 Term Loan – Variable interest (1)	10,775		4,132		6,643		—		—
2028 Term Loan – Principal	200,000		—		—		200,000		—
2028 Term Loan – Variable Interest (2)	29,992		5,820		15,521		8,651		—
2029 Term Loan – Principal	250,000		—		250,000		—		—
2029 Term Loan – Variable interest (3)	28,096		9,348		18,748		—		—
Revolver – Borrowings	75,000		—		75,000		—		—
Revolver – Variable interest	11,368		3,611		7,757		—		—
Facility Fee (4)	1,417		450		967		—		—
Mortgage Note – Principal	8,322		123		348		7,851		—
Mortgage Note – Interest	1,328		280		726		322		—
Property development under contract	24,961		24,961		—		—		—
Additional principal under mortgage notes receivable	12,371		12,371		—		—		—
Tenant improvement allowances	4,089		4,089		—		—		—
Corporate office lease obligations	5,736		466		1,289		1,359		2,622
Total	$	838,455	$	65,651	$	551,999	$	218,183	$	2,622

(1) We entered into five interest rate hedges to fix the base interest rate (daily SOFR) on our 2027 Term Loan. The hedged fixed rate reset effective November 27, 2023 to 1.87% and will reset December 23, 2024 to 2.40%. Accordingly, the projected interest rate obligations for the variable rate 2027 Term Loan are based on the hedged fixed rate of 1.87% through December 23, 2024, and 2.40% thereafter, compared to the variable 2027 Term Loan daily SOFR rate as of March 31, 2024 of 5.31%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15% based on the $175.0 million 2027 Term Loan outstanding through the contractual maturity date of January 15, 2026.

(2) We entered into three interest rate hedges to fix the base interest rate (one-month SOFR) on our 2028 Term Loan. Accordingly, the projected interest rate obligations for the variable rate 2028 Term Loan are based on the hedged fixed rate of 2.63% compared to the variable 2028 Term Loan one-month SOFR rate as of March 31, 2024 of 5.33%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15% based on the $200.0 million 2028 Term Loan outstanding through the maturity date of February 11, 2028.

(3) We entered into four interest rate hedges to fix the base interest rate (daily SOFR) on our 2029 Term Loan. Accordingly, the projected interest rate obligations for the variable rate 2029 Term Loan are based on the hedged fixed rate of 3.74% compared to the variable 2029 Term Loan daily SOFR rate as of March 31, 2024 of 5.32%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15% based on the $150.0 million of the 2029 Term Loan outstanding through the contractual maturity date of July 3, 2026.

(4) We are subject to a facility fee of 0.15% on our Revolver.

In August 2021, we entered into a lease agreement on a new corporate office space, which is classified as an operating lease. We began operating out of the new office in February 2022. The lease has a remaining noncancellable term of 8.3 years that expires on July 31, 2032 and is renewable at our option for two additional periods of five years. Annual rent expense, excluding operating expenses, is approximately $0.5 million during the initial term.

31

Additionally, in the normal course of business, we enter into various types of commitments to purchase real estate properties, fund development projects, or extend funds under mortgage notes receivable. These commitments are generally subject to our customary due diligence process and, accordingly, a number of specific conditions must be met before we are obligated to purchase or extend funding. As of March 31, 2024, we had commitments to fund properties under development and extend funds under mortgage notes receivable totaling $25.0 million and $12.4 million, respectively, all of which is expected to be funded throughout 2024.

Debt

See discussion of our debt and interest rate hedges included in “Note 6 - Debt” and “Note 7 - Derivative Financial Instruments” in “Item 1 – Financial Statements (unaudited).”

Historical Cash Flow Information

Three Months Ended March 31, 2024 Compared with Three Months Ended March 31, 2023

	Three Months Ended March 31,
	2024		2023
(In thousands)	(Unaudited)
Net cash provided by (used in):
Operating activities	$	11,651	$	14,806
Investing activities	(97,202)		(102,412)
Financing activities	77,956		23,659

Cash Flows Provided By Operating Activities. Net cash provided by operating activities decreased by $3.1 million for the three months ended March 31, 2024 compared to the three months ended March 31, 2023. The decrease was largely attributed to the timing of corporate and property related vendor payments and changes to other working capital accounts, including the payment of our annual insurance policies, payments of employee severance and bonus, and increased interest payments along with other net increases in operating and general and administrative expenses associated with our larger portfolio. This was offset by an increase in rental receipts of $6.9 million and an increase in mortgage loan receivable interest of $1.5 million.

Cash Flows Used In Investing Activities. Net cash used in investing activities decreased by $5.2 million for the three months ended March 31, 2024 compared to the three months ended March 31, 2023. The decrease was primarily due to decreases in cash spent on investments in mortgage loans receivable of $35.7 million and $1.8 million less in earnest money deposits made, offset by increases in cash spent on acquisitions of real estate and real estate developments and improvements of $27.5 million and $9.8 million, respectively. The remaining decrease is primarily related to proceeds from the sale of real estate, which increased $5.0 million compared to the prior period.

Cash Flows Provided By Financing Activities. Net cash provided by financing activities increased by $54.3 million for the three months ended March 31, 2024 compared to the three months ended March 31, 2023. The increase was primarily attributed to a $100.0 million draw on our 2029 Term Loan during the three months ended March 31, 2024 and an increase in net borrowings of $12.0 million under our Revolver. The increase was offset by a decrease of $52.9 million from the issuance of our common stock, further offset by an increase in payments of common stock dividends of $3.3 million and increases in the repurchase of common stock for tax withholding obligations of $0.7 million.

Income Taxes

The Company elected to be treated and qualify as a REIT for U.S. federal income tax purposes beginning with its short taxable year ended December 31, 2019. To qualify as a REIT, the Company must meet certain organizational, income, asset and distribution tests. Accordingly, the Company will generally not be subject to corporate U.S. federal or state income tax to the extent that it makes qualifying distributions of all of its taxable income to its stockholders and provided it satisfies on a continuing basis, through actual investment and operating results, the REIT requirements, including certain asset, income, distribution and share ownership tests. The Company intends to make sufficient distributions during 2024 to receive a full dividends paid deduction.

32

We maintain a taxable REIT subsidiary (“TRS”) which may be subject to U.S. federal, state, and local income taxes on its taxable income. In general, our TRS may perform services for tenants of the Company, hold assets that the Company cannot hold directly and may engage in any real estate or non-real estate-related business.

Recent Accounting Pronouncements

A discussion of recent accounting pronouncements and their possible effects on our condensed consolidated financial statements is included in “Note 2 – Summary of Significant Accounting Policies” in “Item 1 – Financial Statements (unaudited).”

Critical Accounting Policies and Estimates

Our accounting policies have been established to conform with U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires us to use judgment in the application of accounting policies, including making estimates and assumptions. These judgments affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that we have made these estimates and assumptions in an appropriate manner and in a way that accurately reflects our financial condition. We continually test and evaluate these estimates and assumptions using our historical knowledge of the business, as well as other factors, to ensure that they are reasonable for reporting purposes. However, actual results may differ from these estimates and assumptions. If our judgment or interpretation of the facts and circumstances relating to the various transactions had been different, it is possible that different accounting policies would have been applied, thus resulting in a different presentation of the financial statements. Additionally, other companies may utilize different estimates that may impact comparability of our results of operations to those of companies in similar businesses. A summary of our critical accounting policies is included in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2023, which is accessible on the SEC’s website at www.sec.gov. There have been no material changes to these policies during the periods covered by this quarterly report.

Non-GAAP Financial Measures

Our reported results are presented in accordance with GAAP. We also disclose the following non-GAAP financial measures: Funds From Operations (“FFO”), Core FFO, Adjusted FFO (“AFFO”), earnings before interest expense, income tax expense, and depreciation and amortization (“EBITDA”), EBITDA further adjusted to exclude gains (or losses) from the sales of depreciable property and real estate impairment losses (“EBITDAre”), Adjusted EBITDAre, Annualized Adjusted EBITDAre, Net Debt, Adjusted Net Debt, property-level net operating income (“Property-Level NOI”), property-level cash net operating income (“Property-Level Cash NOI”), property-level cash net operating income estimated run rate (“Property-Level Cash NOI Estimated Run Rate”), and total property-level cash net operating income estimated run rate (“Total Property-Level Cash NOI Estimated Run Rate”), all of which are detailed below. We believe these non-GAAP financial measures are industry measures used by analysts and investors to compare the operating performance of REITs.

FFO, Core FFO and AFFO

The National Association of Real Estate Investment Trusts ("NAREIT"), an industry trade group, has promulgated a widely accepted non-GAAP financial measure of operating performance known as FFO. Our FFO is net income in accordance with GAAP, excluding gains (or losses) resulting from dispositions of properties, plus depreciation and amortization and impairment charges on depreciable real property.

Core FFO is a non-GAAP financial measure defined as FFO adjusted to remove the effect of unusual and non-recurring items that are not expected to impact our operating performance or operations on an ongoing basis. These include non-recurring executive transition costs, severance and related charges, other loss (gain), net, and loss on debt extinguishments and other related costs.

AFFO is a non-GAAP financial measure defined as Core FFO adjusted for GAAP net income related to non-cash revenues and expenses, such as straight-line rent, amortization of above- and below-market lease-related intangibles, amortization of lease incentives, capitalized interest expense and earned development interest, non-cash interest expense, non-cash compensation expense, amortization of deferred financing costs, amortization of above/below-market assumed debt, and amortization of loan origination costs.

33

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. In fact, real estate values historically have risen or fallen with market conditions. FFO is intended to be a standard supplemental measure of operating performance that excludes historical cost depreciation and valuation adjustments from net income. We consider FFO to be useful in evaluating potential property acquisitions and measuring operating performance.

We further consider FFO, Core FFO and AFFO to be useful in determining funds available for payment of distributions. FFO, Core FFO and AFFO do not represent net income or cash flows from operations as defined by GAAP. You should not consider FFO, Core FFO and AFFO to be alternatives to net income as a reliable measure of our operating performance nor should you consider FFO, Core FFO and AFFO to be alternatives to cash flows from operating, investing or financing activities (as defined by GAAP) as measures of liquidity.

FFO, Core FFO and AFFO do not measure whether cash flow is sufficient to fund our cash needs, including principal amortization, capital improvements and distributions to stockholders. FFO, Core FFO and AFFO do not represent cash flows from operating, investing or financing activities as defined by GAAP. Further, FFO, Core FFO and AFFO as disclosed by other REITs might not be comparable to our calculations of FFO, Core FFO and AFFO.

The following table sets forth a reconciliation of FFO, Core FFO and AFFO for the periods presented to net income before allocation to noncontrolling interests, as computed in accordance with GAAP (in thousands):

	Three Months Ended March 31,
	2024		2023
	(Unaudited)
Net income	$	1,052	$	1,481
Depreciation and amortization of real estate	17,462		14,884
Provisions for impairment	3,662		—
(Gain) loss on sales of real estate, net	(997)		319
FFO	21,179		16,684
Adjustments:
Non-recurring executive transition costs, severance and related charges	857		13
Non-recurring other loss (gain), net	414		(12)
Core FFO	22,450		16,685
Adjustments:
Straight-line rent adjustments	(542)		(311)
Amortization of deferred financing costs	558		308
Amortization of above/below-market assumed debt	29		29
Amortization of loan origination costs and discounts	39		28
Amortization of lease-related intangibles	(95)		(213)
Earned development interest	332		—
Capitalized interest expense	(353)		(134)
Non-cash interest expense	(979)		—
Non-cash compensation expense	1,424		1,027
AFFO	$	22,863	$	17,419

EBITDA, EBITDAre, Adjusted EBITDAre and Annualized Adjusted EBITDAre

We compute EBITDA as earnings before interest expense, income tax expense, and depreciation and amortization. In 2017, NAREIT issued a white paper recommending that companies that report EBITDA also report EBITDAre. We compute EBITDAre in accordance with the definition adopted by NAREIT. NAREIT defines EBITDAre as EBITDA (as defined above) excluding gains (or losses) from the sales of depreciable property and impairment charges on depreciable real property.

Adjusted EBITDAre is a non-GAAP financial measure defined as EBITDAre further adjusted to exclude straight-line rent, non-cash compensation expense, non-recurring executive transition costs, severance and related charges, loss on debt extinguishment and other related costs, other loss (gain), net, other non-recurring expenses (income), lease termination fees, adjustment for construction in process, and adjustment for intraquarter activities. Annualized Adjusted EBITDAre is Adjusted EBITDAre multiplied by four.

34

We present EBITDA, EBITDAre, Adjusted EBITDAre and Annualized Adjusted EBITDAre as they are measures commonly used in our industry. We believe that these measures are useful to investors and analysts because they provide supplemental information concerning our operating performance, exclusive of certain non-cash items and other costs. We use EBITDA, EBITDAre, Adjusted EBITDAre and Annualized Adjusted EBITDAre as measures of our operating performance and not as measures of liquidity.

EBITDA, EBITDAre, Adjusted EBITDAre and Annualized Adjusted EBITDAre do not include all items of revenue and expense included in net income, they do not represent cash generated from operating activities and they are not necessarily indicative of cash available to fund cash requirements; accordingly, they should not be considered alternatives to net income as a performance measure or cash flows from operations as a liquidity measure and should be considered in addition to, and not in lieu of, GAAP financial measures. Additionally, our computation of EBITDA, EBITDAre, Adjusted EBITDAre and Annualized Adjusted EBITDAre may differ from the methodology for calculating these metrics used by other equity REITs and, therefore, may not be comparable to similarly titled measures reported by other equity REITs.

The following table sets forth a reconciliation of EBITDA and EBITDAre for the periods presented to net income before allocation to noncontrolling interests, as computed in accordance with GAAP (in thousands):

	Three Months Ended March 31,
	2024		2023
	(Unaudited)
Net income	$	1,052	$	1,481
Depreciation and amortization of real estate	17,462		14,884
Amortization of lease-related intangibles	(95)		(213)
Non-real estate depreciation and amortization	79		65
Interest expense, net	6,180		3,944
Income tax expense (benefit)	17		(43)
Amortization of loan origination costs	39		28
EBITDA	24,734		20,146
Adjustments:
Provisions for impairments	3,662		—
(Gain) loss on sales of real estate, net	(997)		319
EBITDAre	27,399		20,465

35

The following table sets forth a reconciliation of EBITDA, EBITDAre, Adjusted EBITDAre and Annualized Adjusted EBITDAre for the period presented to net income before allocation to noncontrolling interests, as computed in accordance with GAAP (in thousands):

	Three Months Ended March 31, 2024
Net income	$	1,052
Depreciation and amortization of real estate	17,462
Amortization of lease-related intangibles	(95)
Non-real estate depreciation and amortization	79
Interest expense, net	6,180
Income tax expense (benefit)	17
Amortization of loan origination costs	39
EBITDA	24,734
Adjustments:
Provisions for impairments	3,662
(Gain) loss on sales of real estate, net	(997)
EBITDAre	27,399
Adjustments:
Straight-line rent adjustments	(542)
Non-recurring executive transition costs, severance and related charges	857
Non-recurring other loss (gain), net	414
Other non-recurring expenses, net	158
Non-cash compensation expense	1,424
Adjustment for construction in process (1)	497
Adjustment for intraquarter investment activities (2)	1,469
Adjusted EBITDAre	$	31,676
Annualized Adjusted EBITDAre (3)	$	126,704
Adjusted Net Debt / Annualized Adjusted EBITDAre	3.1

(1) Adjustment reflects the estimated cash yield on developments in process as of March 31, 2024.

(2) Adjustment assumes all re-leasing activity, investments in and dispositions of real estate, including developments and interest earning loan activity completed during the three months ended March 31, 2024 had occurred on January 1, 2024.

(3) We calculate Annualized Adjusted EBITDAre by multiplying Adjusted EBITDAre by four.

Net Debt and Adjusted Net Debt

We calculate our Net Debt as our principal amount of total debt outstanding excluding deferred financing costs, net discounts and debt issuance costs less cash, cash equivalents and restricted cash available for future investment.

We further adjust Net Debt by the net value of unsettled forward equity as of period end to derive Adjusted Net Debt. We believe excluding cash, cash equivalents and restricted cash available for future investment from our principal amount in addition to excluding the net value of unsettled forward equity, all of which could be used to repay debt, provides an estimate of the net contractual amount of borrowed capital to be repaid. We believe these adjustments are additional beneficial disclosures to investors and analysts.

36

The following table reconciles the principal amount of total debt to Net Debt and Adjusted Net Debt:

	As of
	March 31, 2024
Principal amount of total debt	$	708,322
Less: Cash, cash equivalents and restricted cash	(22,334)
Net Debt	685,988
Less: Value of unsettled forward equity (1)	(290,908)
Adjusted Net Debt	$	395,080

(1) There were 17,131,211 unsettled shares under forward equity contracts as of March 31, 2024 at the available weighted-average net settlement price of $16.98.

Property-Level NOI, Property-Level Cash NOI, Property-Level Cash NOI - Estimated Run Rate, and Total Cash NOI - Estimated Run Rate

Property-Level NOI, Property-Level Cash NOI, Property-Level Cash NOI - Estimated Run Rate, and Total Cash NOI - Estimated Run Rate are non-GAAP financial measures which we use to assess our operating results. We compute Property-Level NOI as net income (computed in accordance with GAAP), excluding general and administrative expenses, interest expense (or income), income tax expense, transaction costs, depreciation and amortization, gains (or losses) on sales of depreciable property, real estate impairment losses, interest income on mortgage loans receivable, loss on debt extinguishment, lease termination fees and other expense (income), net. We further adjust Property-Level NOI for non-cash revenue components of straight-line rent and amortization of lease-intangibles to derive Property-Level Cash NOI. We further adjust Property-Level Cash NOI for intraquarter acquisitions, dispositions and completed development to derive Property-Level Cash NOI - Estimated Run Rate. We further adjust Property-Level Cash NOI - Estimated Run Rate for interest income on mortgage loans receivable and intraquarter mortgage loan activity to derive Total Cash NOI - Estimated Run Rate. We believe Property-Level NOI, Property-Level Cash NOI, Property-Level Cash NOI - Estimated Run Rate, and Total Cash NOI - Estimated Run Rate provide useful and relevant information because they reflect only those income and expense items that are incurred at the property level and present such items on an unlevered basis.

Property-Level NOI, Property-Level Cash NOI, Property-Level Cash NOI - Estimated Run Rate, and Total Cash NOI - Estimated Run Rate are not measurements of financial performance under GAAP, and may not be comparable to similarly titled measures of other companies. You should not consider our measures as alternatives to net income or cash flows from operating activities determined in accordance with GAAP.

The following table sets forth a reconciliation of Property-Level NOI and Property-Level Cash NOI for the periods presented (in thousands):

	Three Months Ended March 31,
	2024		2023
	(Unaudited)
Net income	$	1,052	$	1,481
General and administrative	5,707		4,909
Depreciation and amortization	17,541		14,949
Provisions for impairment	3,662		—
Transaction costs	129		109
Interest expense, net	6,180		3,944
(Gain) loss on sales of real estate, net	(997)		319
Income tax expense (benefit)	17		(43)
Interest income on mortgage loans receivable	(2,484)		(978)
Other expense (income), net	280		(152)
Property-Level NOI	31,087		24,538
Straight-line rent adjustments	(542)		(311)
Amortization of lease-related intangibles	(95)		(213)
Property-Level Cash NOI	$	30,450	$	24,014

37

The following table sets forth a reconciliation of Property-Level NOI, Property-Level Cash NOI, Property-Level Cash NOI - Estimated Run Rate, and Total Cash NOI - Estimated Run Rate for the period presented (in thousands):

	Three Months Ended March 31, 2024
Net income	$	1,052
General and administrative	5,707
Depreciation and amortization	17,541
Provisions for impairment	3,662
Transaction costs	129
Interest expense, net	6,180
(Gain) loss on sales of real estate, net	(997)
Gain on forfeited earnest money deposit	—
Income tax expense (benefit)	17
Interest income on mortgage loans receivable	(2,484)
Other expense (income), net	280
Property-Level NOI	31,087
Straight-line rent adjustments	(542)
Amortization of lease-related intangibles	(95)
Property-Level Cash NOI	$	30,450
Adjustment for intraquarter acquisitions, dispositions and interest earning development (1)	1,358
Property-Level Cash NOI Estimated Run Rate	31,808
Interest income on mortgage loans receivable	2,484
Adjustments for intraquarter mortgage loan activity (2)	111
Total Cash NOI - Estimated Run Rate	$	34,403

(1) Adjustment assumes all re-leasing activity, investments in and dispositions of real estate, including developments completed during the three months ended March 31, 2024 had occurred on January 1, 2024.

(2) Adjustment assumes all loan activity completed during the three months ended March 31, 2024 had occurred on January 1, 2024.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our future income, cash flows and fair value relevant to our financial instruments depend upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. Based upon the nature of our operations, the principal market risk to which we are exposed is the risk related to interest rate fluctuations. As of March 31, 2024, we had total indebtedness of approximately $175.0 million under the 2027 Term Loan, $200.0 million under the 2028 Term Loan, $250.0 million under the 2029 Term Loan, and $75.0 million of borrowings under the Revolver, all of which are floating rate debt with a variable interest rate. For the three months ended March 31, 2024, we had average daily outstanding borrowings on our Revolver of $59.6 million.

Effective through the maturity dates of January 15, 2027, February 11, 2028, and January 3, 2029, we entered into interest rate derivative contracts in order to hedge our market interest risk associated with the 2027 Term Loan, 2028 Term Loan, and 2029 Term Loan, respectively. The interest rate derivative contracts convert the variable rate debt on the term loans to a fixed interest rate (as further described in “Note 6 - Debt” in our condensed consolidated financial statements).

Additionally, we will occasionally fund acquisitions through the use of our Revolver which bears an interest rate determined by either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 1.00% to 1.45%, based on our consolidated total leverage ratio, or (ii) a Base Rate (as defined in the New Credit Facility), plus a margin ranging from 0.00% to 0.45%, based on our consolidated total leverage ratio. Many factors, including governmental monetary and tax policies, domestic and international economic and political considerations, and other factors that are beyond our control contribute to our interest rate risk. Based on the results of our sensitivity analysis and daily outstanding borrowings on the Revolver during 2024, which assumes a 1% adverse change in the interest rate as of March 31, 2024, the estimated market risk exposure was approximately $0.6 million.

38

Item 4. Controls and Procedures

Disclosure Controls and Procedures.

At the end of the period covered by this report, the Company conducted an evaluation, under the supervision and with the participation of its principal executive officer and principal financial officer, of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that its disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

Changes in Internal Control over Financial Reporting.

During the period covered by this report, there have been no changes in the Company’s internal control over financial reporting identified in connection with the evaluation described above that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

39

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of our business. We are not currently subject to any lawsuits, claims, or other legal proceedings.

Item 1A. Risk Factors

For a discussion of the most significant factors that may adversely affect us, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, which is accessible on the SEC’s website at www.sec.gov. There have been no material changes to the risk factors disclosed in the Annual Report. These risk factors may not describe every risk facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Company Stock Repurchases

None.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

40

Item 6. Exhibits

Exhibit No.	Description
3.1	Conformed Articles of Amendment and Restatement of NETSTREIT Corp. (incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022).
3.2	Amended and Restated Bylaws of NETSTREIT Corp. (incorporated by reference to Exhibit 3.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022).
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**	XBRL Instance Document.
101.SCH***	XBRL Taxonomy Extension Schema Document.
101.CAL***	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB***	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE***	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF***	XBRL Taxonomy Extension Definition Linkbase Document.
104**	Cover Page Interactive Data File.

*	Filed herewith.
**	The XBRL Instance Document and Cover Page Interactive Data File do not appear in the Interactive Data File because their XBRL tags are embedded within the Inline XBRL document.
***	Submitted electronically with the report.

41

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NETSTREIT Corp.
April 29, 2024	/s/ MARK MANHEIMER
Date	Mark Manheimer
	President, Chief Executive Officer, Secretary and Director
	(Principal Executive Officer)
April 29, 2024	/s/ DANIEL DONLAN
Date	Daniel Donlan
	Chief Financial Officer and Treasurer
	(Principal Financial Officer)
April 29, 2024	/s/ PATRICIA GIBBS
Date	Patricia Gibbs
	Senior Vice President and Chief Accounting Officer
	(Principal Accounting Officer)

42

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Mark Manheimer, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of NETSTREIT Corp.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	April 29, 2024	By:	/s/ MARK MANHEIMER
			Mark Manheimer
			President, Chief Executive Officer, and Secretary

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Daniel Donlan, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of NETSTREIT Corp.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	April 29, 2024	By:	/s/ DANIEL DONLAN
			Daniel Donlan
			Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of NETSTREIT Corp. (the "Company") for the period ended March 31, 2024, as filed with the Securities and Exchange Commission (the "Report"), the undersigned, as the President, Chief Executive Officer, Secretary and Director of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

    1.    The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

    2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	April 29, 2024	Signed:	/s/ MARK MANHEIMER
			Mark Manheimer
			President, Chief Executive Officer, and Secretary

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of NETSTREIT Corp. (the "Company") for the period ended March 31, 2024, as filed with the Securities and Exchange Commission (the "Report"), the undersigned, as the Chief Financial Officer and Treasurer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

    1.    The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

    2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	April 29, 2024	Signed:	/s/ DANIEL DONLAN
			Daniel Donlan
			Chief Financial Officer and Treasurer

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	Apr. 26, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-39443
Entity Registrant Name	NETSTREIT Corp.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	84-3356606
Entity Address, Address Line One	2021 McKinney Avenue
Entity Address, Address Line Two	Suite 1150
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75201
City Area Code	972
Local Phone Number	200-7100
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	NTST
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		73,366,371
Entity Central Index Key	0001798100
Amendment Flag	false
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Real estate, at cost:
Land	$ 472,330	$ 460,896
Buildings and improvements	1,209,333	1,149,809
Total real estate, at cost	1,681,663	1,610,705
Less accumulated depreciation	(110,632)	(101,210)
Property under development	21,800	29,198
Real estate held for investment, net	1,592,831	1,538,693
Assets held for sale	58,856	52,451
Mortgage loans receivable, net	124,617	114,472
Cash, cash equivalents and restricted cash	22,334	29,929
Lease intangible assets, net	165,507	161,354
Other assets, net	61,402	49,337
Total assets	2,025,547	1,946,236
Liabilities:
Term loans, net	621,500	521,912
Revolving credit facility	75,000	80,000
Mortgage note payable, net	7,876	7,883
Lease intangible liabilities, net	24,639	25,353
Liabilities related to assets held for sale	1,110	1,158
Accounts payable, accrued expenses and other liabilities	26,265	36,498
Total liabilities	756,390	672,804
Total liabilities
Equity:
Stockholders’ equity	733	732
Additional paid-in capital	1,368,312	1,367,505
Distributions in excess of retained earnings	(126,270)	(112,276)
Distributions in excess of retained earnings	18,020	8,943
Accumulated other comprehensive income	1,260,795	1,264,904
Total stockholders’ equity	8,362	8,528
Noncontrolling interests	1,269,157	1,273,432
Total equity	$ 2,025,547	$ 1,946,236

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	73,328,411	73,207,080
Common stock, shares outstanding	73,328,411	73,207,080

XML

Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Rental revenue (including reimbursable)	$ 35,189,000	$ 28,474,000
Interest income on loans receivable	2,484,000	978,000
Total revenues	37,673,000	29,452,000
Operating expenses
Property	4,102,000	3,936,000
General and administrative	5,707,000	4,909,000
Depreciation and amortization	17,541,000	14,949,000
Provisions for impairment	3,662,000	0
Transaction costs	129,000	109,000
Total operating expenses	31,141,000	23,903,000
Other (expense) income
Interest expense, net	(6,180,000)	(3,944,000)
Gain (loss) on sales of real estate, net	997,000	(319,000)
Total other (expense) income, net	(5,463,000)	(4,111,000)
Net income before income taxes	1,069,000	1,438,000
Income tax (expense) benefit	(17,000)	43,000
Net income	1,052,000	1,481,000
Net income attributable to noncontrolling interests	7,000	9,000
Net income attributable to common stockholders	$ 1,045,000	$ 1,472,000
Amounts available to common stockholders per common share:
Basic (in dollars per share)	$ 0.01	$ 0.03
Diluted (in dollars per share)	$ 0.01	$ 0.03
Weighted average common shares:
Basic (in shares)	73,248,804	58,155,738
Diluted (in shares)	74,565,790	58,883,386
Change in value on derivatives, net	$ 9,128,000	$ (5,979,000)
Total comprehensive income (loss)	10,180,000	(4,498,000)
Comprehensive income (loss) attributable to noncontrolling interests	58,000	(40,000)
Comprehensive income (loss) attributable to common stockholders	10,122,000	(4,458,000)
Other Income	$ (280,000)	$ 152,000

XML

Condensed Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Total Stockholders’ Equity	Common stock	Additional Paid-in Capital	Distributions in Excess of Retained Earnings	Accumulated Other Comprehensive Income	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022			58,031,879
Beginning balance at Dec. 31, 2022	$ 1,058,423	$ 1,048,830	$ 580	$ 1,091,514	$ (66,937)	$ 23,673	$ 9,593
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock (in shares)			2,759,481
Issuance of stock	52,903	52,903	$ 28	52,875
OP Units converted to common stock (in shares)			5,694
OP Units converted to common stock	0	105		105			(105)
Dividends and distributions declared on common stock and OP units	(11,751)	(11,650)			(11,650)		(101)
Dividends declared on restricted stock, net	(122)	(122)			(122)
Vesting of restricted stock units (in shares)			83,428
Vesting of restricted stock units	0		$ 1	(1)
Repurchase of common stock for tax withholding obligations (in shares)			(18,016)
Repurchase of common stock for tax withholding obligations	(360)	(360)		(360)
Stock-based compensation, net	1,027	1,027		1,027
Other comprehensive income	(5,979)	(5,930)				(5,930)	(49)
Net income (loss)	1,481	1,472			1,472		9
Ending balance (in shares) at Mar. 31, 2023			60,862,466
Ending balance at Mar. 31, 2023	1,095,622	1,086,275	$ 609	1,145,160	(77,237)	17,743	9,347
Beginning balance (in shares) at Dec. 31, 2023			73,207,080
Beginning balance at Dec. 31, 2023	1,273,432	1,264,904	$ 732	1,367,505	(112,276)	8,943	8,528
Increase (Decrease) in Stockholders' Equity [Roll Forward]
OP Units converted to common stock (in shares)			7,119
OP Units converted to common stock	0	126		126			(126)
Dividends and distributions declared on common stock and OP units	(15,129)	(15,031)			(15,031)		(98)
Dividends declared on restricted stock, net	(143)	(143)			(143)
Vesting of restricted stock units (in shares)			176,197
Vesting of restricted stock units	0		$ 2	(2)
Repurchase of common stock for tax withholding obligations (in shares)			(61,985)
Repurchase of common stock for tax withholding obligations	(1,069)	(1,069)	$ (1)	(1,068)
Stock-based compensation, net	1,886	1,886		1,751	135
Other comprehensive income	9,128	9,077				9,077	51
Net income (loss)	1,052	1,045			1,045		7
Ending balance (in shares) at Mar. 31, 2024			73,328,411
Ending balance at Mar. 31, 2024	$ 1,269,157	$ 1,260,795	$ 733	$ 1,368,312	$ (126,270)	$ 18,020	$ 8,362

XML

Condensed Consolidated Statements of Cash Flows	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Cash flows from operating activities
Net income	$ 1,052,000	$ 1,481,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	17,541,000	14,949,000
Amortization of deferred financing costs	558,000	308,000
Amortization of above/below-market assumed debt	29,000	29,000
Noncash revenue adjustments	(583,000)	(509,000)
Amortization of deferred gains on interest rate swaps	(979,000)	0
Stock-based compensation expense	1,751,000	1,027,000
(Gain) loss on sales of real estate, net	(997,000)	319,000
Provisions for impairment	3,662,000	0
Loss (gain) on involuntary conversion of buildings and improvements	414,000	(12,000)
Changes in assets and liabilities, net of assets acquired and liabilities assumed:
Other assets, net	(4,015,000)	(1,845,000)
Accounts payable, accrued expenses and other liabilities	(6,782,000)	(441,000)
Lease incentive payments	0	(500,000)
Net cash provided by operating activities	11,651,000	14,806,000
Cash flows from investing activities
Acquisitions of real estate	(95,153,000)	(67,717,000)
Real estate development and improvements	(12,281,000)	(2,480,000)
Investment in mortgage loans receivable	(10,191,000)	(45,917,000)
Principal collections on mortgage loans receivable	7,000	0
Earnest money deposits	(42,000)	(1,773,000)
Purchase of computer equipment and other corporate assets	(8,000)	0
Proceeds from sale of real estate	20,466,000	15,463,000
Proceeds from the settlement of property-related insurance claims	0	12,000
Net cash used in investing activities	(97,202,000)	(102,412,000)
Cash flows from financing activities
Issuance of common stock in public offerings, net	0	52,903,000
Payment of common stock dividends	(15,031,000)	(11,650,000)
Payment of OP unit distributions	(98,000)	(101,000)
Payment of restricted stock dividends	(384,000)	(92,000)
Principal payments on mortgages payable	(39,000)	(26,000)
Proceeds under revolving credit facilities	82,000,000	99,000,000
Repayments under revolving credit facilities	(87,000,000)	(116,000,000)
Proceeds from term loans	100,000,000	0
Repurchase of common stock for tax withholding obligations	(1,069,000)	(360,000)
Deferred offering costs	(423,000)	(15,000)
Net cash provided by financing activities	77,956,000	23,659,000
Net change in cash, cash equivalents and restricted cash	(7,595,000)	(63,947,000)
Cash, cash equivalents and restricted cash at beginning of the period	29,929,000	70,543,000
Cash, cash equivalents and restricted cash at end of the period	22,334,000	6,596,000
Supplemental disclosures of cash flow information:
Cash paid for interest	6,536,000	3,641,000
Supplemental disclosures of non-cash investing and financing activities:
Dividends declared and unpaid on restricted stock, net	7,000	122,000
Deferred offering costs included in accounts payable, accrued expenses and other liabilities	107,000	0
Cash flow hedge change in fair value	10,107,000	(5,979,000)
Accrued capital expenditures and real estate development and improvement costs	$ 1,110,000	$ 2,516,000

XML

Organization and Description of Business

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Description of Business

Organization and Description of Business

NETSTREIT Corp. (the “Company”) was incorporated on October 11, 2019 as a Maryland corporation and commenced operations on December 23, 2019. The Company conducts its operations through NETSTREIT, L.P., a Delaware limited partnership (the “Operating Partnership”). NETSTREIT GP, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, is the sole general partner of the Operating Partnership.

The Company elected to be treated and to qualify as a real estate investment trust (“REIT”) for U.S. federal income tax purposes beginning with its short taxable year ended December 31, 2019. Additionally, the Operating Partnership formed NETSTREIT Management TRS, LLC (“NETSTREIT TRS”), which together with the Company jointly elected to be treated as a taxable REIT subsidiary under Section 856(a) of the Internal Revenue Code of 1986, as amended, (the “Code”) for U.S. federal income tax purposes.

The Company is structured as an umbrella partnership real estate investment trust (commonly referred to as an “UPREIT”) and is an internally managed real estate company that acquires, owns, invests in and manages a diversified portfolio of single-tenant, retail commercial real estate leased on a long-term basis to high credit quality tenants across the United States. As of March 31, 2024, the Company owned or had investments in 628 properties, located in 45 states, excluding 16 property developments where rent has yet to commence.

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The accompanying condensed consolidated financial statements include the accounts of the Company and subsidiaries in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation and the Company’s net income is reduced by the portion of net income attributable to noncontrolling interests.

Interim Unaudited Financial Information

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. These unaudited interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements, and should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto on the Annual Report on Form 10-K as of and for the year ended December 31, 2023, which provide a more complete understanding of the Company’s accounting policies, financial position, operating results, business properties, and other matters. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2024 and 2023 are not necessarily indicative of the results for the full year.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s most significant assumptions and estimates relate to the useful lives of real estate assets, lease accounting, real estate impairment assessments, and allocation of fair value of purchase consideration. These estimates are based on historical experience and other assumptions which management believes are reasonable under the circumstances. The Company evaluates its estimates on an ongoing basis and makes revisions to these estimates and related disclosures as experience develops or new information becomes known. Actual results could differ from those estimates.

Impairment of Long-Lived Assets

Fair value measurement of an asset group occurs when events or changes in circumstances related to an asset indicate that the carrying amount of the asset is no longer recoverable. An example of an event or changed circumstance is a reduction in the expected holding period of a property. If indicators are present, the Company will prepare a projection of the undiscounted future cash flows of the property, excluding interest charges, and determine if the carrying amount of the asset group is recoverable. When a carrying amount is not recoverable, an impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair market value. The Company estimates fair value using data such as operating income, estimated capitalization rates or multiples, leasing prospects, local market information, and discount rates, and with regard to assets held for sale, based on the estimated or negotiated selling price, less estimated costs of disposal. Based on these unobservable inputs, the Company determined that its valuations of impaired real estate and intangible assets fall within Level 2 and Level 3 of the fair value hierarchy under ASC Topic 820.

The following table summarizes the provision for impairment during the periods indicated below (in thousands):

	Three Months Ended March 31,
	2024		2023
Total provision for impairment	$	3,662	$	—
Number of properties: (1)
Classified as held for sale	4		—
Disposed within the period	2		—

(1) Includes the number of properties that were either (i) impaired during the period on the held for sale classification date and remained as held for sale as of period-end or (ii) impaired and disposed of during the respective period. Excludes properties that did not have impairment recorded during the period. Of the total provision for impairment during the three months ended March 31, 2024, the Company recorded $0.3 million of additional impairment expense on two properties that were classified as held for sale in prior periods, and $2.2 million of impairment expense on four properties held for investment.

Cash, Cash Equivalents and Restricted Cash

The Company considers all cash balances, money market accounts and highly liquid investments with original maturities of three months or less to be cash and cash equivalents. Restricted cash includes cash restricted for property tenant improvements and cash proceeds from the sale of assets held by qualified intermediaries in anticipation of the acquisition of replacement properties in tax-free exchanges under Section 1031 of the Code. Restricted cash is included in cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets. The Company had $0.7 million restricted cash as of March 31, 2024, and $11.5 million of restricted cash as of December 31, 2023.

The Company’s bank balances as of March 31, 2024 and December 31, 2023 included certain amounts over the Federal Deposit Insurance Corporation limits.

Fair Value Measurement

Fair value measurements are utilized in the accounting of the Company’s assets acquired and liabilities assumed in an asset acquisition and also affect the Company’s accounting for certain of its financial assets and liabilities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The hierarchy described below prioritizes inputs to the valuation techniques used in measuring the fair value of assets and liabilities. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs to be used when available. The hierarchy is broken down into three levels based on the reliability of inputs as follows: Level 1 inputs, such as quoted prices in an active market; Level 2 inputs, which are observable inputs for similar assets; or Level 3 inputs, which are unobservable inputs.

The Company uses the following inputs in its fair value measurements:

– Level 2 and Level 3 inputs for its debt and derivative financial instrument fair value disclosures. See “Note 6 - Debt” and “Note 7 - Derivative Financial Instruments,” respectively; and

– Level 2 and Level 3 inputs when assessing the fair value of assets and liabilities in connection with real estate acquisitions and impairment. See “Note 4 - Real Estate Investments.”

Additionally, companies are required to disclose the estimated fair values of all financial instruments, even if they are not carried at their fair value. The fair values of financial instruments are estimates based on market conditions and perceived risks as of March 31, 2024 and December 31, 2023. These estimates require management’s judgment and may not be indicative of the future fair values of the assets and liabilities.

The fair value of the Company’s cash, cash equivalents and restricted cash (including money market accounts), other assets and accounts payable, accrued expenses and other liabilities approximate their carrying value because of the short-term nature of these instruments. Additionally, the Company believes the following financial instruments have carrying values that approximate their fair values as of March 31, 2024:

•Borrowings under the Company’s Revolver (as defined in “Note 6 - Debt”) approximate fair value based on their nature, terms and variable interest rates.

•Carrying values of the Company’s mortgage loans receivable approximate fair values based on a number of factors, including either their short-term nature, the availability of market quotes for comparable instruments, and a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

•Carrying value of the Company’s mortgage note payable approximates fair value based on a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

Provisions for impairment recognized during the three months ended March 31, 2024 partially related to assets held for sale where impairment was determined based on the estimated or negotiated selling price, less costs of disposal, compared to the carrying value of the property. Of the total provision for impairment during the three months ended March 31, 2024, the Company also recorded $2.2 million of impairment expense on four properties held for investment. These properties were accounted for at fair value on a nonrecurring basis using a cash flow model (Level 3 inputs) with adjusted carrying values ranging from $0.6 million to $1.6 million. The Company estimated the fair value using capitalization rates ranging from 9.0% to 12.1% which it believes is reasonable based on current market rates. As of December 31, 2023, there were two real estate assets held for investment accounted for at fair value. Of these properties, one was accounted for at fair value on a nonrecurring basis using a cash flow model (Level 3 inputs) with an adjusted carrying value of $1.5 million.

The following table discloses estimated fair value information for the Company’s 2027 Term Loan, 2028 Term Loan, and 2029 Term Loan (each as defined in “Note 6 - Debt”) which is derived based primarily on unobservable market inputs such as interest rates and discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates and credit spreads (in thousands):

	March 31, 2024				December 31, 2023
	Carrying Value (1)		Estimated Fair Value		Carrying Value (1)		Estimated Fair Value
2027 Term Loan	$	174,155	$	172,770	$	174,037	$	175,641
2028 Term Loan	199,066		198,101		199,006		201,396
2029 Term Loan	248,279		247,002		148,869		150,666

(1) The carrying value of the debt instruments are net of unamortized debt issuance and discount costs.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company is exposed to credit risk with respect to cash held at various financial institutions, access to its credit facilities, amounts due under mortgage loans receivable, and amounts due or payable under derivative contracts. The credit risk exposure with regard to the Company’s cash, credit facilities, and derivative instruments is spread among a diversified group of investment grade financial institutions.

During the three months ended March 31, 2024, one tenant, Dollar General, accounted for 10.43% of total revenues. During the three months ended March 31, 2023, there were no tenants or borrowers with rental revenue or interest income on loans receivable that exceeded 10% of total rental revenue.

Segment Reporting

ASC Topic 280, Segment Reporting, establishes standards for the manner in which companies report information about operating segments. Substantially all of the Company’s investments, at acquisition, are comprised of real estate owned that is leased to tenants on a long-term basis or real estate that secures the Company's investment in mortgage loans receivable. The Company allocates resources and assesses operating performance based on individual investment and property needs. Therefore, the Company aggregates these investments for reporting purposes and operates in one reportable segment.

XML

Leases

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Leases

Leases

Tenant Leases

The Company acquires, owns and manages commercial single-tenant lease properties, with the majority being long-term triple-net leases where the tenant is generally responsible for all improvements and contractually obligated to pay all operating costs (such as real estate taxes, utilities and repairs and maintenance costs). As of March 31, 2024, exclusive of mortgage loans receivable, the Company’s weighted average remaining lease term was 9.2 years.

The Company’s property leases have been classified as operating leases and some have scheduled rent increases throughout the lease term. The Company’s leases typically provide the tenant one or more multi-year renewal options to extend their leases, subject to generally the same terms and conditions, including rent increases, consistent with the initial lease term.

All lease-related income is reported as a single line item, rental revenue (including reimbursable), in the condensed consolidated statements of operations and comprehensive income (loss) and is presented net of any reserves, write-offs, or recoveries for uncollectible amounts.

Fixed lease income includes stated amounts per the lease contract, which include base rent, fixed common area maintenance charges, and straight-line lease adjustments.

Variable lease income primarily includes recoveries from tenants, which represent amounts that tenants are contractually obligated to reimburse the Company for, specific to their portion of actual recoverable costs incurred. Variable lease income also includes percentage rent, which represents amounts billable to tenants based on their actual sales volume in excess of levels specified in the lease contract.

The following table provides a disaggregation of lease income recognized under ASC 842 (in thousands):

	Three Months Ended March 31,
	2024		2023
Rental revenue
Fixed lease income (1)	$	31,865	$	24,723
Variable lease income (2)	3,228		3,538
Other rental revenue:
Above/below market lease amortization, net	287		412
Lease incentives	(191)		(199)
Rental revenue (including reimbursable)	$	35,189	$	28,474

(1) Fixed lease income includes contractual rents under lease agreements with tenants recognized on a straight-line basis over the lease term.

(2) Variable lease income primarily includes tenant reimbursements for real estate taxes, insurance, common area maintenance, and lease termination fees, and the write-off of uncollectible amounts. There were no material reserves, write-offs, or recoveries of uncollectible amounts during the three months ended March 31, 2024 and March 31, 2023.

Scheduled future minimum base rental payments (excluding base rental payments from properties classified as held for sale and straight-line rent adjustments for all properties) due to be received under the remaining non-cancelable term of the operating leases in place as of March 31, 2024 are as follows (in thousands):

	Future Minimum Base Rental Receipts
Remainder of 2024	$	94,421
2025	125,888
2026	123,362
2027	119,701
2028	112,884
Thereafter	615,487
Total	$	1,191,743

Future minimum rentals exclude amounts that may be received from tenants for reimbursements of operating costs and property taxes. In addition, the future minimum rents do not include any contingent rents based on a percentage of the lessees' gross sales or lease escalations based on future changes in the Consumer Price Index or other stipulated reference rate.

XML

Real Estate Investments

3 Months Ended

Mar. 31, 2024

Real Estate [Abstract]

Real Estate Investments

Real Estate Investments

As of March 31, 2024, the Company owned or had investments in 628 properties, excluding 16 property developments where rent has yet to commence. The gross real estate investment portfolio, including properties under development, totaled approximately $1.9 billion and consisted of the gross acquisition cost of land, buildings, improvements, lease intangible assets and liabilities, and property development costs. The investment portfolio is geographically dispersed throughout 45 states with gross real estate investments in Illinois and Texas representing 9.4% and 8.8%, respectively, of the total gross real estate investment of the Company’s investment portfolio.

Acquisitions

During the three months ended March 31, 2024, the Company acquired 28 properties for a total purchase price of $95.2 million, inclusive of $1.2 million of capitalized acquisition costs.

During the three months ended March 31, 2023, the Company acquired 20 properties for a total purchase price of $67.7 million, inclusive of $0.7 million of capitalized acquisition costs.

The acquisitions were all accounted for as asset acquisitions. An allocation of the purchase price and acquisition costs paid for the completed acquisitions is as follows (in thousands):

	Three Months Ended March 31,
	2024		2023
Land	$	16,608	$	14,304
Buildings	59,379		43,133
Site improvements	6,428		3,479
Tenant improvements	1,445		391
In-place lease intangible assets	11,293		6,410
Purchase price (including acquisition costs)	$	95,153	$	67,717

Development

As of March 31, 2024, the Company had 13 property developments under construction. During the three months ended March 31, 2024, the Company invested $11.0 million in property developments, including the land acquisition of two new developments with a combined initial purchase price of $0.8 million. During the three months ended March 31, 2024, the Company completed development on seven projects and reclassified approximately $18.4 million from property under development to land, buildings and improvements, and other assets (leasing commissions) in the accompanying condensed consolidated balance sheets. Rent commenced for four of the seven completed developments in the first quarter of 2024, while rent is expected to commence for the other three completed developments in the second quarter of 2024. The remaining 13 developments are expected to be substantially completed with rent commencing at various points throughout 2024. The purchase price, including acquisition costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of March 31, 2024.

During the three months ended March 31, 2023, the Company invested $4.5 million in property developments. During the three months ended March 31, 2023, the Company completed development on two projects and reclassified approximately $14.8 million from property under development to land, buildings and improvements in the accompanying condensed consolidated balance sheets. Rent commenced for the completed developments in the first quarter of 2023. The purchase price, including acquisitions costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of March 31, 2023.

Additionally, during the three months ended March 31, 2024 and 2023, the Company capitalized approximately $0.4 million and $0.1 million, respectively, of interest expense associated with properties under development.

Dispositions

During the three months ended March 31, 2024, the Company sold 12 properties for a total sales price, net of disposal costs, of $20.5 million, recognizing a net gain of $1.0 million.

During the three months ended March 31, 2023, the Company sold eight properties for a total sales price, net of disposal costs, of $15.5 million, recognizing a net loss of $0.3 million.

Investment in Mortgage Loans Receivable

The Company’s mortgage loans receivable portfolio as of March 31, 2024 and December 31, 2023 is summarized below (in thousands):

Loan Type	Monthly Payment (1)	Number of Secured Properties	Effective Interest Rate (2)	Stated Interest Rate	Maturity Date	March 31, 2024		December 31, 2023
Mortgage (3) (4) (5)	I/O	1	6.74%	7.00%	4/8/2024	$	43,612	$	43,612
Mortgage (4)	I/O	46	9.55%	9.55%	3/10/2026	41,940		41,940
Mortgage (4) (6)	I/O	3	8.10%	6.89%	4/10/2026	4,132		4,132
Mortgage (3) (4) (6)	I/O	9	7.59%	7.59%	6/10/2025	14,023		14,024
Mortgage	None (7)	1	8.50%	8.50%	12/29/2024	660		660
Mortgage (3)	P+I	1	7.50%	7.50%	1/8/2025	3,239		3,246
Mortgage (3) (4) (8)	I/O	11	10.22%	10.25%	3/19/2025	14,209		5,007
Mortgage (3) (4)	I/O	2	10.25%	10.25%	12/22/2024	2,915		1,909
Total						124,730		114,530
Unamortized loan origination costs and fees, net						(10)		58
Unamortized discount						(103)		(116)
Total mortgage loans receivable, net						$	124,617	$	114,472

(1) I/O: Interest Only; P+I: Principal and Interest.

(2) Includes amortization of discount and loan origination costs, as applicable.

(3) The Company has the right, subject to certain terms and conditions, to acquire all or a portion of the underlying collateralized properties.

(4) Loans require monthly payments of interest only with principal payments occurring as borrower disposes of underlying properties, limited to the Company’s allocated investment by property. Any remaining principal balance will be repaid at or before the maturity date.

(5) The $43.6 million mortgage note receivable was scheduled to mature on April 8, 2024, however, the Company executed an amendment in April 2024 that extended the maturity date to January 8, 2025.

(6) The stated interest rate is variable up to 15.0% and is calculated based on contractual rent for existing collateralized properties subject to the loan agreement.

(7) Payments of both interest and principal are due at maturity.

(8) The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from December 5, 2024 to March 19, 2025.

Assets Held for Sale

As of March 31, 2024 and December 31, 2023, there were 23 properties classified as held for sale.

Provisions for Impairment

The Company recorded provisions for impairment of $3.7 million on 12 properties for the three months ended March 31, 2024. The Company recorded no provisions for impairment for the three months ended March 31, 2023.

XML

Intangible Assets and Liabilities

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Liabilities

Intangible Assets and Liabilities

Intangible assets and liabilities consisted of the following (in thousands):

	March 31, 2024						December 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Assets:
In-place leases	$	190,133	$	(48,667)	$	141,466	$	181,564	$	(45,210)	$	136,354
Above-market leases	21,635		(4,749)		16,886		21,661		(4,361)		17,300
Lease incentives	8,577		(1,422)		7,155		8,996		(1,296)		7,700
Total intangible assets	$	220,345	$	(54,838)	$	165,507	$	212,221	$	(50,867)	$	161,354
Liabilities:
Below-market leases	$	33,170	$	(8,531)	$	24,639	$	33,196	$	(7,843)	$	25,353

The remaining weighted average amortization period for the Company’s intangible assets and liabilities as of March 31, 2024 and as of December 31, 2023 by category were as follows:

	Years Remaining
	March 31, 2024	December 31, 2023
In-place leases	8.9	8.8
Above-market leases	12.0	12.2
Below-market leases	10.7	10.9
Lease incentives	10.8	11.1

The Company records amortization of in-place lease assets to amortization expense, and records net amortization of above-market and below-market lease intangibles as well as amortization of lease incentives to rental revenue. The following amounts in the accompanying condensed consolidated statements of operations and comprehensive income (loss) related to the amortization of intangible assets and liabilities for all property and ground leases (in thousands):

	Three Months Ended March 31,
	2024		2023
Amortization:
Amortization of in-place leases	$	4,875	$	4,670
Amortization of assembled workforce	—		—
	$	4,875	$	4,670
Net adjustment to rental revenue:
Above-market lease assets	(416)		(371)
Below-market lease liabilities	702		783
Lease incentives	(191)		(199)
	$	95	$	213

The following table provides the projected amortization of in-place lease assets to amortization expense and the net amortization of above-market, below-market, and lease incentive lease intangible assets and liabilities to rental revenue as of March 31, 2024, for the next five years and thereafter (in thousands):

	Remainder of 2024		2025		2026		2027		2028		Thereafter		Total
In-place leases	$	15,531	$	20,386	$	19,153	$	17,160	$	14,356	$	54,880	$	141,466
Above-market lease assets	(1,241)		(1,655)		(1,632)		(1,568)		(1,523)		(9,267)		(16,886)
Below-market lease liabilities	2,098		2,776		2,686		2,615		2,483		11,981		24,639
Lease incentives	(564)		(752)		(752)		(696)		(666)		(3,725)		(7,155)
Net adjustment to rental revenue	$	293	$	369	$	302	$	351	$	294	$	(1,011)	$	598

XML

Debt

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Debt

Debt

Debt consists of the following (in thousands):

				Amounts Outstanding as of
	Contractual Maturity Date	Fully Extended Maturity Date (1)	Interest Rate (2)	March 31, 2024		December 31, 2023
Debt:
2027 Term Loan (3)	January 15, 2026	January 15, 2027	3.12%	$	175,000	$	175,000
2028 Term Loan (4)	February 11, 2028	—	3.88%	200,000		200,000
2029 Term Loan (5)	July 3, 2026	January 3, 2029	4.99%	250,000		150,000
Revolver (6)	August 11, 2026	August 11, 2027	6.42%	75,000		80,000
Mortgage Note	November 1, 2027	—	4.53%	8,322		8,361
Total debt				708,322		613,361
Unamortized discount and debt issuance costs				(3,946)		(3,566)
Unamortized deferred financing costs, net (7)				(1,757)		(1,942)
Total debt, net				$	702,619	$	607,853

(1) Date represents the fully extended maturity date available to the Company, subject to certain conditions, under each related debt instrument.

(2) Rate represents the effective interest rate as of March 31, 2024 and includes the effect of interest rate swap agreements, as described further in “Note 6 - Debt” and “Note 7 - Derivative Financial Instruments.”

(3) Loan is a floating-rate loan which resets daily at daily SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into five interest rate swap agreements that effectively convert the floating rate to a fixed rate. The hedged fixed rate reset effective November 27, 2023 to 1.87% and will reset again effective December 23, 2024 to 2.40%.

(4) Loan is a floating-rate loan which resets monthly at one-month term SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into three interest rate swap agreements that effectively convert the floating rate to a fixed rate.

(5) Loan is a floating-rate loan which resets daily at daily SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into four interest rate swap agreements that effectively convert the floating rate to a fixed rate.

(6) The annual interest rate of the Revolver assumes daily SOFR as of March 31, 2024 of 5.32% plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.00% as of March 31, 2024.

(7) The Company records deferred financing costs associated with the Revolver in other assets, net on its condensed consolidated balance sheets. The Company reclassed the net amount of loan commitment fees associated with the 2029 Term Loan from other assets, net to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan.

2029 Term Loan

On July 3, 2023, the Company entered into an agreement (the “2029 Term Loan Agreement”) related to a $250.0 million sustainability-linked senior unsecured term loan (the “2029 Term Loan”) which may, subject to the terms of the 2029 Term Loan Agreement, be increased to an amount of up to $400.0 million at the Company’s request. The 2029 Term Loan contains a 12-month delayed draw feature and $150.0 million was drawn on July 3, 2023. The 2029 Term Loan is prepayable at the Company’s option in whole or in part without premium or penalty. The 2029 Term Loan matures on July 3, 2026, subject to extension options at the Company’s election on two occasions, by one year and, on one occasion, by six months (subject to certain conditions). Subject to the terms of the 2029 Term Loan Agreement, the Company drew an additional $100.0 million under the 2029 Term Loan on March 1, 2024.

The interest rate applicable to the 2029 Term Loan is determined by the Company’s Investment Grade Rating (as defined in the 2029 Term Loan Agreement). Prior to the date the Company obtains an Investment Grade Rating, interest shall accrue at either

(i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the 2029 Term Loan Agreement), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company’s consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company’s Investment Grade Rating.

The Company has hedged the entire $250.0 million of the 2029 Term Loan at an all-in fixed interest rate of 4.99%, through January 2029, which consists of a fixed SOFR rate of 3.74%, plus a credit spread adjustment of 0.10% and, at current leverage levels, a borrowing spread of 1.15%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings.

The 2029 Term Loan also contains sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the Company’s annualized based rent attributable to tenants with commitments or quantifiable targets for reduced GHG emission in accordance with the standards of the Science Based Targets initiative (“SBTi”).

In connection with the 2029 Term Loan, the Company incurred $1.4 million of deferred financing costs. Additionally, the Company incurred $0.9 million of loan commitment fees associated with the 2029 Term Loan, which were capitalized to other assets, net on the condensed consolidated balance sheets and subsequently reclassed to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan. Deferred financing costs are amortized over the term of the loan and are included in interest expense, net on the Company’s condensed consolidated statements of operations and comprehensive income (loss).

Credit Facility

On August 11, 2022, the Company entered into a sustainability-linked senior unsecured credit facility consisting of (i) a $200.0 million senior unsecured term loan (the “2028 Term Loan”) and (ii) a $400.0 million senior unsecured revolving credit facility (the “Revolver”, and together with the 2028 Term Loan, the “Credit Facility”). The Credit Facility may be increased by $400.0 million in the aggregate for total availability of up to $800.0 million.

The 2028 Term Loan matures on February 11, 2028. The Revolver matures on August 11, 2026, subject to a one year extension option at the Company’s election (subject to certain conditions) to August 11, 2027. Borrowings under the Credit Facility are repayable at the Company’s option in whole or in part without premium or penalty. Borrowings under the Revolver may be repaid and reborrowed from time to time prior to the maturity date.

Prior to the date the Company obtains an Investment Grade Rating (as defined in the credit agreement governing the Credit Facility (the “Credit Agreement”)), interest rates are based on the Company’s consolidated total leverage ratio, and are determined by (A) in the case of the 2028 Term Loan either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 1.15% to 1.60%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.15% to 0.60%, based on the Company’s consolidated total leverage ratio and (B) in the case of the Revolver either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 1.00% to 1.45%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.00% to 0.45%, based on the Company’s consolidated total leverage ratio.

After the date the Company obtains an Investment Grade Rating, interest rates are based on the Company’s Investment Grade Rating, and are determined by (A) in the case of the 2028 Term Loan either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 0.80% to 1.60%, based on the Company’s Investment Grade Rating, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.00% to 0.60%, based on the Company’s Investment Grade Rating and (B) in the case of the Revolver either (i) SOFR, plus a SOFR adjustment of 0.10%, plus a margin ranging from 0.725% to 1.40%, based on the Company’s Investment Grade Rating, or (ii) a Base Rate (as defined in the Credit Agreement), plus a margin ranging from 0.00% to 0.40%, based on the Company’s Investment Grade Rating.

Additionally, the Company will incur a facility fee based on the total commitment amount of $400.0 million under the Revolver. Prior to the date the Company obtains an Investment Grade Rating, the applicable facility fee will range from 0.15% to 0.30% based on the Company’s consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, the applicable facility fee will range from 0.125% to 0.30% based on the Company’s Investment Grade Rating.

The Credit Facility also contains a sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the

Company’s annualized base rent attributable to tenants with commitments or quantifiable targets for reduced greenhouse gas emission in accordance with the standards of the SBTi.

The Company has fully hedged the 2028 Term Loan with an all-in interest rate of 3.88%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedge is further described in “Note 7 – Derivative Financial Instruments.”

In connection with the Credit Facility, the Company incurred approximately $3.8 million of deferred financing costs which were allocated between the Revolver and 2028 Term Loan in the amounts of $2.4 million and $1.3 million, respectively. Additionally, $0.5 million of unamortized deferred financing costs associated with the Company’s previous revolving credit facility were reclassed to the Revolver. Deferred financing costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

2027 Term Loan

In December 2019, the Company entered into an agreement governing a $175.0 million senior unsecured term loan that was scheduled to mature in December 2024 (the “2024 Term Loan”). On June 15, 2023, the Company amended and restated the agreement governing the 2024 Term Loan to provide for a $175.0 million senior unsecured term loan with a maturity date of January 15, 2026 that is subject to a one year extension option at the Company’s election (subject to certain conditions) (the “2027 Term Loan”). The 2027 Term Loan is repayable at the Company’s option in whole or in part without premium or penalty.

The interest rate applicable to the 2027 Term Loan is determined by the Company’s Investment Grade Rating (as defined in the 2027 Term Loan). Prior to the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the 2027 Term Loan), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company’s consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company’s Investment Grade Rating.

Interest is payable monthly or at the end of the applicable interest period in arrears. The Company has fully hedged the 2027 Term Loan. The interest rate hedges are described in “Note 7 – Derivative Financial Instruments.”

Mortgage Note Payable

As of March 31, 2024, the Company had total gross mortgage indebtedness of $8.3 million, which was collateralized by related real estate and a tenant’s lease with an aggregate net book value of $12.5 million. The Company incurred debt issuance costs of less than $0.1 million and recorded a debt discount of $0.6 million, both of which are recorded as a reduction of the principal balance in mortgage note payable, net in the Company’s condensed consolidated balance sheets. The mortgage note matures on November 1, 2027, but may be repaid in full beginning August 2027.

Debt Maturities

Payments on the 2027 Term Loan, 2028 Term Loan, and 2029 Term Loan are interest only through maturity. As of March 31, 2024, scheduled debt maturities, including balloon payments, are as follows (in thousands):

	Scheduled Principal		Balloon Payment (1)		Total
Remainder of 2024	$	123	$	—	$	123
2025	170		—		170
2026	178		500,000		500,178
2027	170		7,681		7,851
2028	—		200,000		200,000
Total	$	641	$	707,681	$	708,322

(1) Does not assume the exercise of any extension options available to the Company.

Interest Expense

The following table is a summary of the components of interest expense related to the Company’s borrowings (in thousands):

	Three Months Ended March 31,
	2024		2023
Revolving credit facilities (1)	$	1,158	$	1,150
Term loans (2)	5,672		2,499
Mortgage note payable	95		93
Non-cash:
Amortization of deferred financing costs	238		185
Amortization of debt discount and debt issuance costs, net	349		151
Amortization of deferred gains on interest rate swaps	(979)		—
Capitalized interest	(353)		(134)
Total interest expense, net	$	6,180	$	3,944

(1) Includes facility fees and non-utilization fees of approximately $0.2 million for both the three months ended March 31, 2024 and 2023.

(2) Includes the effects of interest rate hedges in place as of such date.

Deferred financing, discount, and debt issuance costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

During the three months ended March 31, 2024 and 2023, term loans had a weighted average interest rate, exclusive of amortization of deferred financing costs and the effects of interest rate hedges, of 6.69% and 5.77%, respectively.

During the three months ended March 31, 2024 and 2023, the Company incurred interest expense on revolving credit facilities with a weighted average interest rate, exclusive of amortization of deferred financing costs and facility fees, of 6.54% and 5.86%, respectively.

The estimated fair values of the Company’s term loans have been derived based on market observable inputs such as interest rates and discounted cash flow analysis using estimates of the amount and timing of future cash flows. These measurements are classified as Level 2 within the fair value hierarchy. Refer to “Note 2 - Summary of Significant Accounting Policies” for additional detail on fair value measurements.

The Company was in compliance with all of its debt covenants as of March 31, 2024 and expects to be in compliance for the twelve-month period ending December 31, 2024.

XML

Derivative Financial Instruments

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

The Company uses interest rate derivative contracts to manage its exposure to changes in interest rates on its variable rate debt. These derivatives are considered cash flow hedges and are recorded on a gross basis at fair value. Assessments of hedge effectiveness are performed quarterly using either a qualitative or quantitative approach. The Company recognizes the entire change in the fair value in Accumulated Other Comprehensive Income (“AOCI”) and the change is reflected as cash flow hedge changes in fair value in the supplemental disclosures of non-cash investing and financing activities in the condensed consolidated statements of cash flows.

Effective July 3, 2023, such derivatives were initiated to hedge the variable cash flows associated with the 2029 Term Loan. The interest rate for the variable rate 2029 Term Loan is based on the hedged fixed rate of 3.74% compared to the variable 2029 Term Loan daily SOFR rate as of March 31, 2024 of 5.32%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15%. The maturity dates of the interest rate swaps coincide with the fully extended maturity date of the 2029 Term Loan.

Effective September 1, 2022, such derivatives were initiated to hedge the variable cash flows associated with the 2028 Term Loan. The interest rate for the variable rate 2028 Term Loan is based on the hedged fixed rate of 2.63% compared to the variable 2028 Term Loan one-month SOFR rate as of March 31, 2024 of 5.33%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15%. The maturity dates of the interest rate swaps coincide with the maturity date of the 2028 Term Loan.

Effective January 27, 2023, the Company converted its four existing LIBOR swap agreements associated with the 2024 Term Loan into four new SOFR swaps that convert the SOFR variable rate to a fixed rate of 0.12% and on June 15, 2023, the Company amended and restated its 2024 Term Loan, providing for the 2027 Term Loan. In anticipation of the amendment and restatement of the 2024 Term Loan, additional derivatives, effective November 27, 2023 and December 23, 2024 at hedged fixed rates of 1.87% and 2.40%, respectively, were initiated to hedge the variable cash flows associated with the 2027 Term Loan through the fully extended maturity date. The interest rate on the variable 2027 Term Loan includes a daily SOFR rate as of March 31, 2024 of 5.31%, plus a SOFR adjustment of 0.10% and applicable margin of 1.15%.

Amounts will subsequently be reclassified to earnings when the hedged item affects earnings. The Company does not enter into derivative contracts for speculative or trading purposes and does not have derivative netting arrangements.

The Company is exposed to credit risk in the event of non-performance by its derivative counterparties. The Company evaluates counterparty credit risk through monitoring the creditworthiness of counterparties, which includes review of debt ratings and financial performance. To mitigate credit risk, the Company enters into agreements with counterparties it considers credit-worthy, such as large financial institutions with favorable credit ratings.

The Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk (in thousands, except number of instruments):

	Number of Instruments		Notional
Interest Rate Derivatives	March 31, 2024	December 31, 2023	March 31, 2024		December 31, 2023
Interest rate swaps	12	12	$	650,000	$	650,000

The following table presents the fair value of the Company's derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023 (in thousands):

	Derivative Assets
		Fair Value as of March 31,
Derivatives Designated as Hedging Instruments:	Balance Sheet Location	2024		2023
Interest rate swaps	Other assets, net	$	21,476	$	14,442

	Derivative Liabilities
		Fair Value as of March 31,
Derivatives Designated as Hedging Instruments:	Balance Sheet Location	2024		2023
Interest rate swaps	Accounts payable, accrued expenses and other liabilities	$	—	$	3,073

The following table presents the effect of the Company's interest rate swaps on the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2024 and 2023 (in thousands):

	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
Derivatives in Cash Flow Hedging Relationships	2024		2023			2024		2023
Interest Rate Products	$	13,761	$	(3,141)	Interest expense, net	$	4,633	$	2,837

The Company did not exclude any amounts from the assessment of hedge effectiveness for the three months ended March 31, 2024 and 2023. During the next twelve months, the Company estimates that an additional $14.5 million will be reclassified as a decrease to interest expense.

The valuation of these instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves.

To comply with the provisions of ASC 820, the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. However, as of March 31, 2024, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivatives. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.

The table below presents the Company’s derivative assets measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023, aggregated by the level in the fair value hierarchy within which those measurements fall (in thousands):

	Fair Value Hierarchy Level
Description	Level 1		Level 2		Level 3		Total Fair Value
March 31, 2024
Derivative assets	$	—	$	21,476	$	—	$	21,476
December 31, 2023
Derivative assets	$	—	$	14,442	$	—	$	14,442
Derivative liabilities	$	—	$	3,073	$	—	$	3,073

XML

Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets

Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets

Other assets, net consist of the following (in thousands):

	March 31, 2024		December 31, 2023
Accounts receivable, net	$	10,813	$	10,074
Deferred rent receivable	8,594		7,744
Prepaid assets	3,904		1,387
Earnest money deposits	492		450
Fair value of interest rate swaps	21,476		14,442
Deferred offering costs	1,554		1,031
Deferred financing costs, net	1,757		2,724
Right-of-use asset	3,772		3,866
Leasehold improvements and other corporate assets, net	1,651		1,723
Interest receivable	1,929		1,397
Other assets, net	5,460		4,499
	$	61,402	$	49,337

Accounts payable, accrued expenses and other liabilities consists of the following (in thousands):

	March 31, 2024		December 31, 2023
Accrued expenses	$	8,176	$	8,826
Accrued bonus	520		2,575
Prepaid rent	3,394		3,896
Operating lease liability	4,994		5,104
Accrued interest	2,958		2,921
Deferred rent	3,627		3,257
Accounts payable	622		4,691
Fair value of interest rate swaps	—		3,073
Other liabilities	1,974		2,155
	$	26,265	$	36,498

XML

Shareholders’ Equity, Partners’ Capital and Preferred Equity

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Shareholders’ Equity, Partners’ Capital and Preferred Equity

Shareholders’ Equity, Partners’ Capital and Preferred Equity

ATM Program

On September 1, 2021, the Company entered into a $250.0 million at-the-market equity program (the “2021 ATM Program”). In March 2023, the Company issued 146,745 shares of common stock under the 2021 ATM Program at a weighted average price of $20.22 per share for net proceeds of approximately $2.9 million, net of sales commissions and offering costs of less than $0.1 million. The Company contributed the net proceeds to the Operating Partnership in exchange for 146,745 Class A OP Units.

On October 25, 2023, the Company entered into a $300.0 million at-the-market equity program (the “2023 ATM Program”) through which, from time to time, it may sell shares of its common stock in registered transactions. Effective October 24, 2023, in connection with the establishment of the new at-the-market offering program, the 2021 ATM Program was terminated.

On March 28, 2024, the Company entered into a forward confirmation with respect to 107,500 shares of its common stock under the 2023 ATM Program, at a public offering price of $18.29 per share. 107,500 shares remain unsettled under the forward confirmation as of March 31, 2024. The Company may physically settle this forward confirmation (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than April 12, 2025.

The following table presents information about the 2023 ATM Program and the 2021 ATM Program (in thousands):

				Maximum Sales Authorization		Gross Sales through March 31, 2024
Program Name	Date Established	Date Terminated
2021 ATM Program (1)	September 2021	October 2023		$	250,000	$	150,391
2023 ATM Program (2)	October 2023	—	0	$	300,000	$	77,323

(1) Includes 1,516,289 shares of common stock partially physically settled at a price of $16.49 per share under the forward confirmation with respect to the 2021 ATM Program. 5,983,711 shares remain unsettled under the forward confirmation as of March 31, 2024 at the available net settlement price of $16.46.

(2) 107,500 shares remain unsettled under the forward confirmation as of March 31, 2024 at the available net settlement price of $18.12.

January 2024 Follow-On Offering

In January 2024, the Company completed a registered public offering of 11,040,000 shares of its common stock at a public offering price of $18.00 per share. In connection with the offering, the Company entered into forward sale agreements for 11,040,000 shares of its common stock. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than January 9, 2025. The Company may also elect to cash settle or net share settle all or a portion of its obligations under a forward sale agreement if it concludes it is in its best interest to do so. If the Company elects to cash settle a forward sale agreement, it may not receive any proceeds and it may owe cash to the relevant forward counterparty in certain circumstances. As of March 31, 2024, 11,040,000 shares remain unsettled under the January 2024 forward sale agreements.

Surrendered Shares on Vested Stock Unit Awards

During the three months ended March 31, 2024 and 2023, portions of restricted stock unit awards (“RSUs”) granted to certain of the Company’s officers, directors, and employees vested. The vesting of these awards, granted pursuant to the NETSTREIT Corp. 2019 Omnibus Incentive Plan (the “Omnibus Incentive Plan”), resulted in federal and state income tax liabilities for the recipients. During the three months ended March 31, 2024 and 2023, as permitted by the terms of the Omnibus Incentive Plan and the award grants, certain executive officers and employees elected to surrender an approximate total of 62 thousand and 18 thousand RSUs, respectively, valued at approximately $1.1 million and $0.4 million, respectively, solely to pay the associated statutory tax withholding. The surrendered RSUs are included in the row entitled “repurchase of common stock for tax withholding obligations” in the condensed consolidated statements of cash flows.

Dividends

During the three months ended March 31, 2024, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Three Months Ended March 31, 2024
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 13, 2024	$	0.205	March 15, 2024	$	15,031	March 28, 2024

During the three months ended March 31, 2023, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Three Months Ended March 31, 2023
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 21, 2023	$	0.200	March 15, 2023	$	11,650	March 30, 2023

The holders of OP Units are entitled to an equal distribution per each OP Unit held as of each record date. Accordingly, during each of the three months ended March 31, 2024 and 2023, the Operating Partnership paid distributions of $0.1 million to holders of OP Units.

Noncontrolling Interests

Noncontrolling interests represent noncontrolling holders of OP Units in the Operating Partnership. OP Units are convertible into common stock as the OP Units may be redeemed for cash or, at the Company’s election, exchanged for shares of the Company’s common stock on a one-for-one basis. As of March 31, 2024 and December 31, 2023, noncontrolling interests represented 0.6% and 0.7%, respectively, of OP Units. During the three months ended March 31, 2024 and 2023, OP Unit holders redeemed 7,119 and 5,694 and OP units, respectively, into shares of common stock on a one-for-one basis.

XML

Stock Based Compensation

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Stock Based Compensation

Stock-Based Compensation

Under the Omnibus Incentive Plan, 2,094,976 shares of common stock are reserved for issuance. The Omnibus Incentive Plan provides for the grant of stock options, stock appreciation rights, restricted shares, RSUs, long-term incentive plan units, dividend equivalent rights, and other share-based, share-related or cash-based awards, including performance-based awards, to employees, directors and consultants, with each grant evidenced by an award agreement providing the terms of the award. The Omnibus Incentive Plan is administered by the Compensation Committee of the Board of Directors.

As of March 31, 2024, the only stock-based compensation granted by the Company were RSUs. The total amount of stock-based compensation costs recognized in general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive income (loss) was $1.8 million and $1.0 for the three months ended March 31, 2024 and 2023, respectively. All awards of unvested restricted stock units are expected to fully vest over the next one to five years.

Performance-Based RSUs (effectiveness of Initial Public Offering)

Pursuant to the Omnibus Incentive Plan, the Company made performance-based RSUs to certain employees and non-employee directors. The performance condition required the Company to effectively file a resale registration statement. Up until the point of filing the registration statement, performance was not deemed probable and accordingly, no RSUs had the capability of vesting and no stock-based compensation expense was recorded. As a result of the Company's initial public offering in August 2020, the performance condition was satisfied and the Company recorded a stock-based compensation expense catch-up adjustment of $1.4 million. The vesting terms of these grants are specific to the individual grant and are expected to fully vest during the current year.

The following table summarizes performance-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	30,379	$	19.75
Granted during the period	—	—
Forfeited during the period	—	—
Vested during the period	—	—
Unvested RSU grants outstanding as of March 31, 2024	30,379	$	19.75

For the three months ended March 31, 2024, the Company recognized less than $0.1 million in stock-based compensation expense associated with performance-based RSUs. As of March 31, 2024 and December 31, 2023, the remaining unamortized stock-based compensation expense totaled $0.1 million and $0.1 million, respectively, and as of March 31, 2024, these awards are expected to be recognized over a remaining weighted average period of 0.7 years. These units are subject to graded vesting and stock-based compensation expense is recognized ratably over the requisite service period for each vesting tranche in the award.

The grant date fair value of unvested RSUs is calculated as the per share price in the private offering that closed on December 23, 2019.

Service-Based RSUs

Pursuant to the Omnibus Incentive Plan, the Company has made service-based RSU grants to certain employees and non-employee directors. The vesting terms of these grants are specific to the individual grant and vest in equal annual installments over the next one to five years.

The following table summarizes service-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	298,108	$	19.79
Granted during the period	200,140	17.33
Forfeited during the period	—	—
Vested during the period	(130,220)	19.85
Unvested RSU grants outstanding as of March 31, 2024	368,028	$	18.50

For the three months ended March 31, 2024, the Company recognized $1.0 million in stock-based compensation expense associated with service-based RSUs. As of March 31, 2024 and December 31, 2023, the remaining unamortized stock-based compensation expense totaled $5.4 million and $3.4 million, respectively, and as of March 31, 2024, these awards are expected to be recognized over a remaining weighted average period of 2.2 years. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award.

The grant date fair value of service-based unvested RSUs is calculated as the per share price determined in the initial public offering for awards granted in 2020, and as the per share price of the Company’s stock on the date of grant for those granted in years subsequent to 2020.

Performance-Based RSUs (total shareholder return)

Pursuant to the Omnibus Incentive Plan, the Company has made market-based RSU grants to certain employees. These grants are subject to the participant’s continued service over a three year period with 40% of the award based on the Company’s total shareholder return (“TSR”) as compared to the TSR of identified peer companies and 60% of the award based on total absolute TSR over the cumulative three year period. The performance period of these grants runs through February 28, 2025, February 28, 2026, and December 31, 2026. Grant date fair value of the market-based share awards was calculated using the Monte Carlo simulation model, which incorporated stock price volatility of the Company and each of the Company’s peers and other variables over the performance period. Significant inputs for the current period calculation were expected volatility of the Company of 24.9% and expected volatility of the Company's peers, ranging from 19.9% to 49.4%, with an average volatility of 27.1% and a risk-free interest rate of 4.41%. The fair value per share on the grant date specific to the target TSR relative to the Company’s peers was $18.03 and the target absolute TSR was $14.56 for a weighted average grant date fair value of $15.77 per share. Stock-based compensation expense associated with unvested market-based share awards is recognized on a straight-line basis over the minimum required service period, which is three years.

The following table summarizes market-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	258,558	$	20.38
Granted during the period	169,002	16.05
Forfeited during the period	(69,959)	16.92
Vested during the period	(45,977)	20.29
Unvested RSU grants outstanding as of March 31, 2024	311,624	$	18.82

For the three months ended March 31, 2024, the Company recognized $0.6 million in stock-based compensation expense associated with market-based RSUs. As of March 31, 2024, the remaining unamortized stock-based compensation expense totaled $4.0 million and as of March 31, 2024, these awards are expected to be recognized over a remaining weighted average period of 2.4 years.

Alignment of Interest Program

During March 2021, the Company adopted the Alignment of Interest Program (the “Program”), which allows employees to elect to receive a portion of their annual bonus in RSUs in the first quarter of the following year, that vests from one to four years based on the terms of the grant agreement. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award, which begins in the period the bonus relates. The Program is deemed to be a liability-classified award (accounted for as an equity-classified award as the service date precedes the grant date and the award would otherwise be classified as equity on grant date), which will be fair-valued and accrued over the applicable service period. The total estimated fair value of the elections made for 2024 under the Program was approximately $1.7 million. The award will be remeasured to fair value each reporting period until the unvested RSUs are granted. For the three months ended March 31, 2024, the Company recognized approximately $0.1 million in stock-based compensation expense associated with these awards. Previous awards under the Program that have been granted are included within service-based RSUs above.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Net income per common share has been computed pursuant to the guidance in the FASB ASC Topic 260, Earnings per Share. Basic earnings per share is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is similarly calculated except that the denominator is increased by using the treasury stock method to determine the potential dilutive effect of the Company’s outstanding unvested RSUs and unsettled shares under open forward equity contracts and using the if-converted method to determine the potential dilutive effect of the OP Units. The Company has noncontrolling interests in the form of OP Units which are convertible into common stock and represent potentially dilutive securities, as the OP Units may be redeemed for cash or, at the Company’s election, exchanged for shares of the Company’s common stock on a one-for-one basis.

The following table is a reconciliation of the numerator and denominator used in the computation of basic and diluted net income per common share for the three months ended March 31, 2024 and 2023.

	Three Months Ended March 31,
(In thousands, except share and per share data)	2024		2023
Numerator:
Net income	$	1,052	$	1,481
Net (income) attributable to noncontrolling interest	(7)		(9)
Net income attributable to common shares, basic	1,045		1,472
Net income attributable to noncontrolling interest	7		9
Net income attributable to common shares, diluted	$	1,052	$	1,481
Denominator:
Weighted average common shares outstanding, basic	73,248,804		58,155,738
Effect of dilutive shares for diluted net income per common share:
OP Units	478,524		511,402
Unvested RSUs	168,556		175,859
Unsettled shares under open forward equity contracts	669,906		40,387
Weighted average common shares outstanding, diluted	74,565,790		58,883,386
Net income available to common stockholders per common share, basic	$	0.01	$	0.03
Net income available to common stockholders per common share, diluted	$	0.01	$	0.03

As of March 31, 2024 and December 31, 2023, there were 472,179 and 479,298 of OP Units outstanding, respectively.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Litigation and Regulatory Matters

In the ordinary course of business, from time to time, the Company may be subject to litigation, claims and regulatory matters, none of which are currently outstanding, which the Company believes could have, individually or in the aggregate, a material adverse effect on its business, financial condition or results of operations, liquidity or cash flows.

Environmental Matters

The Company is subject to environmental regulations related to the ownership of real estate. The cost of complying with the environmental regulations was not material to the Company’s results of operations for any of the periods presented. The Company is not aware of any environmental condition on any of its properties that is likely to have a material adverse effect on the condensed consolidated financial statements when the fair value of such liability can be reasonably estimated and is required to be recognized.

Commitments

In the normal course of business, the Company enters into various types of commitments to purchase real estate properties, fund development projects, or extend funds under mortgage notes receivable. These commitments are generally subject to the Company’s customary due diligence process and, accordingly, a number of specific conditions must be met before the Company is obligated to purchase or extend funding. As of March 31, 2024, the Company had tenant improvement allowance commitments totaling approximately $4.1 million, which is expected to be funded over the next two years. Additionally, as of March 31, 2024, the Company had commitments to fund 13 properties under development totaling $25.0 million, all of which is expected to be funded throughout the remainder of 2024. The Company also had commitments to extend funds under mortgage notes receivable of $12.4 million as of March 31, 2024, which is expected to occur throughout 2024.

In August 2021, the Company entered into a lease agreement on a new corporate office space, which is classified as an operating lease. The Company began operating out of the new office in February 2022. The lease has a remaining noncancellable term of 8.3 years that expires on July 31, 2032 and is renewable at the Company’s option for two additional periods of five years. Annual rent expense, excluding operating expenses, is approximately $0.5 million during the initial term.

As of March 31, 2024, the Company did not have any other material commitments for re-leasing costs, recurring capital expenditures, non-recurring building improvements, or similar types of costs.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

The Company has evaluated all events that occurred subsequent to March 31, 2024 through the date on which these condensed consolidated financial statements were issued to determine whether any of these events required disclosure in the financial statements.

Common Stock Dividend

On April 23, 2024, the Company's Board of Directors declared a cash dividend of $0.205 per share for the second quarter of 2024. The dividend will be paid on June 14, 2024 to stockholders of record on June 3, 2024.

Revolver Activity

In April 2024, the Company paid $12.0 million, net of borrowings, on the 2026 Revolver.

2023 ATM Program

In April 2024, the Company entered into forward sale agreements with respect to an aggregate 1,635,600 shares of its common stock under the 2023 ATM Program at a weighted average price of $17.63 per share. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchaser. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than April 12, 2025. The Company may also elect to cash settle or net share settle all or a portion of its obligations under a forward sale agreement if it concludes it is in its best interest to do so. If the Company elects to cash settle a forward sale agreement, it may not receive any proceeds and it may owe cash to the relevant forward counterparty in certain circumstances. No physical settlement has occurred through the date on which these consolidated financial statements were issued.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Interim Unaudited Financial Information

Basis of Presentation

The accompanying interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The accompanying condensed consolidated financial statements include the accounts of the Company and subsidiaries in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation and the Company’s net income is reduced by the portion of net income attributable to noncontrolling interests.

Interim Unaudited Financial Information

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. These unaudited interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements, and should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto on the Annual Report on Form 10-K as of and for the year ended December 31, 2023, which provide a more complete understanding of the Company’s accounting policies, financial position, operating results, business properties, and other matters. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2024 and 2023 are not necessarily indicative of the results for the full year.

Use of Estimates

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s most significant assumptions and estimates relate to the useful lives of real estate assets, lease accounting, real estate impairment assessments, and allocation of fair value of purchase consideration. These estimates are based on historical experience and other assumptions which management believes are reasonable under the circumstances. The Company evaluates its estimates on an ongoing basis and makes revisions to these estimates and related disclosures as experience develops or new information becomes known. Actual results could differ from those estimates.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

Fair value measurement of an asset group occurs when events or changes in circumstances related to an asset indicate that the carrying amount of the asset is no longer recoverable. An example of an event or changed circumstance is a reduction in the expected holding period of a property. If indicators are present, the Company will prepare a projection of the undiscounted future cash flows of the property, excluding interest charges, and determine if the carrying amount of the asset group is recoverable. When a carrying amount is not recoverable, an impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair market value. The Company estimates fair value using data such as operating income, estimated capitalization rates or multiples, leasing prospects, local market information, and discount rates, and with regard to assets held for sale, based on the estimated or negotiated selling price, less estimated costs of disposal. Based on these unobservable inputs, the Company determined that its valuations of impaired real estate and intangible assets fall within Level 2 and Level 3 of the fair value hierarchy under ASC Topic 820.

Cash, Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted Cash

The Company considers all cash balances, money market accounts and highly liquid investments with original maturities of three months or less to be cash and cash equivalents. Restricted cash includes cash restricted for property tenant improvements and cash proceeds from the sale of assets held by qualified intermediaries in anticipation of the acquisition of replacement properties in tax-free exchanges under Section 1031 of the Code. Restricted cash is included in cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets. The Company had $0.7 million restricted cash as of March 31, 2024, and $11.5 million of restricted cash as of December 31, 2023.

The Company’s bank balances as of March 31, 2024 and December 31, 2023 included certain amounts over the Federal Deposit Insurance Corporation limits.

Fair Value Measurement

Fair Value Measurement

Fair value measurements are utilized in the accounting of the Company’s assets acquired and liabilities assumed in an asset acquisition and also affect the Company’s accounting for certain of its financial assets and liabilities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The hierarchy described below prioritizes inputs to the valuation techniques used in measuring the fair value of assets and liabilities. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs to be used when available. The hierarchy is broken down into three levels based on the reliability of inputs as follows: Level 1 inputs, such as quoted prices in an active market; Level 2 inputs, which are observable inputs for similar assets; or Level 3 inputs, which are unobservable inputs.

The Company uses the following inputs in its fair value measurements:

– Level 2 and Level 3 inputs for its debt and derivative financial instrument fair value disclosures. See “Note 6 - Debt” and “Note 7 - Derivative Financial Instruments,” respectively; and

– Level 2 and Level 3 inputs when assessing the fair value of assets and liabilities in connection with real estate acquisitions and impairment. See “Note 4 - Real Estate Investments.”

Additionally, companies are required to disclose the estimated fair values of all financial instruments, even if they are not carried at their fair value. The fair values of financial instruments are estimates based on market conditions and perceived risks as of March 31, 2024 and December 31, 2023. These estimates require management’s judgment and may not be indicative of the future fair values of the assets and liabilities.

The fair value of the Company’s cash, cash equivalents and restricted cash (including money market accounts), other assets and accounts payable, accrued expenses and other liabilities approximate their carrying value because of the short-term nature of these instruments. Additionally, the Company believes the following financial instruments have carrying values that approximate their fair values as of March 31, 2024:

•Borrowings under the Company’s Revolver (as defined in “Note 6 - Debt”) approximate fair value based on their nature, terms and variable interest rates.

•Carrying values of the Company’s mortgage loans receivable approximate fair values based on a number of factors, including either their short-term nature, the availability of market quotes for comparable instruments, and a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

•Carrying value of the Company’s mortgage note payable approximates fair value based on a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

Provisions for impairment recognized during the three months ended March 31, 2024 partially related to assets held for sale where impairment was determined based on the estimated or negotiated selling price, less costs of disposal, compared to the carrying value of the property. Of the total provision for impairment during the three months ended March 31, 2024, the Company also recorded $2.2 million of impairment expense on four properties held for investment. These properties were accounted for at fair value on a nonrecurring basis using a cash flow model (Level 3 inputs) with adjusted carrying values ranging from $0.6 million to $1.6 million. The Company estimated the fair value using capitalization rates ranging from 9.0% to 12.1% which it believes is reasonable based on current market rates. As of December 31, 2023, there were two real estate assets held for investment accounted for at fair value. Of these properties, one was accounted for at fair value on a nonrecurring basis using a cash flow model (Level 3 inputs) with an adjusted carrying value of $1.5 million.

The following table discloses estimated fair value information for the Company’s 2027 Term Loan, 2028 Term Loan, and 2029 Term Loan (each as defined in “Note 6 - Debt”) which is derived based primarily on unobservable market inputs such as interest rates and discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates and credit spreads (in thousands):

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company is exposed to credit risk with respect to cash held at various financial institutions, access to its credit facilities, amounts due under mortgage loans receivable, and amounts due or payable under derivative contracts. The credit risk exposure with regard to the Company’s cash, credit facilities, and derivative instruments is spread among a diversified group of investment grade financial institutions.

Segment Reporting

Segment Reporting

ASC Topic 280, Segment Reporting, establishes standards for the manner in which companies report information about operating segments. Substantially all of the Company’s investments, at acquisition, are comprised of real estate owned that is leased to tenants on a long-term basis or real estate that secures the Company's investment in mortgage loans receivable. The Company allocates resources and assesses operating performance based on individual investment and property needs. Therefore, the Company aggregates these investments for reporting purposes and operates in one reportable segment.

Recent Accounting Pronouncements Issued But Not Yet Adopted

Recent Accounting Pronouncements Issued But Not Yet Adopted

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to improve reportable segment disclosures by requiring disclosure of incremental segment information on an annual and interim basis such as, annual and interim disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, interim disclosure of a reportable segment’s profit or loss and assets, and the requirement that a public entity that has a single reportable segment provide all the disclosures required by ASU 2023-07 and all existing segment disclosures in Topic 280. The amendments in ASU 2023-07 do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The disclosures are applied retrospectively to all periods presented and early adoption is permitted. The Company has one reportable segment and continues to evaluate additional disclosures that may be required for entities with a single reportable segment.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires annual disclosure of specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold within the rate reconciliation. In addition, the amendments require annual disclosure of income taxes paid disaggregated by federal, state and foreign jurisdictions as well as individual jurisdictions in which income taxes paid is equal to or greater than 5 percent of total income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, however early adoption and retrospective application is permitted. The Company continues to evaluate the potential impact of the guidance and potential additional disclosures required.

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Fair Value Disclosure of Asset and Liability Not Measured at Fair Value

	March 31, 2024				December 31, 2023
	Carrying Value (1)		Estimated Fair Value		Carrying Value (1)		Estimated Fair Value
2027 Term Loan	$	174,155	$	172,770	$	174,037	$	175,641
2028 Term Loan	199,066		198,101		199,006		201,396
2029 Term Loan	248,279		247,002		148,869		150,666

(1) The carrying value of the debt instruments are net of unamortized debt issuance and discount costs.

Schedule of Provision for Impairment

The following table summarizes the provision for impairment during the periods indicated below (in thousands):

	Three Months Ended March 31,
	2024		2023
Total provision for impairment	$	3,662	$	—
Number of properties: (1)
Classified as held for sale	4		—
Disposed within the period	2		—

(1) Includes the number of properties that were either (i) impaired during the period on the held for sale classification date and remained as held for sale as of period-end or (ii) impaired and disposed of during the respective period. Excludes properties that did not have impairment recorded during the period. Of the total provision for impairment during the three months ended March 31, 2024, the Company recorded $0.3 million of additional impairment expense on two properties that were classified as held for sale in prior periods, and $2.2 million of impairment expense on four properties held for investment.

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Disaggregation of Lease Income

The following table provides a disaggregation of lease income recognized under ASC 842 (in thousands):

	Three Months Ended March 31,
	2024		2023
Rental revenue
Fixed lease income (1)	$	31,865	$	24,723
Variable lease income (2)	3,228		3,538
Other rental revenue:
Above/below market lease amortization, net	287		412
Lease incentives	(191)		(199)
Rental revenue (including reimbursable)	$	35,189	$	28,474

(1) Fixed lease income includes contractual rents under lease agreements with tenants recognized on a straight-line basis over the lease term.

(2) Variable lease income primarily includes tenant reimbursements for real estate taxes, insurance, common area maintenance, and lease termination fees, and the write-off of uncollectible amounts. There were no material reserves, write-offs, or recoveries of uncollectible amounts during the three months ended March 31, 2024 and March 31, 2023.

Schedule of Future Minimum Base Rental Receipts

Scheduled future minimum base rental payments (excluding base rental payments from properties classified as held for sale and straight-line rent adjustments for all properties) due to be received under the remaining non-cancelable term of the operating leases in place as of March 31, 2024 are as follows (in thousands):

	Future Minimum Base Rental Receipts
Remainder of 2024	$	94,421
2025	125,888
2026	123,362
2027	119,701
2028	112,884
Thereafter	615,487
Total	$	1,191,743

XML

Real Estate Investments (Tables)

3 Months Ended

Mar. 31, 2024

Real Estate [Abstract]

Allocation of Purchase Price Paid for Completed Acquisitions

An allocation of the purchase price and acquisition costs paid for the completed acquisitions is as follows (in thousands):

	Three Months Ended March 31,
	2024		2023
Land	$	16,608	$	14,304
Buildings	59,379		43,133
Site improvements	6,428		3,479
Tenant improvements	1,445		391
In-place lease intangible assets	11,293		6,410
Purchase price (including acquisition costs)	$	95,153	$	67,717

Schedule of Mortgage Loans Receivable

The Company’s mortgage loans receivable portfolio as of March 31, 2024 and December 31, 2023 is summarized below (in thousands):

Loan Type	Monthly Payment (1)	Number of Secured Properties	Effective Interest Rate (2)	Stated Interest Rate	Maturity Date	March 31, 2024		December 31, 2023
Mortgage (3) (4) (5)	I/O	1	6.74%	7.00%	4/8/2024	$	43,612	$	43,612
Mortgage (4)	I/O	46	9.55%	9.55%	3/10/2026	41,940		41,940
Mortgage (4) (6)	I/O	3	8.10%	6.89%	4/10/2026	4,132		4,132
Mortgage (3) (4) (6)	I/O	9	7.59%	7.59%	6/10/2025	14,023		14,024
Mortgage	None (7)	1	8.50%	8.50%	12/29/2024	660		660
Mortgage (3)	P+I	1	7.50%	7.50%	1/8/2025	3,239		3,246
Mortgage (3) (4) (8)	I/O	11	10.22%	10.25%	3/19/2025	14,209		5,007
Mortgage (3) (4)	I/O	2	10.25%	10.25%	12/22/2024	2,915		1,909
Total						124,730		114,530
Unamortized loan origination costs and fees, net						(10)		58
Unamortized discount						(103)		(116)
Total mortgage loans receivable, net						$	124,617	$	114,472

(1) I/O: Interest Only; P+I: Principal and Interest.

(2) Includes amortization of discount and loan origination costs, as applicable.

(3) The Company has the right, subject to certain terms and conditions, to acquire all or a portion of the underlying collateralized properties.

(4) Loans require monthly payments of interest only with principal payments occurring as borrower disposes of underlying properties, limited to the Company’s allocated investment by property. Any remaining principal balance will be repaid at or before the maturity date.

(5) The $43.6 million mortgage note receivable was scheduled to mature on April 8, 2024, however, the Company executed an amendment in April 2024 that extended the maturity date to January 8, 2025.

(6) The stated interest rate is variable up to 15.0% and is calculated based on contractual rent for existing collateralized properties subject to the loan agreement.

(7) Payments of both interest and principal are due at maturity.

XML

Intangible Assets and Liabilities (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Intangible Assets and Liabilities

Intangible assets and liabilities consisted of the following (in thousands):

	March 31, 2024						December 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Assets:
In-place leases	$	190,133	$	(48,667)	$	141,466	$	181,564	$	(45,210)	$	136,354
Above-market leases	21,635		(4,749)		16,886		21,661		(4,361)		17,300
Lease incentives	8,577		(1,422)		7,155		8,996		(1,296)		7,700
Total intangible assets	$	220,345	$	(54,838)	$	165,507	$	212,221	$	(50,867)	$	161,354
Liabilities:
Below-market leases	$	33,170	$	(8,531)	$	24,639	$	33,196	$	(7,843)	$	25,353

Weighted Average Amortization Period for Intangible Assets and Liabilities

The remaining weighted average amortization period for the Company’s intangible assets and liabilities as of March 31, 2024 and as of December 31, 2023 by category were as follows:

	Years Remaining
	March 31, 2024	December 31, 2023
In-place leases	8.9	8.8
Above-market leases	12.0	12.2
Below-market leases	10.7	10.9
Lease incentives	10.8	11.1

Amortization of Intangible Assets and Liabilities

The following amounts in the accompanying condensed consolidated statements of operations and comprehensive income (loss) related to the amortization of intangible assets and liabilities for all property and ground leases (in thousands):

	Three Months Ended March 31,
	2024		2023
Amortization:
Amortization of in-place leases	$	4,875	$	4,670
Amortization of assembled workforce	—		—
	$	4,875	$	4,670
Net adjustment to rental revenue:
Above-market lease assets	(416)		(371)
Below-market lease liabilities	702		783
Lease incentives	(191)		(199)
	$	95	$	213

Projected Amortization of Intangible Assets and Liabilities

The following table provides the projected amortization of in-place lease assets to amortization expense and the net amortization of above-market, below-market, and lease incentive lease intangible assets and liabilities to rental revenue as of March 31, 2024, for the next five years and thereafter (in thousands):

	Remainder of 2024		2025		2026		2027		2028		Thereafter		Total
In-place leases	$	15,531	$	20,386	$	19,153	$	17,160	$	14,356	$	54,880	$	141,466
Above-market lease assets	(1,241)		(1,655)		(1,632)		(1,568)		(1,523)		(9,267)		(16,886)
Below-market lease liabilities	2,098		2,776		2,686		2,615		2,483		11,981		24,639
Lease incentives	(564)		(752)		(752)		(696)		(666)		(3,725)		(7,155)
Net adjustment to rental revenue	$	293	$	369	$	302	$	351	$	294	$	(1,011)	$	598

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

The following table provides the projected amortization of in-place lease assets to amortization expense and the net amortization of above-market, below-market, and lease incentive lease intangible assets and liabilities to rental revenue as of March 31, 2024, for the next five years and thereafter (in thousands):

	Remainder of 2024		2025		2026		2027		2028		Thereafter		Total
In-place leases	$	15,531	$	20,386	$	19,153	$	17,160	$	14,356	$	54,880	$	141,466
Above-market lease assets	(1,241)		(1,655)		(1,632)		(1,568)		(1,523)		(9,267)		(16,886)
Below-market lease liabilities	2,098		2,776		2,686		2,615		2,483		11,981		24,639
Lease incentives	(564)		(752)		(752)		(696)		(666)		(3,725)		(7,155)
Net adjustment to rental revenue	$	293	$	369	$	302	$	351	$	294	$	(1,011)	$	598

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of Debt

Debt consists of the following (in thousands):

				Amounts Outstanding as of
	Contractual Maturity Date	Fully Extended Maturity Date (1)	Interest Rate (2)	March 31, 2024		December 31, 2023
Debt:
2027 Term Loan (3)	January 15, 2026	January 15, 2027	3.12%	$	175,000	$	175,000
2028 Term Loan (4)	February 11, 2028	—	3.88%	200,000		200,000
2029 Term Loan (5)	July 3, 2026	January 3, 2029	4.99%	250,000		150,000
Revolver (6)	August 11, 2026	August 11, 2027	6.42%	75,000		80,000
Mortgage Note	November 1, 2027	—	4.53%	8,322		8,361
Total debt				708,322		613,361
Unamortized discount and debt issuance costs				(3,946)		(3,566)
Unamortized deferred financing costs, net (7)				(1,757)		(1,942)
Total debt, net				$	702,619	$	607,853

(1) Date represents the fully extended maturity date available to the Company, subject to certain conditions, under each related debt instrument.

(2) Rate represents the effective interest rate as of March 31, 2024 and includes the effect of interest rate swap agreements, as described further in “Note 6 - Debt” and “Note 7 - Derivative Financial Instruments.”

(3) Loan is a floating-rate loan which resets daily at daily SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into five interest rate swap agreements that effectively convert the floating rate to a fixed rate. The hedged fixed rate reset effective November 27, 2023 to 1.87% and will reset again effective December 23, 2024 to 2.40%.

(4) Loan is a floating-rate loan which resets monthly at one-month term SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into three interest rate swap agreements that effectively convert the floating rate to a fixed rate.

(5) Loan is a floating-rate loan which resets daily at daily SOFR plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.15% as of March 31, 2024. The Company has entered into four interest rate swap agreements that effectively convert the floating rate to a fixed rate.

(6) The annual interest rate of the Revolver assumes daily SOFR as of March 31, 2024 of 5.32% plus a SOFR adjustment of 0.10% plus the applicable margin which was 1.00% as of March 31, 2024.

(7) The Company records deferred financing costs associated with the Revolver in other assets, net on its condensed consolidated balance sheets. The Company reclassed the net amount of loan commitment fees associated with the 2029 Term Loan from other assets, net to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan.

Interest Income and Interest Expense Disclosure

The following table is a summary of the components of interest expense related to the Company’s borrowings (in thousands):

	Three Months Ended March 31,
	2024		2023
Revolving credit facilities (1)	$	1,158	$	1,150
Term loans (2)	5,672		2,499
Mortgage note payable	95		93
Non-cash:
Amortization of deferred financing costs	238		185
Amortization of debt discount and debt issuance costs, net	349		151
Amortization of deferred gains on interest rate swaps	(979)		—
Capitalized interest	(353)		(134)
Total interest expense, net	$	6,180	$	3,944

(1) Includes facility fees and non-utilization fees of approximately $0.2 million for both the three months ended March 31, 2024 and 2023.

(2) Includes the effects of interest rate hedges in place as of such date.

Schedule of Maturities of Long-term Debt

Payments on the 2027 Term Loan, 2028 Term Loan, and 2029 Term Loan are interest only through maturity. As of March 31, 2024, scheduled debt maturities, including balloon payments, are as follows (in thousands):

	Scheduled Principal		Balloon Payment (1)		Total
Remainder of 2024	$	123	$	—	$	123
2025	170		—		170
2026	178		500,000		500,178
2027	170		7,681		7,851
2028	—		200,000		200,000
Total	$	641	$	707,681	$	708,322

XML

Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Interest Rate Derivatives

The Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk (in thousands, except number of instruments):

	Number of Instruments		Notional
Interest Rate Derivatives	March 31, 2024	December 31, 2023	March 31, 2024		December 31, 2023
Interest rate swaps	12	12	$	650,000	$	650,000

Fair Value of Derivative Financial Instruments

The following table presents the fair value of the Company's derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023 (in thousands):

	Derivative Assets
		Fair Value as of March 31,
Derivatives Designated as Hedging Instruments:	Balance Sheet Location	2024		2023
Interest rate swaps	Other assets, net	$	21,476	$	14,442

Effect of Interest Rate Swaps

The following table presents the effect of the Company's interest rate swaps on the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2024 and 2023 (in thousands):

	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
Derivatives in Cash Flow Hedging Relationships	2024		2023			2024		2023
Interest Rate Products	$	13,761	$	(3,141)	Interest expense, net	$	4,633	$	2,837

Schedule of Derivative Liabilities at Fair Value

The table below presents the Company’s derivative assets measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023, aggregated by the level in the fair value hierarchy within which those measurements fall (in thousands):

	Fair Value Hierarchy Level
Description	Level 1		Level 2		Level 3		Total Fair Value
March 31, 2024
Derivative assets	$	—	$	21,476	$	—	$	21,476
December 31, 2023
Derivative assets	$	—	$	14,442	$	—	$	14,442
Derivative liabilities	$	—	$	3,073	$	—	$	3,073

XML

Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Assets, net

Other assets, net consist of the following (in thousands):

	March 31, 2024		December 31, 2023
Accounts receivable, net	$	10,813	$	10,074
Deferred rent receivable	8,594		7,744
Prepaid assets	3,904		1,387
Earnest money deposits	492		450
Fair value of interest rate swaps	21,476		14,442
Deferred offering costs	1,554		1,031
Deferred financing costs, net	1,757		2,724
Right-of-use asset	3,772		3,866
Leasehold improvements and other corporate assets, net	1,651		1,723
Interest receivable	1,929		1,397
Other assets, net	5,460		4,499
	$	61,402	$	49,337

Schedule of Accounts Payable, Accrued Expenses and Other Liabilities

Accounts payable, accrued expenses and other liabilities consists of the following (in thousands):

	March 31, 2024		December 31, 2023
Accrued expenses	$	8,176	$	8,826
Accrued bonus	520		2,575
Prepaid rent	3,394		3,896
Operating lease liability	4,994		5,104
Accrued interest	2,958		2,921
Deferred rent	3,627		3,257
Accounts payable	622		4,691
Fair value of interest rate swaps	—		3,073
Other liabilities	1,974		2,155
	$	26,265	$	36,498

XML

Shareholders’ Equity, Partners’ Capital and Preferred Equity (Tables)

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure

The following table presents information about the 2023 ATM Program and the 2021 ATM Program (in thousands):

				Maximum Sales Authorization		Gross Sales through March 31, 2024
Program Name	Date Established	Date Terminated
2021 ATM Program (1)	September 2021	October 2023		$	250,000	$	150,391
2023 ATM Program (2)	October 2023	—	0	$	300,000	$	77,323

(1) Includes 1,516,289 shares of common stock partially physically settled at a price of $16.49 per share under the forward confirmation with respect to the 2021 ATM Program. 5,983,711 shares remain unsettled under the forward confirmation as of March 31, 2024 at the available net settlement price of $16.46.

(2) 107,500 shares remain unsettled under the forward confirmation as of March 31, 2024 at the available net settlement price of $18.12.

Common Stock Dividends Declared and Paid

During the three months ended March 31, 2024, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Three Months Ended March 31, 2024
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 13, 2024	$	0.205	March 15, 2024	$	15,031	March 28, 2024

During the three months ended March 31, 2023, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Three Months Ended March 31, 2023
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 21, 2023	$	0.200	March 15, 2023	$	11,650	March 30, 2023

XML

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Summary of Restricted Stock Unit Activity

The following table summarizes performance-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	30,379	$	19.75
Granted during the period	—	—
Forfeited during the period	—	—
Vested during the period	—	—
Unvested RSU grants outstanding as of March 31, 2024	30,379	$	19.75

The following table summarizes service-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	298,108	$	19.79
Granted during the period	200,140	17.33
Forfeited during the period	—	—
Vested during the period	(130,220)	19.85
Unvested RSU grants outstanding as of March 31, 2024	368,028	$	18.50

The following table summarizes market-based RSU activity for the period ended March 31, 2024:

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2023	258,558	$	20.38
Granted during the period	169,002	16.05
Forfeited during the period	(69,959)	16.92
Vested during the period	(45,977)	20.29
Unvested RSU grants outstanding as of March 31, 2024	311,624	$	18.82

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Net Loss Attributable to Common Shares, Weighted Average Common Shares and Effect of Dilutive Securities

The following table is a reconciliation of the numerator and denominator used in the computation of basic and diluted net income per common share for the three months ended March 31, 2024 and 2023.

	Three Months Ended March 31,
(In thousands, except share and per share data)	2024		2023
Numerator:
Net income	$	1,052	$	1,481
Net (income) attributable to noncontrolling interest	(7)		(9)
Net income attributable to common shares, basic	1,045		1,472
Net income attributable to noncontrolling interest	7		9
Net income attributable to common shares, diluted	$	1,052	$	1,481
Denominator:
Weighted average common shares outstanding, basic	73,248,804		58,155,738
Effect of dilutive shares for diluted net income per common share:
OP Units	478,524		511,402
Unvested RSUs	168,556		175,859
Unsettled shares under open forward equity contracts	669,906		40,387
Weighted average common shares outstanding, diluted	74,565,790		58,883,386
Net income available to common stockholders per common share, basic	$	0.01	$	0.03
Net income available to common stockholders per common share, diluted	$	0.01	$	0.03

XML

Organization and Description of Business (Details)	Mar. 31, 2024 property state
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of single-tenant retail net leased properties owned	628
Number of states in which entity operates | state	45
Property developments where rent has yet to commence	16

XML

Summary of Significant Accounting Policies - Schedule of Provision for Impairment (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) property	Mar. 31, 2023 USD ($) property
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Provisions for impairment | $	$ 3,662,000	$ 0
Number of properties
Classified as held for sale	4	0
Properties sold	2	0
Classified as held for sale	4	0
Held-for-Sale | Two Properties
Number of properties
Classified as held for sale	2
Impairment of Real Estate | $	$ 300,000
Classified as held for sale	2
Held-for-Sale | Three Properties
Number of properties
Classified as held for sale	4
Impairment of Real Estate | $	$ 2,200,000
Classified as held for sale	4

XML

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)
Product Information [Line Items]
Restricted cash	$ 700,000	$ 11,500,000
Number of reportable segments | segment	1
Tenant Improvement Allowance Commitment Period	2 years
Customer Concentration Risk | Revenue Benchmark | Dollar General
Product Information [Line Items]
Concentration risk (as a percent)	10.43%
Real Estate | Level 3
Product Information [Line Items]
Adjusted carrying value		$ 1,500,000
Minimum | Real Estate | Level 3
Product Information [Line Items]
Adjusted carrying value	$ 600,000
Minimum | Measurement Input, Cap Rate
Product Information [Line Items]
Capitalization rates	0.090
Maximum | Real Estate | Level 3
Product Information [Line Items]
Adjusted carrying value	$ 1,600,000
Maximum | Measurement Input, Cap Rate
Product Information [Line Items]
Capitalization rates	0.121

XML

Summary of Significant Accounting Policies - Schedule of Fair Value Information (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value	$ 702,619	$ 607,853
Term loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value	708,322
Term loans | Line of Credit | 2027 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value	174,155	174,037
Estimated Fair Value	172,770	175,641
Term loans | Line of Credit | 2028 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value	199,066	199,006
Estimated Fair Value	198,101	201,396
Term loans | Line of Credit | 2029 Term Loan
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value	248,279	148,869
Estimated Fair Value	$ 247,002	$ 150,666

XML

Leases - Narrative (Details)		3 Months Ended
	Aug. 01, 2021 renewalOption	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Aug. 11, 2022 USD ($)	Feb. 28, 2022
Lessor, Lease, Description [Line Items]
Remaining term of leases		9 years 2 months 12 days
Right-of-use asset			$ 3,866,000
Operating lease liability		$ 4,994,000	$ 5,104,000
Remaining terms of leases (in years)					8 years 3 months 18 days
Revolving credit facility | 2028 Term Loan | Line of Credit
Lessor, Lease, Description [Line Items]
Increase limit				$ 400,000,000
Corporate Office Space
Lessor, Lease, Description [Line Items]
Renewal options | renewalOption	2
Lease extension term	5 years
Right-of-use asset		$ 3,772,000

XML

Leases - Disaggregation of Lease Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Rental revenue
Fixed lease income	$ 31,865	$ 24,723
Variable lease income	3,228	3,538
Other rental revenue:
Above/below market lease amortization, net	287	412
Lease incentives	(191)	(199)
Rental revenue (including reimbursable)	$ 35,189	$ 28,474

XML

Leases - Schedule of Future Minimum Base Rental Receipts (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Leases [Abstract]
Remainder of 2024	$ 94,421
2025	125,888
2026	123,362
2027	119,701
2028	112,884
Thereafter	615,487
Total Future Minimum Base Rental Receipts	$ 1,191,743

XML

Real Estate Investments - Narrative (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024 USD ($) property tenant state	Mar. 31, 2023 USD ($) property	Dec. 31, 2023 USD ($) property
Real Estate [Line Items]
Number of single-tenant retail net leased properties owned | property	628
Property developments where rent has yet to commence | property	16
Real estate investments	$ 1,900,000
Number of states in which entity operates | state	45
Payments to acquire real estate held-for-investment	$ 95,153	$ 67,717
Investment in real estate development project	$ 12,281	2,480
Number of properties developed | tenant	7
Property under development	$ (21,800)		$ (29,198)
Property under development to land, building, and improvements	1,681,663		$ 1,610,705
Investment	$ 11,000	$ 4,500
Properties sold | property	2	0
Proceeds from sale of real estate	$ 20,466	$ 15,463
Gain (loss) on sales of real estate, net	$ 997	(319)
Number of real estate properties held for sale | property	23		23
Interest Costs Capitalized	$ 353	134
Development Property Transferred
Real Estate [Line Items]
Property under development to land, building, and improvements	$ 18,400
TEXAS
Real Estate [Line Items]
Gross real estate investments (as a percent)	8.80%
ILLINOIS
Real Estate [Line Items]
Gross real estate investments (as a percent)	9.40%
One Property
Real Estate [Line Items]
Number of properties developed | property			2
One Property | Completed Projects
Real Estate [Line Items]
Property under development to land, building, and improvements		$ 14,800
Two Properties
Real Estate [Line Items]
Number of property developments under construction | property	2
Investment	$ 800
Current Dispositions
Real Estate [Line Items]
Properties sold | property	12
Proceeds from sale of real estate	$ 20,500
Gain (loss) on sales of real estate, net	$ 1,000
Prior DIspositions
Real Estate [Line Items]
Properties sold | property		8
Proceeds from sale of real estate		$ 15,500
Gain (loss) on sales of real estate, net		$ (300)
2022 Acquisitions
Real Estate [Line Items]
Number of properties acquired | property	28
Payments to acquire real estate held-for-investment	$ 95,200
Acquisition fees incurred	$ 1,200
Number of property developments under construction | property	13
2020 Acquisitions
Real Estate [Line Items]
Number of properties acquired | property		20
Payments to acquire real estate held-for-investment		$ 67,700
Acquisition fees incurred		$ 700

XML

Real Estate Investments - Allocation of Purchase Price Paid for Completed Acquisitions (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
2022 Acquisitions
Real Estate [Line Items]
Purchase price (including acquisition costs)	$ 95,153
2022 Acquisitions | Land
Real Estate [Line Items]
Property, plant and equipment, additions	16,608
2022 Acquisitions | Building [Member]
Real Estate [Line Items]
Property, plant and equipment, additions	59,379
2022 Acquisitions | Site improvements
Real Estate [Line Items]
Property, plant and equipment, additions	6,428
2022 Acquisitions | Tenant improvements
Real Estate [Line Items]
Property, plant and equipment, additions	1,445
2022 Acquisitions | In-place leases
Real Estate [Line Items]
Finite-lived intangible assets acquired	$ 11,293
2021 Acquisitions
Real Estate [Line Items]
Purchase price (including acquisition costs)		$ 67,717
2021 Acquisitions | Land
Real Estate [Line Items]
Property, plant and equipment, additions		14,304
2021 Acquisitions | Building [Member]
Real Estate [Line Items]
Property, plant and equipment, additions		43,133
2021 Acquisitions | Site improvements
Real Estate [Line Items]
Property, plant and equipment, additions		3,479
2021 Acquisitions | Tenant improvements
Real Estate [Line Items]
Property, plant and equipment, additions		391
2021 Acquisitions | In-place leases
Real Estate [Line Items]
Finite-lived intangible assets acquired		$ 6,410

XML

Real Estate Investments - Schedule of Mortgage Loans Receivable (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) tenant	Dec. 31, 2023 USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Total	$ 124,730	$ 114,530
Unamortized loan origination costs and fees, net	(10)	58
Unamortized discount	(103)	(116)
Total mortgage loans receivable, net	$ 124,617	114,472
Mortgage Receivable Due July 26, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	1
Stated Interest Rate	7.00%
Total	$ 43,612	43,612
Interest Rate	6.74%
Mortgage Receivable Due March 10, 2026
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	46
Stated Interest Rate	9.55%
Total	$ 41,940	41,940
Interest Rate	9.55%
Mortgage Receivable Due April 10, 2026
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	3
Stated Interest Rate	6.89%
Total	$ 4,132	4,132
Interest Rate	8.10%
Mortgage Receivable Due April 10, 2026 | Maximum
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Stated Interest Rate	15.00%
Mortgage Receivable Due June 10, 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	9
Stated Interest Rate	7.59%
Total	$ 14,023	14,024
Interest Rate	7.59%
Mortgage Receivable Due December 29, 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	1
Stated Interest Rate	8.50%
Total	$ 660	660
Interest Rate	8.50%
Mortgage Receivable Due January 8, 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	1
Stated Interest Rate	7.50%
Total	$ 3,239	3,246
Interest Rate	7.50%
Mortgage Receivable Due March 19, 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	11
Stated Interest Rate	10.25%
Total	$ 14,209	5,007
Interest Rate	10.22%
Mortgage Receivable Due December 22, 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of Secured Properties | tenant	2
Stated Interest Rate	10.25%
Total	$ 2,915	$ 1,909
Interest Rate	10.25%

XML

Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets:
Gross Carrying Amount	$ 220,345	$ 212,221
Accumulated Amortization	(54,838)	(50,867)
Net Carrying Amount	165,507	161,354
Liabilities:
Gross Carrying Amount	33,170	33,196
Accumulated Amortization	(8,531)	(7,843)
Net Carrying Amount	24,639	25,353
In-place leases
Assets:
Gross Carrying Amount	190,133	181,564
Accumulated Amortization	(48,667)	(45,210)
Net Carrying Amount	141,466	136,354
Above-market leases
Assets:
Gross Carrying Amount	21,635	21,661
Accumulated Amortization	(4,749)	(4,361)
Net Carrying Amount	16,886	17,300
Lease incentives
Assets:
Gross Carrying Amount	8,577	8,996
Accumulated Amortization	(1,422)	(1,296)
Net Carrying Amount	$ 7,155	$ 7,700

XML

Intangible Assets and Liabilities - Weighted Average Amortization Period for Intangible Assets and Liabilities (Details) - Weighted Average	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period, below-market leases	10 years 8 months 12 days	10 years 10 months 24 days
In-place leases
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period, intangible assets	8 years 10 months 24 days	8 years 9 months 18 days
Above-market leases
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period, intangible assets	12 years	12 years 2 months 12 days
Lease incentives
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period, intangible assets	10 years 9 months 18 days	11 years 1 month 6 days

XML

Intangible Assets and Liabilities - Amortization of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization:	$ 4,875	$ 4,670
Net adjustment to rental revenue:
Below-market lease liabilities	702	783
Net adjustment to rental revenue	95	213
In-place leases
Finite-Lived Intangible Assets [Line Items]
Amortization:	4,875	4,670
Amortization of assembled workforce
Finite-Lived Intangible Assets [Line Items]
Amortization:	0	0
Above-market leases
Net adjustment to rental revenue:
Above-market lease assets	(416)	(371)
Lease incentives
Net adjustment to rental revenue:
Above-market lease assets	$ (191)	$ (199)

XML

Intangible Assets and Liabilities - Projected Amortization of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Below-market lease liabilities
Remainder of 2024	$ 2,098
2025	2,776
2026	2,686
2027	2,615
2028	2,483
Thereafter	11,981
Net Carrying Amount	24,639	$ 25,353
Net adjustment to rental revenue
Remainder of 2024	293
2025	369
2026	302
2027	351
2028	294
Thereafter	(1,011)
Total	598
In-place leases
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remainder of 2024	15,531
2025	20,386
2026	19,153
2027	17,160
2028	14,356
Thereafter	54,880
Total	141,466
Above-market leases
Above-market lease assets
Remainder of 2024	(1,241)
2025	(1,655)
2026	(1,632)
2027	(1,568)
2028	(1,523)
Thereafter	(9,267)
Total	(16,886)
Lease incentives
Above-market lease assets
Remainder of 2024	(564)
2025	(752)
2026	(752)
2027	(696)
2028	(666)
Thereafter	(3,725)
Total	$ (7,155)

XML

Debt - Schedule of Debt (Details)			3 Months Ended
	Jun. 15, 2023	Aug. 11, 2022 USD ($)	Mar. 31, 2024 USD ($) derivative	Dec. 31, 2023 USD ($)	Nov. 28, 2023	Jul. 03, 2023	Jan. 27, 2023 derivative	Jan. 26, 2023 derivative	Sep. 01, 2022
Debt Instrument [Line Items]
Long-term debt, gross			$ 708,322,000	$ 613,361,000
Unamortized discount and debt issuance costs			(3,946,000)	(3,566,000)
Unamortized deferred financing costs, net			(1,757,000)	(1,942,000)
Total			702,619,000	607,853,000
Number of derivatives | derivative							4	4
Term loans
Debt Instrument [Line Items]
Total			$ 708,322,000
2027 Term Loan | Line of Credit
Debt Instrument [Line Items]
Unamortized deferred financing costs, net		$ (500,000)
2027 Term Loan | Line of Credit | Term loans
Debt Instrument [Line Items]
Interest Rate			3.12%
Long-term debt, gross			$ 175,000,000	175,000,000
Total			$ 174,155,000	174,037,000
Debt instrument, extension term	1 year
Hedged fixed rate					1.87%		0.12%
2027 Term Loan | Line of Credit | Term loans | Interest rate swaps
Debt Instrument [Line Items]
Number of derivatives | derivative			5
2027 Term Loan | Line of Credit | Term loans | Interest rate swaps | Period One
Debt Instrument [Line Items]
Hedged fixed rate			1.87%
2027 Term Loan | Line of Credit | Term loans | Interest rate swaps | Period Two
Debt Instrument [Line Items]
Hedged fixed rate			2.40%
2027 Term Loan | Line of Credit | SOFR adjustment | Term loans
Debt Instrument [Line Items]
Variable rate (as a percent)			0.10%
2027 Term Loan | Line of Credit | SOFR adjustment margin | Term loans
Debt Instrument [Line Items]
Variable rate (as a percent)			1.15%
2028 Term Loan | Line of Credit | Term loans
Debt Instrument [Line Items]
Interest Rate			3.88%
Long-term debt, gross			$ 200,000,000	200,000,000
Total			$ 199,066,000	199,006,000
Debt instrument, extension term		1 year
Hedged fixed rate									2.63%
2028 Term Loan | Line of Credit | Term loans | Interest rate swaps
Debt Instrument [Line Items]
Number of derivatives | derivative			3
2028 Term Loan | Line of Credit | Revolving credit facility
Debt Instrument [Line Items]
Interest Rate			6.42%
Long-term debt, gross			$ 75,000,000	80,000,000
Debt instrument, extension term		1 year
Line of credit facility, maximum borrowing capacity		$ 400,000,000
2028 Term Loan | Line of Credit | Daily SOFR | Revolving credit facility
Debt Instrument [Line Items]
Variable rate (as a percent)			5.32%
2028 Term Loan | Line of Credit | SOFR adjustment | Term loans
Debt Instrument [Line Items]
Variable rate (as a percent)			0.10%
2028 Term Loan | Line of Credit | SOFR adjustment | Revolving credit facility
Debt Instrument [Line Items]
Variable rate (as a percent)			0.10%
2028 Term Loan | Line of Credit | SOFR adjustment margin | Term loans
Debt Instrument [Line Items]
Variable rate (as a percent)			1.15%
2028 Term Loan | Line of Credit | SOFR adjustment margin | Revolving credit facility
Debt Instrument [Line Items]
Variable rate (as a percent)			1.00%
Mortgage Note Payable | Mortgages
Debt Instrument [Line Items]
Interest Rate			4.53%
Long-term debt, gross			$ 8,322,000	8,361,000
2029 Term Loan | Line of Credit
Debt Instrument [Line Items]
Hedged fixed rate						3.74%
2029 Term Loan | Line of Credit | Term loans
Debt Instrument [Line Items]
Interest Rate			4.99%
Long-term debt, gross			$ 250,000,000	150,000,000
Total			$ 248,279,000	$ 148,869,000
2029 Term Loan | Line of Credit | Term loans | Interest rate swaps
Debt Instrument [Line Items]
Number of derivatives | derivative			4
2029 Term Loan | Line of Credit | SOFR adjustment rate | Term loans
Debt Instrument [Line Items]
Variable rate (as a percent)			0.10%
2029 Term Loan | Line of Credit | SOFR) Overnight Index Swap Rate | Term loans
Debt Instrument [Line Items]
Variable rate (as a percent)			1.15%

XML

Debt - Narrative (Details)					3 Months Ended
	Mar. 01, 2024 USD ($)	Jul. 03, 2023 USD ($) tenant	Jun. 15, 2023 USD ($)	Aug. 11, 2022 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Nov. 28, 2023	Jan. 27, 2023 derivative	Jan. 26, 2023 derivative	Sep. 01, 2022	Dec. 31, 2019 USD ($)
Debt Instrument [Line Items]
Long-term debt, gross					$ 708,322,000		$ 613,361,000
Unamortized deferred financing costs					1,757,000		1,942,000
Number of derivatives | derivative									4	4
Proceeds under revolving credit facilities					82,000,000	$ 99,000,000
Revolving credit facility | Line of Credit
Debt Instrument [Line Items]
Facility fees					$ 200,000
Credit Facility | Term Loan
Debt Instrument [Line Items]
Weighted average effective interest rate (as a percent)					6.69%	5.77%
Credit Facility | Revolving credit facility | Line of Credit
Debt Instrument [Line Items]
Weighted average effective interest rate (as a percent)					6.54%	5.86%
2028 Term Loan | Line of Credit
Debt Instrument [Line Items]
Deferred financing costs, gross (less than)				$ 3,800,000
2028 Term Loan | Revolving credit facility | Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity				400,000,000
Available increase				$ 800,000,000
Long-term debt, gross					$ 75,000,000		80,000,000
Debt instrument, extension term				1 year
Rate reduction				0.025%
Interest Rate					6.42%
Deferred financing costs, gross (less than)				$ 2,400,000
Increase limit				400,000,000
2028 Term Loan | Term loans | Line of Credit
Debt Instrument [Line Items]
Debt instrument, face amount				$ 200,000,000
Long-term debt, gross					$ 200,000,000		200,000,000
Debt instrument, extension term				1 year
Interest Rate					3.88%
Deferred financing costs, gross (less than)				$ 1,300,000
Hedged fixed rate											2.63%
2028 Term Loan | Minimum | Revolving credit facility | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Revolver facility fee (as a percent)				0.15%
2028 Term Loan | Minimum | Revolving credit facility | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Revolver facility fee (as a percent)				0.125%
2028 Term Loan | Maximum | Revolving credit facility | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Revolver facility fee (as a percent)				0.30%
2028 Term Loan | Maximum | Revolving credit facility | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Revolver facility fee (as a percent)				0.30%
2028 Term Loan | SOFR rate | Minimum | Revolving credit facility | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				1.00%
2028 Term Loan | SOFR rate | Minimum | Revolving credit facility | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.725%
2028 Term Loan | SOFR rate | Minimum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				1.15%
2028 Term Loan | SOFR rate | Minimum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.80%
2028 Term Loan | SOFR rate | Maximum | Revolving credit facility | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				1.45%
2028 Term Loan | SOFR rate | Maximum | Revolving credit facility | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				1.40%
2028 Term Loan | SOFR rate | Maximum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				1.60%
2028 Term Loan | SOFR rate | Maximum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				1.60%
2028 Term Loan | Base Rate | Minimum | Revolving credit facility | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.00%
2028 Term Loan | Base Rate | Minimum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.15%
2028 Term Loan | Base Rate | Minimum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.00%
2028 Term Loan | Base Rate | Maximum | Revolving credit facility | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.45%
2028 Term Loan | Base Rate | Maximum | Revolving credit facility | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.40%
2028 Term Loan | Base Rate | Maximum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.60%
2028 Term Loan | Base Rate | Maximum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.60%
2028 Term Loan | SOFR adjustment rate | Revolving credit facility | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.10%
2028 Term Loan | SOFR adjustment rate | Revolving credit facility | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.10%
2028 Term Loan | SOFR adjustment rate | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.10%
2028 Term Loan | SOFR adjustment rate | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)				0.10%
2028 Term Loan | SOFR rate | Term loans | Line of Credit
Debt Instrument [Line Items]
Weighted average effective interest rate (as a percent)					5.33%
2028 Term Loan | SOFR adjustment | Revolving credit facility | Line of Credit
Debt Instrument [Line Items]
Variable rate (as a percent)					0.10%
2028 Term Loan | SOFR adjustment | Term loans | Line of Credit
Debt Instrument [Line Items]
Variable rate (as a percent)					0.10%
2027 Term Loan | Line of Credit
Debt Instrument [Line Items]
Unamortized deferred financing costs				$ 500,000
2027 Term Loan | Term loans | Line of Credit
Debt Instrument [Line Items]
Debt instrument, face amount			$ 175,000,000									$ 175,000,000
Long-term debt, gross					$ 175,000,000		175,000,000
Debt instrument, extension term			1 year
Interest Rate					3.12%
Hedged fixed rate								1.87%	0.12%
2027 Term Loan | SOFR rate | Minimum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			1.15%
2027 Term Loan | SOFR rate | Minimum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			0.80%
2027 Term Loan | SOFR rate | Maximum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			1.60%
2027 Term Loan | SOFR rate | Maximum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			1.60%
2027 Term Loan | Base Rate | Minimum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			0.15%
2027 Term Loan | Base Rate | Minimum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			0.00%
2027 Term Loan | Base Rate | Maximum | Term loans | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			0.60%
2027 Term Loan | Base Rate | Maximum | Term loans | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)			0.60%
2027 Term Loan | SOFR rate | Term loans | Line of Credit
Debt Instrument [Line Items]
Variable rate (as a percent)					531.00%
2027 Term Loan | SOFR adjustment | Term loans | Line of Credit
Debt Instrument [Line Items]
Variable rate (as a percent)					0.10%
Mortgage Note Payable | Mortgages
Debt Instrument [Line Items]
Long-term debt, gross					$ 8,322,000		8,361,000
Interest Rate					4.53%
Deferred financing costs, gross (less than)					$ 100,000
Mortgages Outstanding					8,300,000
Collateral aggregate net book value					12,500,000
Debt discount					600,000
2029 Term Loan | Line of Credit
Debt Instrument [Line Items]
Deferred financing costs, gross (less than)		$ 1,400,000
Hedged fixed rate		3.74%
Facility fees		$ 900,000
2029 Term Loan | Term loans | Line of Credit
Debt Instrument [Line Items]
Long-term debt, gross					$ 250,000,000		$ 150,000,000
Interest Rate					4.99%
Increase limit		400,000,000
Proceeds under revolving credit facilities	$ 100,000,000.0	$ 150,000,000
Debt term		12 months
2029 Term Loan | Term loans | Line of Credit | Period One
Debt Instrument [Line Items]
Extension term		1 year
Available extensions | tenant		2
2029 Term Loan | Term loans | Line of Credit | Period Two
Debt Instrument [Line Items]
Extension term		6 months
Available extensions | tenant		1
2029 Term Loan | SOFR adjustment rate | Term loans | Line of Credit
Debt Instrument [Line Items]
Variable rate (as a percent)					0.10%
2029 Term Loan | SOFR rate | Term loans | Line of Credit
Debt Instrument [Line Items]
Variable rate (as a percent)					5.32%
2029 Term Loan | SOFR rate | Minimum | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		1.15%
2029 Term Loan | SOFR rate | Minimum | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		0.80%
2029 Term Loan | SOFR rate | Maximum | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		1.60%
2029 Term Loan | SOFR rate | Maximum | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		1.60%
2029 Term Loan | Applicable margin | Minimum | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		0.15%
2029 Term Loan | Applicable margin | Maximum | Line of Credit | Prior To Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		0.60%
2029 Term Loan | Secured Overnight Financing Rate (SOFR) Base Rate | Minimum | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		0.00%
2029 Term Loan | Secured Overnight Financing Rate (SOFR) Base Rate | Maximum | Line of Credit | After Investment Grade
Debt Instrument [Line Items]
Variable rate (as a percent)		0.60%

XML

Debt - Schedule of Maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total	$ 702,619	$ 607,853
Term loans
Debt Instrument [Line Items]
Remainder of 2024	123
2025	170
2026	500,178
2027	7,851
2028	200,000
Total	708,322
Term loans | Scheduled Principal
Debt Instrument [Line Items]
Remainder of 2024	123
2025	170
2026	178
2027	170
2028	0
Total	641
Term loans | Balloon Payment (1)
Debt Instrument [Line Items]
Remainder of 2024	0
2025	0
2026	500,000
2027	7,681
2028	200,000
Total	$ 707,681

XML

Debt - Components of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Debt Instrument [Line Items]
Amortization of deferred financing costs	$ 238	$ 185
Amortization of debt discount and debt issuance costs, net	349	151
Amortization of deferred gains on interest rate swaps	979	0
Capitalized interest	(353)	(134)
Total interest expense, net	6,180	3,944
Mortgages
Debt Instrument [Line Items]
Interest expense	95	93
Revolving credit facility | Line of Credit
Debt Instrument [Line Items]
Interest expense	1,158	1,150
Facility fees	200
Term loans | Line of Credit
Debt Instrument [Line Items]
Interest expense	5,672	2,499
Amortization of deferred gains on interest rate swaps	$ (979)	$ 0

XML

Derivative Financial Instruments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 24, 2024	Nov. 28, 2023	Jul. 03, 2023	Mar. 31, 2023	Jan. 27, 2023	Sep. 01, 2022
2028 Term Loan | Line of Credit | Term loans
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged fixed rate							2.63%
2028 Term Loan | Line of Credit | SOFR adjustment | Revolving credit facility
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	0.10%
2028 Term Loan | Line of Credit | SOFR adjustment | Term loans
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	0.10%
2028 Term Loan | Line of Credit | SOFR rate | Term loans
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Weighted average effective interest rate (as a percent)	5.33%
2028 Term Loan | Line of Credit | SOFR rate | Term loans | SOFR adjustment
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	0.10%
2028 Term Loan | Line of Credit | SOFR rate | Term loans | SOFR adjustment margin
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	1.15%
2027 Term Loan | Line of Credit | Term loans
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged fixed rate			1.87%			0.12%
2027 Term Loan | Line of Credit | Term loans | Forecast
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged fixed rate		2.40%
2027 Term Loan | Line of Credit | SOFR adjustment | Term loans
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	0.10%
2027 Term Loan | Line of Credit | SOFR rate | Term loans
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	531.00%
2027 Term Loan | Line of Credit | SOFR rate | Term loans | Applicable margin
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	1.15%
2027 Term Loan | Line of Credit | SOFR rate | Term loans | SOFR adjustment
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	0.10%
2029 Term Loan | Line of Credit
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged fixed rate				3.74%
2029 Term Loan | Line of Credit | SOFR rate | Term loans
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	5.32%
2029 Term Loan | Line of Credit | SOFR rate | Term loans | Applicable margin
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	1.15%
2029 Term Loan | Line of Credit | SOFR rate | Term loans | SOFR adjustment
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Variable rate (as a percent)	0.10%
Interest rate swaps | Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount estimated to be reclassified as increase to interest expense	$ 14.5				$ 14.5

XML

Derivative Financial Instruments - Schedule of Interest Rate Derivatives (Details) - Interest rate swaps $ in Thousands	Mar. 31, 2024 USD ($) instrument	Dec. 31, 2023 USD ($) instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments | instrument	12	12
Notional | $	$ 650,000	$ 650,000

XML

Derivative Financial Instruments - Fair Value of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Derivatives, Fair Value [Line Items]
Derivative assets	$ 21,476	$ 14,442
Interest rate swaps | Other assets, net | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative assets	21,476		$ 14,442
Interest rate swaps | Accounts payable, accrued expenses and other liabilities | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative assets	$ 0		$ 3,073

XML

Derivative Financial Instruments - Effect of Interest Rate Swaps (Details) - Interest rate swaps - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)	$ 13,761	$ (3,141)
Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	$ 4,633	$ 2,837

XML

Derivative Financial Instruments - Schedule of Derivative Liabilities at Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Liabilities, Fair Value Disclosure [Abstract]
Derivative assets	$ 21,476	$ 14,442
Derivative liabilities	0	3,073
Fair Value, Recurring
Liabilities, Fair Value Disclosure [Abstract]
Derivative assets	21,476	14,442
Derivative liabilities		3,073
Fair Value, Recurring | Level 1
Liabilities, Fair Value Disclosure [Abstract]
Derivative assets	0	0
Derivative liabilities		0
Fair Value, Recurring | Level 2
Liabilities, Fair Value Disclosure [Abstract]
Derivative assets	21,476	14,442
Derivative liabilities		3,073
Fair Value, Recurring | Level 3
Liabilities, Fair Value Disclosure [Abstract]
Derivative assets	$ 0	0
Derivative liabilities		$ 0

XML

Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets - Schedule of Other Assets, net (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounts receivable, net	$ 10,813	$ 10,074
Deferred rent receivable	8,594	7,744
Prepaid assets	3,904	1,387
Earnest money deposits	492	450
Fair value of interest rate swaps	21,476	14,442
Deferred offering costs	1,554	1,031
Deferred financing costs, net	1,757	2,724
Right-of-use asset		3,866
Leasehold improvements and other corporate assets, net	1,651	1,723
Interest receivable	1,929	1,397
Other assets, net	5,460	4,499
Other assets, net	$ 61,402	$ 49,337
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets, net	Other assets, net

XML

Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets - Schedule of Accounts Payable, Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 8,176	$ 8,826
Accrued bonus	520	2,575
Prepaid rent	3,394	3,896
Operating lease liability	4,994	5,104
Accrued interest	2,958	2,921
Deferred rent	3,627	3,257
Accounts payable	622	4,691
Derivative liabilities	0	3,073
Other liabilities	1,974	2,155
Liabilities related to assets held for sale	$ 26,265	$ 36,498

XML

Shareholders’ Equity, Partners’ Capital and Preferred Equity - Narrative (Details)	1 Months Ended	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2024 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 28, 2024 $ / shares	Jan. 31, 2024 $ / shares	Dec. 31, 2023	Oct. 25, 2023 USD ($)	Sep. 01, 2021 USD ($)
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock in public offerings, net | $		$ 0	$ 52,903,000
Payments of offering costs | $		423,000	15,000
Payment of OP unit distributions | $		$ 98,000	$ 101,000
OP unit conversion ratio	1	1	1
Common stock
Subsidiary, Sale of Stock [Line Items]
Units converted (in shares) | shares		7,119	5,694
Shares withheld for restricted stock units vested (in shares) | shares		61,985	18,016
Netstreit, L.P. (The Operating Partnership)
Subsidiary, Sale of Stock [Line Items]
Non-controlling interest holders ownership		0.60%				0.70%
Restricted Stock Units (RSUs)
Subsidiary, Sale of Stock [Line Items]
Forfeited during period (in shares) | shares		62,000	18,000
Forfeited during period | $		$ 1,100,000	$ 400,000
Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of shares sold (in shares) | shares		11,040,000
ATM Program | Common stock
Subsidiary, Sale of Stock [Line Items]
Aggregate gross offering price | $								$ 250,000,000
Number of shares sold (in shares) | shares	146,745
Weighted average price (in dollars per share) | $ / shares	$ 20.22		$ 20.22
Issuance of common stock in public offerings, net | $	$ 2,900,000
Payments of offering costs | $	$ 100,000
August 2022 Follow-On Offering
Subsidiary, Sale of Stock [Line Items]
Shares sold (in dollars per share) | $ / shares					$ 18.00
Forward Sale Agreement | Common stock
Subsidiary, Sale of Stock [Line Items]
Number of shares sold (in shares) | shares		1,516,289
Weighted average price (in dollars per share) | $ / shares		$ 16.49		$ 18.29
Forward confirmation (in shares) | shares		5,983,711
Shares sold (in dollars per share) | $ / shares		$ 16.46
2023 ATM Program | Common stock
Subsidiary, Sale of Stock [Line Items]
Aggregate gross offering price | $		$ 300,000,000					$ 300,000,000
Forward confirmation (in shares) | shares		107,500
Shares sold (in dollars per share) | $ / shares		$ 18.12

XML

Shareholders’ Equity, Partners’ Capital and Preferred Equity - Schedule of ATM Program Activity (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 28, 2024	Oct. 25, 2023
Subsidiary, Sale of Stock [Line Items]
Payments of offering costs	$ 423,000	$ 15,000
Net proceeds	0	$ 52,903,000
Common stock | 2021 ATM Program
Subsidiary, Sale of Stock [Line Items]
Aggregate gross offering price	250,000,000
Gross proceeds	150,391,000
Common stock | 2023 ATM Program
Subsidiary, Sale of Stock [Line Items]
Aggregate gross offering price	300,000,000			$ 300,000,000
Gross proceeds	$ 77,323,000
Shares sold (in dollars per share)	$ 18.12
Forward confirmation (in shares)	107,500
Common stock | Forward Sale Agreement
Subsidiary, Sale of Stock [Line Items]
Number of shares sold (in shares)	1,516,289
Shares sold (in dollars per share)	$ 16.46
Weighted average price (in dollars per share)	$ 16.49		$ 18.29
Forward confirmation (in shares)	5,983,711

XML

Stockholders’ Equity, Partners’ Capital and Preferred Equity - Common Stock Dividends Declared and Paid (Details) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended
	Mar. 28, 2024	Feb. 13, 2024	Mar. 30, 2023	Feb. 21, 2023	Mar. 31, 2024	Mar. 31, 2023
Equity [Abstract]
Cash dividend paid (in dollars per share)	$ 0.205		$ 0.200
Cash dividend declared (in dollars per share)		$ 0.205		$ 0.200
Dividends, common stock, cash					$ 15,031	$ 11,650

XML

Stock Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended
	Mar. 31, 2021	Aug. 31, 2020	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 23, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for issuance						2,094,976
Catch-up adjustment		$ 1,400
Stock-based compensation expense			$ 1,751	$ 1,027
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			1,800	$ 1,000
Restricted Stock Units (RSUs) | The Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			100
Total unrecognized compensation cost			$ 1,700
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			1 year
Restricted Stock Units (RSUs) | Minimum | Alignment Of Interest Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			5 years
Restricted Stock Units (RSUs) | Maximum | Alignment Of Interest Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			$ 100
Total unrecognized compensation cost			$ 100		$ 100
Weighted average remaining contractual term			8 months 12 days
Granted during the period (in dollars per share)			$ 0
Service-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			$ 1,000
Total unrecognized compensation cost			$ 5,400		$ 3,400
Weighted average remaining contractual term			2 years 2 months 12 days
Granted during the period (in dollars per share)			$ 17.33
Service-Based Awards | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			1 year
Service-Based Awards | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			5 years
Market-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			$ 600
Award vesting period			3 years
Total unrecognized compensation cost			$ 4,000
Weighted average remaining contractual term			2 years 4 months 24 days
Granted during the period (in dollars per share)			$ 16.05
Market-Based Awards | Vesting period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			3 years
Award vesting rights (as a percent)			40.00%
Expected volatility (as a percent)			24.90%
Minimum expected volatility (as a percent)			19.90%
Maximum expected volatility (as a percent)			49.40%
Weighted average expected volatility (as a percent)			27.10%
Risk free interest rate (as a percent)			4.41%
Targeted TSR (in dollars per share)			$ 18.03
Absolute TSR (in dollars per share)			14.56
Granted during the period (in dollars per share)			$ 15.77
Market-Based Awards | Vesting period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights (as a percent)			60.00%

XML

Stock Based Compensation - Summary of Restricted Stock Unit Activity (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Performance Shares
Unvested Restricted Stock Grants Outstanding
Beginning balance (in shares) | shares	30,379
Granted during the period (in shares) | shares	0
Forfeited during the period (in shares) | shares	0
Vesting during the period (in shares) | shares	0
Ending balance (in shares) | shares	30,379
Weighted Average Grant Date Fair Value per Share
Beginning balance (in dollars per share) | $ / shares	$ 19.75
Granted during the period (in dollars per share) | $ / shares	0
Forfeited during the period (in dollars per share) | $ / shares	0
Vesting during the period (in dollars per share) | $ / shares	0
Ending balance (in dollars per share) | $ / shares	$ 19.75
Service-Based Awards
Unvested Restricted Stock Grants Outstanding
Beginning balance (in shares) | shares	298,108
Granted during the period (in shares) | shares	200,140
Forfeited during the period (in shares) | shares	0
Vesting during the period (in shares) | shares	(130,220)
Ending balance (in shares) | shares	368,028
Weighted Average Grant Date Fair Value per Share
Beginning balance (in dollars per share) | $ / shares	$ 19.79
Granted during the period (in dollars per share) | $ / shares	17.33
Forfeited during the period (in dollars per share) | $ / shares	0
Vesting during the period (in dollars per share) | $ / shares	19.85
Ending balance (in dollars per share) | $ / shares	$ 18.50
Market-Based Awards
Unvested Restricted Stock Grants Outstanding
Beginning balance (in shares) | shares	258,558
Granted during the period (in shares) | shares	169,002
Forfeited during the period (in shares) | shares	(69,959)
Vesting during the period (in shares) | shares	(45,977)
Ending balance (in shares) | shares	311,624
Weighted Average Grant Date Fair Value per Share
Beginning balance (in dollars per share) | $ / shares	$ 20.38
Granted during the period (in dollars per share) | $ / shares	16.05
Forfeited during the period (in dollars per share) | $ / shares	16.92
Vesting during the period (in dollars per share) | $ / shares	20.29
Ending balance (in dollars per share) | $ / shares	$ 18.82

XML

Earnings Per Share - Schedule of Net Income Attributable to Common Shares, Weighted Average Common Shares and Effect of Dilutive Securities (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net income	$ 1,052	$ 1,481
Net (income) attributable to noncontrolling interest	(7)	(9)
Net income attributable to common shares, basic	1,045	1,472
Net (income) attributable to noncontrolling interest	7	9
Net income attributable to common shares, diluted	$ 1,052	$ 1,481
Denominator:
Weighted average common shares outstanding, basic (in shares)	73,248,804	58,155,738
Effect of dilutive shares for diluted net income per common share:
OP Units (in shares)	478,524	511,402
Unvested RSUs (in shares)	168,556	175,859
Unsettled shares under open forward equity contracts (in shares)	669,906	40,387
Weighted average common shares outstanding - diluted (in shares)	74,565,790	58,883,386
Net income available to common stockholders per common share, basic (in dollars per share)	$ 0.01	$ 0.03
Net income available to common stockholders per common share, diluted (in dollars per share)	$ 0.01	$ 0.03

XML

Earnings Per Share - Narrative (Details) - shares	Mar. 31, 2024	Dec. 31, 2023
OP Units | Netstreit, L.P. (The Operating Partnership)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Units outstanding (in shares)	472,179	479,298

XML

Commitments and Contingencies (Details) $ in Millions		3 Months Ended
	Aug. 01, 2021 USD ($) renewalOption	Mar. 31, 2024 USD ($) property	Feb. 28, 2022
Other Commitments [Line Items]
Tenant improvement allowance commitments		$ 4.1
Tenant Improvement Allowance Commitment Period		2 years
Expected investment in real estate assets		$ 25.0
Commitments to extend funds		$ 12.4
Remaining terms of leases (in years)			8 years 3 months 18 days
2022 Acquisitions
Other Commitments [Line Items]
Number of property developments under construction | property		13
Corporate Office Space
Other Commitments [Line Items]
Renewal options | renewalOption	2
Lease extension term	5 years
Annual rent expense	$ 0.5

XML

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended	3 Months Ended
	Apr. 23, 2024	Feb. 13, 2024	Feb. 21, 2023	Apr. 26, 2026	Mar. 31, 2024	Mar. 31, 2023	Apr. 29, 2024	Mar. 28, 2024
Subsequent Event [Line Items]
Cash dividend declared (in dollars per share)		$ 0.205	$ 0.200
Proceeds under revolving credit facilities					$ 82,000	$ 99,000
Common stock | Forward Sale Agreement
Subsequent Event [Line Items]
Forward confirmation (in shares)					5,983,711
Weighted average price (in dollars per share)					$ 16.49			$ 18.29
Subsequent Event
Subsequent Event [Line Items]
Cash dividend declared (in dollars per share)	$ 0.205
Proceeds under revolving credit facilities				$ 12,000
Subsequent Event | Common stock | Forward Sale Agreement
Subsequent Event [Line Items]
Forward confirmation (in shares)							1,635,600
Weighted average price (in dollars per share)							$ 17.63